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ABSTRACT 
 Telomerase is a special reverse transcriptase that extends the linear chromosome 
termini in eukaryotes. Telomerase is also a unique ribonucleoprotein complex which is 
composed of the protein component called Telomerase Reverse Transcriptase (TERT) 
and a telomerase RNA component (TR). The enzyme from most vertebrate species is able 
to utilize a short template sequence within TR to synthesize a long stretch of telomeric 
DNA, an ability termed “repeat addition processivity”. By using human telomerase 
reconstituted both in vitro (Rabbit Reticulocyte Lysate) and in vivo (293FT cells), I have 
demonstrated that a conserved motif in the reverse transcriptase domain of the telomerase 
protein is crucial for telomerase repeat addition processivity and rate. Furthermore, I have 
designed a “template-free” telomerase to show that RNA/DNA duplex binding is a 
critical step for telomere repeat synthesis. In an attempt to expand the understanding of 
vertebrate telomerase, I have studied RNA-protein interactions of telomerase from teleost 
fish. The teleost fish telomerase RNA (TR) is by far the smallest vertebrate TR identified, 
providing a valuable model for structural research. 
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CHAPTER 1  
INTRODUCTION 
 The Nobel Prize in Physiology or Medicine of 2009 was awarded to Elizabeth H. 
Blackburn, Carol W. Greider and Jack W. Szostak for their discovery of how 
chromosomes are protected by telomeres and the enzyme telomerase. The importance of 
telomere and telomerase study is apparent as they have strong implications in cancer and 
aging. Telomeres are protective capping structures located at the ends of linear 
chromosomes. Replication of chromosomes results in telomere shortening due to the end 
replication problem (1). The loss of telomeres leads to senescence and programed cell 
death. Thus, telomere shortening acts as a molecular clock for cellular aging. Telomerase 
is a specialized reverse transcriptase that can extend telomeres and counter balance the 
chromosomal termini shortening. In most multi-cellular organisms, telomerase is inactive 
in somatic cells and active in stem cells and germ line cells. On the other hand, about 
90% of the human cancer have detectable telomerase activity, making it a promising 
target for anticancer therapies (2). The enzyme telomerase is a special ribonucleoprotein 
(RNP) containing two core components: Telomerase RNA (TR) and Telomerase Reverse 
Transcriptase (TERT). The unique RNA-protein association, repeat addition processivity 
(detailed in section 1.2) of telomerase reaction and its evolutional relation to all the other 
reverse transcriptases make this enzyme an invaluable model to study the biogenesis, 
evolution and functional interactions of RNP complexes. 
2 
1.1 History of telomere and telomerase research 
 The study of telomere and telomerase can be dated back to the 1930s, when 
Herman Muller and Barbara McClintock proposed that the natural termini of linear 
chromosomes have special sequence or structure which could be distinguished from 
DNA breaks (3, 4). After 40 years, the first telomeric sequence (repetitive T2G4) from the 
ciliate Tetrahymena thermophila was determined by Elizabeth Blackburn (5). 
Subsequently, repetitive G4T4 telomeric sequence was found in another ciliate, Oxytricha, 
(6) and another GT rich telomere was identified in Saccharomyces cerevisiae (7). These 
results indicated that the telomere is comprised of both double stranded region and 3’ 
overhang ends that are repetitive and rich in G and Ts. The vertebrate telomere sequence 
was also discovered to be TG-rich, with regular T2AG3 repeats. 
 Although there were multiple hypotheses of the mechanisms by which telomere 
sequences are maintained or extended at that time, Carol Greider and Liz Blackburn 
correctly predicted that telomere extension is carried out by a polymerase. The enzyme 
telomerase which extends telomeres was first identified in post-mating Tetrahymena cell-
free extract (8). They further demonstrated that the purified telomerase activity was 
ensitive to RNase digestion. And the enzyme uses a template sequence residing in the 
RNA moiety to carry out telomere extension (9, 10). Telomerase was thus proven to be a 
ribonucleoprotein complex enzyme, which consists of both essential RNA and protein 
components. 
 In the following decade, extensive efforts had been directed to determine the core 
components of the telomerase complex. The telomerase RNA was first identified in 
3 
Tetrahymena by Greider as mentioned previously (10). Like all other large RNA 
molecules in the RNPs, telomerase RNA ought to form a conserved secondary and 
tertiary structure correspondent to its function. In 1991, phylogenetic comparative 
analysis was rendered to determine the conserved secondary structure of ciliate TRs (11). 
Later, the first yeast and vertebrate TRs were cloned from S. cerevisiae and human in 
1994 and 1995 (12, 13). Discovery of these TRs revealed a surprising divergence in 
primary sequence from different groups of species. Therefore, more TRs from the same 
group of species were needed to deduce the conserved secondary structure. In 2000, 
vertebrate TR structure was finally determined using phylogentic comparative analysis, 
after the cloning of TR from 35 species (14). The yeast TR structure, due to its extremely 
large size (>1500 nt), was even more difficult to determine. The completetion of yeast TR 
secondary structure determination in 2004 revealed a pseudoknot structure near the 
template is a conserved core structure among all three groups of species: ciliates, 
vertebrates and the yeast (15). 
 The TERT gene from Euplotes, S. cerevisiae, S. pombe and human were 
simultaneously identified in the year 1997 (16,17). Interestingly, TERTs from various 
species are quite conserved when compared to each other. With only a couple of 
exceptions, they all include a TEN (Telomerase Essential N-terminus) domain important 
for DNA binding, a TRBD (Telomerase RNA Binding Domain) that tightly associates 
with the TR, a central RT Domain (Reverse Transcriptase Domain) which is responsible 
for the catalytic activity of telomerase and a less conserved C terminus extension domain 
(CTE) (18). 
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 Ever since its discovery, the enzyme telomerase has been closely implicated to 
cell immortality. In both S. cerevisiea and mouse systems, a telomerase knock-out strain 
is viable in the first few generations, but the gradual loss of telomere sequence eventually 
results in cellular death or animal infertality in the following generations (19, 20). 
Telomerase RNA is universally expressed in all human cells. However, it is discovered 
that the TERT gene is not expressed in human somatic cells, but present in the cells that 
requires proliferative abilities, such as stem cells (21). Interestingly, most tumor cells also 
require telomerase activity to maintain their telomere length and infinite growth (2, 22, 
23). Inhibition of telomerase activity in cancer cells thus will stop cell proliferation (24). 
Conversely, cell life span could be extended by introducing TERT gene expression (25). 
Therefore, telomerase provides a potential target for anti-cancer drugs design (26). On the 
other hand, dysfunctional, deficient or deregulated telomerase holoenzyme in stem cells 
will lead to multiple diseases, such as Dyskeratosis Congenita (DKC), Idiopathic 
Pulmonary Fibrosis (IPF), and Aplastic Anemia (AA). Mutations in TERT, TR gene and 
the telomerase associated Dyskerin gene (DKC) have been linked to these diseases (27). 
 Comprehensive mutagenesis studies aiming at deciphering the critical functional 
motifs/domains/groups in both TR and TERT were carried out after the domain 
organization of both components became more clear and after the discovery of disease 
related mutations (18,27). From these studies, mutations affecting overall telomerase 
activity, repeat addition processivity, repeat extension rate, RNP assembly, nucleotide 
incorporation fidelity and RNA/protein biogenesis were identified. 
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 In the last few years, unveiling the structure of telomerase enzyme become urgent 
as it would provide a final explanation of a lot of biochemical and functional data 
obtained previously. Solving the structure of the critical pseudoknot domain and three-
way junction (CR4-CR5) domain of human TR received the highest priority in the RNA 
component. The NMR structure of these two fragments offered structural basis for 
interpreting possible roles of hTR contribution to telomerase activity (28, 29, 30). The 
structure of Tetrahymena TR stem IV suggested it might be analogous to hTR CR4-CR5 
domain (31). Additionally, the structure of the template boundary of Tetrahymena TR 
was also determined (32). 
 The crystal structure of full length TERT protein was difficult to solve due to the 
obstacle of large-scale protein expression and protein solubility. Therefore, the first 
TERT protein crystal structure was a fragment obtained from the Tetrahymena TEN 
domain (33). Soon after, the TRBD from Tetrahymena was also successfully crystalized 
(34). Both structures revealed possible DNA and/or RNA binding surfaces on the 
molecule. The full length TERT crystal was finally determined from the flour beetle 
Tribolium castaneum. Although lacking the TEN domain, Tribolium TERT provided the 
first insight into the spatial domain organization of the whole TERT protein (35). 
 In summary, the discovery of telomerase has revealed a route to understanding 
diverse biological questions, e.g. the molecular bases of cancer, stem cell biology, as well 
as many human diseases. The intensive ongoing research aiming at deciphering the 
molecular mechanism of how telomerase extends telomere substrates will further uncover 
the fundamental basis of many telomerase-deficiency related diseases. 
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1.2 Telomerase specific repeat addition processivity 
 One unique property of telomerase is the “repeat addition processivity” or “type II 
processivity” (hereafter referred to as “processivity”), which occurs when the short 
template in TR is used to repetitively synthesize a long stretch of telomeric DNA without 
complete dissociation between telomerase and the DNA substrate. (36) The processive 
addition of telomere repeats by telomerase relies on a translocation event, in which the 
template RNA dissociates from the telomeric DNA strand and then realigns with it to 
provide a template for subsequent repeat synthesis. This translocation process can be 
divided into three basic steps: (I) the dissociation between the RNA template and the 
telomeric DNA, (II) the movement of RNA template in relation to the telomeric DNA, 
and (III) the base-pairing between the alignment region of the RNA template and the 
telomere DNA 3’ terminus (Figure 1.1). During this translocation process, the TERT 
protein presumably undergoes step-wise or concerted conformational changes that might 
involve multiple TERT domains to accommodate the events of RNA/DNA duplex 
melting and reformation.  
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Fig. 1.1 A working model for repeat addition processivity. Schematic of the basic steps 
for the translocation of the RNA template. Positioned within the active site (red 
arrowhead), the 3’ end of the telomeric DNA primer (blue) base-pairs with the alignment 
region of telomerase RNA (violet) leaving the template region (orange) available for the 
synthesis of the first telomere repeat (step 1). As new nucleotides (red) are incorporated, 
both strands of the duplex move relatively away from the active site, but maintain a 
similar number of base-pairings. Once the end of the template is reached, the 
translocation process begins with the dissociation of the RNA template from the 
telomeric DNA (step 2).  The dissociated RNA will then re-align with the telomeric 
DNA (step 3) and provide template for the synthesis of the second repeat (step 4). 
Alternatively, the telomeric DNA product can dissociate entirely from the enzyme (step 
5). As shown in the inset, the repeat addition processivity of telomerase is proportional to 
the ratio of template realignment events over the product release events. Higher 
probability of template realignment event will lead to higher processivity of repeat 
addition.  
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 Telomerase processivity varies to a great extent among different species. The 
telomerase from most ciliates and vertebrates are processive. The apparent low 
processive property of mouse and Chinese hamster telomerase is due to the lack of an 
alignment region in the TR template (37, 38). In contrast, most yeast telomerase can only 
add no more than two telomeric repeats onto the primer in vitro before dissociation (39, 
40), with the exception of S. castellii (41). 
 Processivity can be affected by the reaction conditions such as temperature, ionic 
strength, primer concentration, dNTP substrate and certain nucleotide homologs. (42, 43, 
44, 45, 46, 47). Moreover, accessory proteins in the telomerase holoenzyme, such as 
Euplotes p43 and human TPP1-POT1 complex, can also affect processivity (48, 49). 
 In spite of numerous processivity-related factors, the two essential core 
components alone can reconstitute the active and processive telomerase in Rabbit 
Reticulocyte lysate, indicating processivity as an intrinsic property. In most telomerase 
RNAs, the template sequence is usually one and a half repeats long and complementary 
to the telomeric DNA (38). The 3’ region of TR template is referred to as the alignment 
region and contributes to the processivity by providing extra complementary sequence for 
the DNA to align during translocation (38, 50). Other regions of the RNA, such as the 
pseudoknot structure and stem IV in tetrahymena TR, also contribute to processivity (18).    
 As a specialized ribonucleoprotein complex, the TERT has probably co-evolved 
with the TR component for the optimal processivity for each species. Comparing to other 
RTs, the unique domain(s) in TERT might harbor the critical element for processivity. 
Because the translocation requires complete dissociation between the RNA template and 
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the DNA product, it has been proposed that a portion(s) of TERT serves as an “anchor 
site” to keep telomeric DNA bound to the telomerase, thus facilitating the translocation. 
(18) Direct interaction between the telomere primer and TERT has been shown by 
crosslinking experiments in E. aediculatus, Tetrahymena and S. cerevisiea TERTs in the 
presence of TR. In tetrahymena and yeast TERTs, the crosslinking site was mapped in the 
TEN domain (33, 51, 52, 53). The crystal structure of the TEN domain from tetrahymena 
TERT revealed a positively charged patch on the surface. Mutating certain amino acids 
on this patch severely reduces primer binding ability and telomerase activity, 
interestingly, without apparent decrease of processivity (33, 52). However, functional 
assays performed with yeast TERT bearing mutations of the homologous TEN residues 
indeed reduce the second repeat products (54). Furthermore, several human TERT TEN 
domain deletions and single amino acid mutants decrease the processivity. Amino acids 
on these mutation sites are proposed to form a “proximal anchor site” for the primers (55, 
56, 57). A recent study of Tetrahymena TERT suggests that the Leu14 in the TEN 
domain acts as a switch to control processivity without affecting telomerase activity and 
telomere binding. Thus, the TEN domain might have two independent processivity 
related functions (58). On the other hand, the TEN domain is not the only portion of 
TERT interacting with the telomere substrate. Primer binding assays with different 
fragments of TERT have shown that the RT domain and the C-terminal extension also 
contribute to DNA binding, probably in a cooperative manner (57, 59). Consistent with 
interaction data, mutations in the RT domain and C-terminal extension affect processivity 
as well. Human TERT C-terminus deletion mutants decrease processivity (60). Point 
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mutations in Tetrahymena TERT Motif C promotes processivity by increasing affinity 
between TERT and DNA (61). Lastly, the long insertion in between motif A and B in the 
S. cerevisiea TERT RT domain promotes processivity by stabilizing the short RNA-DNA 
duplex formed in the template region (62). 
1.3 Projects 
 Although the mechanism of telomerase reaction has been vigorously studied, the 
detailed procedure during template translocation and the functional motifs in TR/TERT 
are unclear. I have chosen the vertebrate telomerases, especially human telomerase, to 
study telomerase processivity. As aforementioned, vertebrate telomerases synthesize 
regular TTAGGG repeats, and the human telomerase reconstituted in vitro is very 
processive, and is able to synthesize more than 100 repeats, providing an excellent model 
to study processivity. Another advantage is that understanding of human telomerase 
function might provide direct information to reveal the molecular basis of several 
disease-related mutations. Besides, telomerase RNAs and TERT proteins in the vertebrate 
lineage are diverse enough to provide information to help understand RNP evolution. The 
telomerase from teleost fish were missing from the original study of telomerase RNA 
identification. One of my tasks, therefore, was to fill this gap in the vertebrate telomerase 
evolution map. The research projects described in each chapter are outlined below. 
 In Chapter 2, focus was on specific motif(s) evolved in TERT that is responsible 
for processivity. As a unique function specifically evolved in telomerase, a specialized 
structural domain in TERT or TR should be responsible for processivity. Indeed, we have 
identified a motif, termed motif 3, in the catalytic domain of TERT protein that is 
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specifically evolved in telomerases with high processivity. Mutations in this motif reduce 
telomerase processivity presumably by affecting RNA/DNA duplex binding during 
translocation. Repeat addition rate was also altered by some of the motif 3 mutants. This 
was not surprising because repeat addition rate is also an outcome affected by template 
translocation. 
 In Chapters 3 and 4, as a continuation of motif 3 study, I designed a template free 
telomerase system to directly test RNA/DNA duplex binding by the telomerase catalytic 
site. The data suggested that telomerase still retains the ability to recognize duplex 
substrate like conventional RTs. The studies in Chapter 3 provide a comprehensive 
understanding of how a variety of different substrates are preferred by the telomerase 
active site, and what is the difference of duplex extension activity between telomerase 
and conventional RTs. In Chapter 4, the template free telomerase was applied to test 
duplex binding abiliy of different processivity mutants. It was evident that less-processive 
mutants have lower affinity towards the telomeric duplexes, suggesting duplex binding is 
one of the steps during template translocation. More surprisingly, telomerase active site 
shows sequence specificity toward different circular permuted duplexes. This suggested a 
possible novel mechanism used by telomerase to determine a complete telomeric 
sequence and initiate translocation at the end of a complete repeat. 
 In Chapter 5, vertebrate telomerase research is extended to a previously missing 
area, the teleost fish. The divergent nature of telomerase RNA sequence hampered the 
identification of TR genes in the fast evolving teleost fish. Using a novel bioinformatics 
method supplied by our collaborator, Dr. Peter Stadler in University of Leipzig, five 
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teleost fish TRs were identified from completed fish genome databases. In vitro 
reconstituted telomerase were assayed for activity. The data proved that teleost fish 
telomerases are also processive and the key determinants for processivity in TR are 
similar to human TR. 
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2.1 Abstract 
Telomerase is a specialized reverse transcriptase that adds telomeric DNA repeats 
onto chromosome termini. Here, we characterize a new telomerase-specific motif, called 
motif 3, in the catalytic domain of telomerase reverse transcriptase, that is crucial for 
telomerase function and evolutionally conserved between vertebrates and ciliates. 
Comprehensive mutagenesis of motif 3 identified mutations that remarkably increase the 
rate or alter the processivity of telomere repeat addition. More importantly, the rate and 
processivity of repeat addition are affected independently by separate motif 3 mutations. 
The processive telomerase action relies upon a template translocation mechanism 
whereby the RNA template and the telomeric DNA strand separate and realign between 
each repeat synthesis. By analyzing the mutant telomerases reconstituted in vitro and in 
cells, we show that the hyperactive mutants exhibit higher repeat addition rates and faster 
enzyme turnovers, suggesting higher rates of strand-separation during template 
translocation. In addition, the strong correlation between the processivity of the motif 3 
mutants and their ability to use an 8 nt DNA primer, suggests that motif 3 facilitates 
realignment between the telomeric DNA and the template RNA following strand-
separation. These findings support motif 3 as a key determinant for telomerase activity 
and processivity.  
2.2 Introduction 
Telomerase is a specialized reverse transcriptase (RT) responsible for adding 
telomeric DNA repeats onto the 3’ ends of chromosomes. Telomere elongation counter-
balances the natural shortening of linear chromosomes due to the end-replication 
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problem, preventing senescence, apoptosis and genome instability (1). The deficiency in 
telomerase function leads to limited renewal capacity in highly proliferative cells, and is 
associated with human diseases including dyskeratosis congenita, aplastic anemia and 
idiopathic pulmonary fibrosis (2,3). 
Reconstitution of catalytically active telomerase in vitro requires two core 
components: the telomerase RNA (TR) and the telomerase reverse transcriptase (TERT) 
protein. The TR contains a short template region for the synthesis of telomeric DNA 
repeats, and conserved structural domains essential to in vivo biogenesis and assembly 
with the TERT protein. The TERT subunit is a multi-domain protein comprised of an N-
terminal extension (NTE), a central catalytic RT domain and a C-terminal extension 
(CTE) (4). In most eukaryotes, the NTE consists of a telomerase-essential N-terminal 
(TEN) domain (5) that binds telomeric DNA and a TR binding domain. However, the 
TEN domain is dispensable in certain species, such as insects (6). The catalytic RT 
domain encompasses seven essential motifs (1, 2, A, B, C, D and E) that are universally 
conserved among RTs (7).  
Telomerase has the unique ability to add multiple telomeric repeats to a given primer 
before complete dissociation from the DNA, called “repeat addition processivity” 
(abbreviated to “processivity”). Unlike conventional RTs which can utilize a variety of 
single-stranded RNA templates, telomerase uses only a short sequence from its intrinsic 
RNA component as template. During telomere DNA synthesis, the 3’ end of telomeric 
DNA base pairs with the RNA template forming an RNA/DNA duplex which is 
positioned within the catalytic site of TERT protein for nucleotide addition. When 
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telomerase completes the synthesis of one telomeric DNA repeat, a “template 
translocation” must occur whereby the RNA template dissociates from the DNA strand, 
translocates and realigns relative to the 3’ end of the DNA, providing an unoccupied 
template for the next round of repeat synthesis. This translocation process is the rate-
limiting step in a processive telomerase reaction, as indicated by the strong pause after 
each round of repeat synthesis, giving rise to the characteristic ladder banding pattern of 
telomere products (8,9). While the repeat addition rate is determined by the rate-limiting 
translocation step, the processivity of the reaction is determined by the probability, or 
efficiency, of RNA/DNA realignment over complete product release during translocation. 
The extent of telomerase processivity varies dramatically among species. Telomerase 
from ciliates and most vertebrates are highly processive (8-10). In contrast, telomerase 
from certain rodents and yeasts have little to no processivity (11-14). Reaction conditions 
and accessory proteins appear to contribute to the disparity in processivity observed in 
vitro (15-17). However, the intrinsic properties of TERT and TR components are by and 
large the major determinants for the varying degrees of processivity observed among 
species.  
Mutations in both TERT and TR components have been found to affect the rate and 
processivity of the telomerase reaction. Several elements within TERT were shown to be 
crucial for telomerase processivity. The TEN domain contains an “anchor site” that binds 
single-stranded telomeric DNA, preventing complete product release from the enzyme 
during template translocation (4,18). A recent study has shown that a mutation at Leu14 
in the Tetrahymena TEN domain abolished processivity while leaving activity or DNA 
21 
binding affinity intact. The Leu14 residue was proposed to function as an intra-molecular 
switch for processivity (19). In S. cerevisiae, a motif called IFD (insertion in finger 
domain), located in the RT domain between motifs A and B, contains four conserved 
residues shown to be important for second repeat synthesis (20). Also within the RT 
domain, a point mutation in motif C of Tetrahymena TERT increases processivity by 
increasing protein-DNA primer affinity (21). Beyond the RT domain, a mutation in the 
CTE, a putative homologue to the HIV RT thumb, was shown to reduce repeat addition 
processivity (22). Within the TR, the template length and conserved structural elements 
also contribute to telomerase processivity, through affecting telomeric DNA/template 
RNA base-pairing interactions during template translocation (23,24) or the RNA/TERT 
protein interactions (25,26). A previous study by Drosopoulos et al. showed that varying 
the template sequence can alter the rate of telomere repeat addition, possibly through 
modulating interactions between the template RNA, DNA product and TERT protein 
(27). Although the TERT protein was shown to contribute to the processivity of 
telomerase activity, its involvement in the regulation of telomere repeat addition rate is 
unclear.  
In this study, we carried out a comprehensive alanine-substitution screening in a 
novel motif of the TERT protein and discovered mutations that surprisingly increased the 
rate or altered the processivity of telomere repeat addition. Characterization of the in vitro 
reconstituted telomerase enzymes containing these unusual hyperactive mutations 
indicates a higher rate of enzyme turnover or product dissociation. In addition, mutations 
that alter processivity alter the ability of the enzymes to use the short 8 nt primer as 
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substrate, the use of which resembles the realignment of the 3’-end of DNA with the 
template RNA - the second step of the template translocation. We conclude that this 
novel TERT motif is an important determinant for telomerase activity and processivity, 
regulating both strand-separation and realignment of telomeric DNA and template RNA 
during template translocation. 
2.3 Materials and Methods 
2.3.1 Sequence alignment analysis 
The sequence alignment of the RT domain for TERT and other RTs was 
performed within the program BioEdit using the ClustalW algorithm, and further refined 
manually using the highly conserved RT motifs as anchor points. The alignment was 
carried out initially for individual groups of closely related species, then expanded to 
include sequences from more divergent species. The complete sequence alignment is 
available at the telomerase database (http://telomerase.asu.edu) (28). 
2.3.2 Plasmid construction and mutagenesis 
Specific mutations in the human TERT (hTERT) genes were introduced into 
pNFLAG-hTERT (a generous gift from Dr. Vinayaka Prasad) by site-directed 
mutagenesis using an overlapping PCR strategy (29). For in vivo expression of TERT, 
gene fragments that contain specific mutations were sub-cloned from pNFLAG-hTERT 
into a modified pcDNA-hTERT vector (generous gifts from Dr. Joachim Lingner) via 
two SacII sites within the TERT gene. Intended mutations were confirmed by 
sequencing. 
2.3.3 Reconstitution of telomerase in vitro and in cells 
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 Human telomerase was reconstituted in vitro using the TNT Quick Coupled rabbit 
reticulocyte lysate system (Promega) as described previously with minor modifications 
(30). To assemble telomerase, 1 µM of human TR (hTR) pseudoknot (nt 32-195) and 
CR4-CR5 (nt 239-328) RNA fragments were added to the hTERT synthesis reactions, 
and incubated at 30ºC for 30 min. 
 To purify sufficient amount of mutant telomerase from cells for telomerase direct 
assay, we used the telomerase reconstitution system developed by Lingner’s group with 
minor modifications (31,32). Recombinant telomerase enzyme was reconstituted by over-
expressing the hTERT and hTR genes in 293FT cells (Invitrogen) using pcDNA-hTERT 
and pBS-U1-hTR (generous gifts from Dr. Joachim Lingner) as described previously. 
Cells were grown in DMEM media supplemented with 10% FBS at 37ºC with 5% CO2. 
After reaching 80-90% confluency, cells were transfected with 1 µg of plasmid DNA 
(200 ng of pcDNA-hTERT and 800 ng of pBS-U1-hTR diluted in 50 µl of FBS-free 
DMEM media) and 4 µl of Fugene HD transfection reagent (Roche) in 12-well plates, 
following the manufacturer’s instruction. Two days post transfection, cells were 
harvested and lysed (31). 
2.3.4 Telomerase activity assay 
 Telomerase reconstituted in vitro or in cells was assayed using the conventional 
direct primer-extension assay as previously described (30), with the exception of that 
0.165 µM of [α-32P]dGTP (3000 Ci/mmole, Perkin Elmer) was used in a 10 µl reaction. 
Telomerase processivity was determined by measuring the intensity of each major band, 
normalized by the numbers of 32P-dGTP incorporated and plotted versus the repeat 
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numbers as previously described (15). Processivity was calculated using the equation: 
Processivity=-ln2/(2.303k), where k is the slope. The processivity of mutant telomerase 
was presented relative to the wild-type enzyme. 
 The pulse-chase time course experiments were carried out using in vitro 
reconstituted telomerase and the conventional direct assay as described above. The pulse-
chase assay tracks the progressive extension of telomere products that were labeled (or 
pulsed) during the pulse reaction and extended by the processive telomerase enzymes 
during the chase reaction. During the pulse reaction, the enzymes add telomere repeats to 
the DNA primer with the incorporation of radioactive [α-32P]dGTP. In brief, telomerase 
was incubated with 4 µM (TTAGGG)3 primer in the presence of 1X PE buffer (50 mM 
Tris-HCl, pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2 and 1 mM spermidine) at 30ºC 
for 5 min to allow sufficient primer-enzyme complex formation prior to the pulse 
reaction. The pulse reaction was initiated by the addition of 1 mM dATP, 1 mM dTTP, 2 
µM dGTP and 0.33 µM α-32P-dGTP (3000 Ci/mmole, Perkin Elmer) and incubated at 
30ºC for 5 min. The chase reaction was then carried out by adding non-radioactive dGTP 
to 100 µM in the reaction and incubated at 30ºC for various amount of time as indicated. 
Upon addition of 50-fold excess non-radioactive dGTP, the initially labeled telomere 
products continue to be extended in the chase reaction by the same enzyme. During the 
chase reaction, the primers extended by the enzymes dissociated from the initially pulsed 
telomere products will not be seen. The chase reaction was terminated by ethanol 
precipitation and analyzed by gel-electrophoresis. For each chase reaction, 10 bands with 
highest intensity above initial pulse product bands were used to deduce a “modal band” 
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and calculate the extension rate as previously described (27). Because of the short 
extension time, the processivity cannot be accurately measured during the pulse reaction 
and the chase reactions at the early time points. Instead, telomerase processivity in the 
pulse-chase assay was determined from the first ten major bands (1-10 repeats added) in 
the chase reaction at the last time point (10 min).  
 For the short-primer telomerase assay, different telomere primers tel8, tel10, tel12, 
tel15, tel18 were used as indicated. For Km measurements, the primers were supplied at 
varying concentrations and the reaction mixture was incubated for 5-60 min, which falls 
in the linear range of product formation. A 32P end-labeled oligonucleotide (50 nt) was 
used as the recovery and loading control. The product intensity of each reaction was 
quantitated, normalized with loading control and expressed as a relative activity 
compared to the reaction with highest primer concentration. The relative activities were 
plotted against primer concentration and the Michaelis-Menten equation, 
Y=Vmax*X/(Km+X), was used to fit the nonlinear curve to determine the Km (Prism 5, 
Graphpad Software). 
 To measure enzyme turnover rate, the in vitro reconstituted telomerase was pre-
incubated with 10 µM tel7 primer (5’-AGGGTTA-3’) in the presence of 1X PE buffer at 
30°C for 10 min. Telomerase reaction was initiated by addition of 2 µM dGTP and 0.33 
µM [α-32P]dGTP (3000 Ci/mmole, Perkin Elmer), and aliquots were removed from the 
reaction mixture at different time points. The intensity of product was first adjusted by 
the TERT protein level, and normalized by the intensity of loading controls. The intensity 
of each band was normalized by that of the wild-type reaction at the last time point (10 
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min). The relative product intensities were then plotted against the amount of time. The 
slope of linear trend line represents the enzyme turnover rate. The enzyme turnover rates 
of mutant telomerases were indicated as relative values to the wild-type enzyme. 
 Tetrahymena telomerase was reconstituted in vitro using pCITE-5XT7-tTERT as 
human telomerase reaction. Telomerase activity assay: a 10 µL reaction was carried out 
with 2.5 µL of in vitro reconstituted telomerase in the presence of 1X tPE buffer (50mM 
Tris-HCl, pH 8.3, 5mM KCl, 1.25 mM MgCl2 and 5 mM DTT), 200 µM dTTP, 9 µM 
dGTP, 1 µM (TTGGGG)3 telomere primer and 0.165 µM (α-32P dGTP (3000 Ci/mmole, 
10m Ci/ml, Perkin Elmer) at 30°C for 1 h. The subsequent steps were the same as human 
telomerase activity assay, except processivity was quantitated by the ration of the 
intensity of the second repeat to the first of the primer extension products. 
2.3.5 Western blot analysis 
 Ten micrograms of total protein of 293FT cell lysate was heated at 95°C for 5 min 
in 1X Laemmli buffer (0.125M Tris-HCl, pH6.8, 2% SDS, 10% glycerol, 5% 2-
mercaptoethanol and 0.0025% bromophenol blue), fractionated on a 6% or 8% SDS-
PAGE gel, and electro-transferred onto the PVDF membrane. Blocking (overnight at 
4ºC) and incubation with antibodies (1 hour at room temperature) were carried out in 5% 
nonfat milk/1X TTBS (20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.05% Tween 20). 
Anti-hTERT goat polyclonal antibody L-20 (Santa Cruz Biotechnology) and anti-
GAPDH mouse monoclonal antibody 6C5 (Ambion) were used as the primary antibodies. 
After incubation with the HRP-conjugated secondary antibody (Santa Cruz 
Biotechnology), the blots were developed using the Immobilon Western 
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Chemiluminescent HRP substrate (Millipore), and the blot images were acquired and 
analyzed using a Gel Logic440 system (Kodak). 
2.3.6 Northern blot analysis 
Total RNA was extracted from transfected cells using Tri-reagent (Molecular 
Research Center, Inc.) following manufacturer’s instruction. Three micrograms of total 
RNA was resolved on a 4% polyacrylamide/8M urea denaturing gel and electro-
transferred to the Hybond-XL membrane (GE Healthcare). Preparation of the riboprobes 
and hybridization of the blot were carried out as described previously (10). 
2.3.7 Homology modeling 
  The RNA-DNA duplex was modeled into the Tribolium TERT structure (3DU6) 
by superimposition with the HIV1 p66 structure (1HYS) containing an RNA/DNA 
duplex. The two pdb files were superimposed in the CCP4 program using the following 
seven conserved resides within the RT domain as anchor points: three Asp residues in 
motifs A and C; Arg in motif 2; Glu and Gly in motif B; and Gly in motif E. These seven 
residues are highly conserved between TERTs and retroviral RTs. 
2.3.8 Direct DNA/RNA Binding Assay with TERT RT Fragments 
Oligonucleotides were synthesized and gel-purified by IDT (Integrated DNA 
technologies). All oligonucleotides were prepared to a final concentration of 50 µM in 
1X annealing buffer (100 mM Tris-HCl, pH 7.5, 500 mM NaCl, 50 mM EDTA). For 
preparing the RNA/DNA duplex, DNA oligo (GTTAGG)2 was added in 10% excess of 
molar concentration to the biotin-labeled RNA oligo. The mixtures were heated at 80°C 
for 3 min and cooled down slowly to room temperature. The TERT-oligo binding assay 
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was carried out by mixing 5 µL of TNT expressed hTERT 601-939, 1 µL of MBP-
hTERT 601-927 (internal control), 50 µM oligo-dT18 in a 10 µL reaction in 1X PE 
buffer (50 mM Tris-HCl, pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2 and 1 mM 
spermidine) and the biotin-labeled oligonucleotides at the final concentration of 10 µM 
and incubated at 30°C for 1 h. Before use, 50 µL Dynabeads M-280 Streptavidin 
(Invitrogen) was washed twice with 250 µL Hypobuffer (90.7 mM HEPES, pH7.3, 7 mM 
KCl, 2.3 mM MgCl2, 0.05 mM BME), surface blocked with 50 µL blocking buffer 
(hypobuffer with 0.75 mg/mL BSA, 0.15 mg/mL glycogen, 0.015 mg/mL yeast total 
RNA, 0.5% NP40 and 1 µM oligo-dT18) for 30 min at 4ºC with agitation and 
resuspended in 100 µL blocking buffer. A hundred µL pre-treated beads were then added 
with 10 µL TERT/biotin-oligo binding reaction and mixed at 4 ºC for 15 min. The beads 
were washed three times with 300 µL wash buffer (hypobuffer with 0.5% TritonX 100) 
and resuspended in 25 µL 2X SDS loading buffer (125 mM Tris-HCl pH6.8, 10% β-
mercapto-ethanol, 4% SDS, 0.01% Bromophenol blue, 20% glycerol), boiled for 5 min, 
and 20 µL of the supernatant was loaded onto a 12% SDS-PAGE gel. After 
electrophoresis, the gel was dried, exposed to a film and analyzed using a Bio-Rad FX 
Pro Imager. 
2.4 Results 
2.4.1 Sequence conservation of motif 3 
  The novel motif 3, located in the catalytic RT domain of TERT between motifs 2 
and A (Fig. 2.1a), was previously found conserved in vertebrate and invertebrate 
chordates (33). To determine the extent of conservation of this motif in species beyond 
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chordates, we extended the sequence alignment analysis to include additional groups of 
eukaryotes (detailed in Materials and Methods). Remarkably, the sequence of motif 3 is 
conserved also in non-yeast fungi, plants and ciliates (Fig. 2.1b). The conservation of 
motif 3 sequences over a large evolutionary distance, from vertebrates to ciliates, implies 
necessity for telomerase function. Secondary structure prediction of the motif 3 
sequences from a large number of species suggested a putative helix-coil-helix fold (Fig. 
S2.1a). Interestingly, the recent crystal structure of TERT from an insect, Tribolium 
castaneum, contains a helix-coil-helix structure between motif 2 and A, supporting the 
secondary structure prediction (34). Despite the apparent similarity in predicted 
secondary structure, TERTs from insects, nematodes and yeasts did not show the same 
degree of sequence conservation, particularly in the central region of motif 3 (Fig. S2.2). 
Previously in the RTs closely related to the TERT, including the Penelope-like 
retrotransposons, non-LTR retrotransposons and group II introns, a conserved motif 
between motif 2 and motif A was identified as motif 2a (35-37), which however shares 
no common sequence to the TERT motif 3 (Fig. S2.2). Since motif 3 appears conserved 
specifically in vertebrates and ciliates whose telomerase is highly processive, but not in 
yeasts whose telomerase is not processive, we speculated that motif 3 might be important 
for telomerase processivity.  
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Fig. 2.1. Multiple sequence alignment of TERT motif 3. (A) Schematic of domain and 
motif organization of human TERT protein. Motif 3 (red) and the conserve RT motifs 1, 
2 and A-E (cyan and blue) are colored. (B). Sequence alignment of TERT motif 3 from 
vertebrates, invertebrates, fungi, plants and ciliates. Shading indicates a minimum of 55% 
identity (dark cyan, red and blue) and 55% similarity (light cyan, red and blue) 
conservation. The degree of identity conservation with the human sequence at each 
residue is shown below the sequence alignment. No conservation determined where more 
than two sequences had gaps present. Darker shading indicates greater identity 
conservation with the human sequence (<30% light, 30-60% medium and >60% dark). 
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2.4.2 Mutations in motif 3 affect telomerase activity and processivity independently 
 To experimentally determine the function of motif 3, we conducted 
comprehensive alanine substitution mutagenesis on human TERT and analyzed the 
telomerase mutants reconstituted in rabbit reticulocyte lysate (RRL) for activity and 
processivity (see Materials and Methods). Certain residues in motif 3 appear to be critical 
for telomerase catalysis, as the alanine substitutions W690A and F693A nearly abolished 
telomerase activity (Fig. 2.2a, lanes 38 and 42). This is not unexpected for the F693 
residue as it is one of the three most conserved residues in motif 3 (Fig. 2.1b). The W690 
residue, although not as highly conserved as F693, is naturally substituted with 
hydrophobic leucine or valine in most species (Fig. 2.1b).  
One intriguing finding from analyzing these motif 3 mutants was that telomerase 
activity and processivity can be independently altered (Fig. 2.2). Three mutations 
(V658A, K659A and R669A) in the N-terminal region of motif 3 increased telomerase 
activity up to 1.7 fold, but had different effects on processivity (Fig. 2.2b). For example, 
mutant V658A is hyperactive and hyper-processive, compared to wild-type enzyme (Fig. 
2.2a, lane 4). In contrast, hyperactive mutants K659A and R669A had reduced 
processivity (Fig. 2.2a, lanes 5 and 15). Unlike V658A, mutants E668A, D684A and 
V697A showed greater processivity, but lower activity (Fig. 2.2b). Mutations L661A, 
N666A, R669A, L681A, G682A and I686A, while all reduced processivity, altered 
activity differently (Fig. 2.2b). In summary, the analysis of motif 3 mutants showed no 
correlation between changes in activity and changes in processivity, suggesting that 
telomerase activity and processivity are independent and possibly regulated through 
32 
separate mechanisms. 
 
a. Activity assays of the motif 3 mutants 
Fig. 2.2. Alanine substitution screening of motif 3. (a) Activity assays of the motif 3 
mutants. Human telomerases with alanine substitutions in motif 3 were reconstituted in 
vitro and assayed for activity. Numbers on the left (+4, +10, +16 etc.) of the gel indicate 
the number of nucleotides added to the primer in each major band. l.c.: loading control, a 
32P end-labeled 15 nt DNA oligonucleotide, shown with the contrast adjusted. Below the 
gel, the [35S] methionine labeled TERTs analyzed by SDS-PAGE for quantitation are 
shown. 
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b. Quantitation of activity and processivity of motif 3 mutants. 
 
Fig. 2.2. continued (b) Quantitation of activity and processivity of motif 3 mutants. The 
residues in the human motif 3 sequence are shaded according to their identity and 
similarity as shown in Fig. 1B. Below the sequence, the bar graph shows the activity and 
processivity of each mutant relative to wild-type. The dash line across the graph indicates 
the wild-type level of activity and processivity. The shaded bars indicate a relative 
activity lower than 50% or a processivity lower than 75% of the wild-type level. Alanine 
residues in the wild-type motif 3 sequence were omitted from the analysis and labeled as 
n/a (not available). Error bars indicate the standard deviation derived from 2-4 
independent experiments. *: For the mutants with an extremely low activity, a special 
assay (3-fold more enzyme and reagents, and longer exposure time of the gel) was 
performed to determine processivity. 
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 To determine if the telomerase mutants assembled in vitro and in cells behave 
similarly, we assayed two hypo-processive mutants (G682A and I686A) and three hyper-
processive mutants (E668A, D684A and V697A). The mutant telomerases were 
reconstituted by over-expressing the full-length hTR and mutant hTERT genes in the 
293FT cells to generate a high telomerase activity sufficient for direct telomerase assay, a 
system developed by Cristofari and Lingner (31,32). The endogenous telomerase activity 
from 293FT cells transfected with the empty vector was undetectable by the direct 
primer-extension assay (Fig. 2.3, lane 1). The telomerase mutants reconstituted in RRL 
and in human cells exhibited similar levels of activity and processivity (Fig. 2.3, lanes 7, 
8, 16, 17 and 18), confirming the results from the in vitro reconstituted enzymes. 
Additionally, we rescued two nearly inactive alanine-substituted mutants, L665A and 
F693A, with substitutions of conservative amino acids L665I and F693Y (Fig. 2.3, 
compare lanes 10 to 11, and lanes 12 to 13), suggesting the bulky hydrophobic side-
chains of these two residues are required for telomerase function. 
We also tested two disease-associating motif 3 mutations, G682D and V694M, 
previously identified in aplastic anemia patients (38,39). While both mutations 
significantly reduced telomerase activity (Fig. 2.3, lanes 9 and 20), the G682D mutation 
caused also a significant reduction in processivity (Fig. 2.3, lane 20). The reduced 
telomerase activity and processivtiy of the disease-associating motif 3 mutants, together 
with the shortened telomere length in the patients harboring the mutations, support the 
importance of motif 3 for telomerase function and telomere maintenance in vivo. 
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Fig. 2.3 Activity assay of telomerase mutants reconstituted in cells. (Top panel) Mutant 
telomerases were reconstituted in 293FT cells and analyzed for activity. The TERT mutants 
d643-649 and d699-701 contain deletions of 7 and 3 residues, respectively. The TERT mutants 
i644AAA645 and i702KKK703 contain insertions of three alanine residues and three lysine 
residues between 644-645 and 702-703, respectively. The TERT mutants that contain different 
amino acid substitutions at the same residue are indicated by brackets. Numbers on the right (+1, 
+2, +3 etc.) indicate the number of repeats added to the telomeric primer. A 32P end-labeled 15-
mer DNA oligonucleotide is used as a loading control (l.c.). 
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Fig.2.3. continued (Middle panel) Expression level of hTERT protein in the transfected 
cells was analyzed by western blots of hTERT and GAPDH using anti-hTERT L-20 and 
anti-GAPDH antibodies. The level of GAPDH was used as a loading control. (Bottom 
panel) Expression level of hTR in the transfected cells was analyzed by northern blots of 
hTR and 5S ribosomal RNA (rRNA) using riboprobes against hTR or 5S rRNA. The 
level of 5S rRNA was used as a loading contrnnnnnol. The endogenous hTR is not visible 
in the vector-only sample (lane 1) due to the short exposure time. (In vivo reconstituted) 
Quantitation of telomerase activity and processivity of telomerase reconstituted in cells in 
relation to the wild-type TERT are shown below the gel. (In vitro reconstituted) Activity 
and processivity of telomerase mutants reconstituted in vitro analyzed in Fig. 2.2 is 
shown at bottom for comparison. n/d: not determined. 
 
2.4.3 The length of N-terminal linker of motif 3 affects telomerase activity 
  Based on the sequence alignment, the upstream linker connecting motif 2 to motif 
3 is more variable in length than the downstream linker connecting motif 3 to motif A 
(Fig. 2.1b). To assess the functional importance of the motif 3 flanking linkers, we 
generated TERT mutants with insertions (i644AAA645 and i702KKK703) or deletions 
(d643-649 and d699-701) in the linker regions and assayed the in vivo reconstituted 
enzymes for telomerase activity.  
 Both linker regions are more sensitive to deletions than insertions.  Insertions 
i644AAA645 (N-terminal linker) and i702KKK703 (C-terminal linker) did not 
significantly decrease telomerase activity or processivity (Fig. 2.3, lanes 4 and 6).  In 
contrast, deletions in the linker regions caused dramatic alterations in telomerase activity. 
The 3-residue deletion d699-701 in the C-terminal linker 3/A nearly abolished activity 
(Fig. 2.3, lane 5). Surprisingly, a 7-residue deletion d643-649 in the N-terminal linker 
increased activity by nearly two-fold without significant changes in processivity (Fig. 2.3, 
lane 3). The N-terminal linker appeared more flexible than of the C-terminus, as a 12-
residue deletion in the N-terminal linker did not affect telomerase activity (Fig. S2.4, 
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compare lane 1 and 4). Notably, the hyperactive alanine-substitution mutations, V658A, 
K659A, R669A, are located within the N-terminal portion of motif 3 near the upstream 
linker, implicating a similar role for the N-terminal linker and the N-terminal portion of 
motif 3 in regulating telomerase activity. 
2.4.4 Motif 3 is functionally conserved in Tetrahymena TERT 
The sequence of motif 3 is well conserved between vertebrates and ciliates (Figure 
2.1b). To determine if motif 3 is required for telomerase function in ciliates, we 
reconstituted eight Tetrahymena telomerase motif 3 mutants in vitro (L565A, R573A, 
G584A, F588A, D589A, I593A, F597A and F600A) with alanine substitutions at 
positions homologous to the residues critical for activity or processivity in human 
telomerase (Figure S2.6a). All eight mutants exhibited 3-20 fold reductions in activity 
(Figure S2.6b), indicating that motif 3 is critical for telomerase activity in Tetrahymena. 
Similar to the human telomerase mutants, W690A and F693A, the Tetrahymena mutants, 
F597A and F600A, impaired only telomerase activity, not processivity (Figure S2.6b, 
lanes 8 and 9). Furthermore, four Tetrahymena mutants, R573A, G584, F588A and 
I593A, showed 10-20 fold reductions in processivity (Figure S2.6b, lanes 3-5 and 7). We 
concluded that motif 3 is essential and evolutionarily conserved for telomerase 
processivity. 
2.4.5 Hyperactive motif 3 mutants exhibit faster rates of repeat addition  
 To determine if the greater activity observed within the hyperactive mutants was 
due to faster repeat addition, we carried out a pulse-chase time-course assay to measure 
repeat addition rate. Our results demonstrate that, regardless of their differences in 
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processivity, the hyperactive d643-649, V658A, K659A and R669A mutants add 
telomere repeats at a faster rate of 5-6 repeats/min, higher than the wild-type enzyme, 3-4 
repeats/min (Fig. 2.4, lanes 7-32). Conversely, the hypoactive mutants E668A, D684A 
and V697A present slower repeat addition rates than the wild-type enzyme (Fig. 2.4, 
lanes 38-52).  These results suggest a critical role for motif 3 in regulating repeat 
addition rate of telomerase enzyme.  
 The increase or decrease in repeat addition rate is independent of the processivity 
level of the mutants. In the pulse-chase assay, the extent of telomerase processivity was 
measured at the last time point where the processive enzyme-product complexes have 
already moved up to the top of the gel and separated from the products dissociated from 
the enzyme during the time course. While the hyperactive V658A mutant was more 
processive, the other two hyperactive mutants, K659A and R669A, were less processive 
(Fig. 2.4, compare lanes 17, 22, 27 and 32). Moreover, by combining two motif 3 
mutations (d643-649 and V658A) and an hTR-57C template mutation that increases 
processivity (23), we generated a telomerase mutant that is super-active and super-
processive (Fig. S2.3, lane 6), demonstrating an additive effect for these mutations in 
telomerase activity and processivity. 
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Fig. 2.4. Pulse-chase time course analysis to measure repeat addition rates of the motif 3 
mutants. In vitro reconstituted wild-type, hyperactive (d643-649, V658A, K659A and 
R669A) or hypoactive (E668A, D684A and V697A) telomerase mutants were incubated 
with (TTAGGG)3 primer in the pulse reaction for 5 min in which the [α-32P]dGTP is 
incorporated to the newly synthesized telomere repeats. After 5 min of pulse reaction, 
non-radioactive dGTP was added to 100 µM to initiate the chase reactions and the 
reactions were terminated at different time points (2-10 min). The vertical lines on the gel 
denote the major bands of telomere products synthesized and labeled in the initial 5-min 
pulse reaction, and extended in the following chase reactions. Numbers on the right (+1, 
+2, +3 etc.) indicate the number of repeats added to the telomeric primer. Repeat-
extension rate, expressed as repeats per minute, of each enzyme were calculated (see 
Materials and Methods) and indicated below the gel. Asterisk (*) denotes the 10 min 
chase reaction from which the processivity of each mutant was measured based on the 
first 10 major bands (repeats 1 to 10) (see Materials and Methods). 
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2.4.6 Low-processivity motif 3 mutants are defective in utilizing short DNA primers 
 The motif 3 mutations that altered processivity presumably affected either the 
template realignment or product release step of translocation, as telomerase processivity 
correlates to the probability of template realignment over product release. To determine if 
the low-processivity mutations affect the template realignment step, we designed a short 
primer assay to analyze the ability of telomerase to use short primers that, when base-pair 
with the RNA template, leave no single-stranded overhang for the TEN domain anchor 
site to bind (Fig. 2.5b). This assay thus discounts the effect of the TEN domain on 
substrate binding, as it binds to the upstream single-stranded region of a longer telomeric 
DNA primer (40). The base-pairing between the short tel8 DNA primer and the template 
RNA resembles the realignment of the 3’-end of telomeric DNA with the RNA template 
during translocation. By using a short primer, i.e. the 8-nt tel8 primer, in the telomerase 
assay, we can then determine solely the contribution of motif 3 in facilitating formation, 
or recognition, of the RNA/DNA duplex inside the active site. Thus, a low-processivity 
mutant with an inability to complete the realignment step in a translocation cycle would 
be predicted unable to use a short primer as substrate. 
 Using the short-primer assay, we tested six motif 3 mutants (V658A, N666A, 
L681A, G682A, D684A and I686A) with either increased or decreased processivity. In 
addition to motif 3, we also analyzed low-processivity mutations that are located in other 
parts of TERT, or in the TR component. Mutations N95A (TEN), L980A (CTE), 790-
VVIE-793-4A (IFD) and hTR-A55G (RNA template) have been previously shown to 
reduce telomerase processivity (20,22,23,41). The wild-type telomerase can utilize all 
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primers (8, 10, 12 or 18 nt) tested with similar activity (Fig. 2.5A, lanes 1-4). 
Remarkably, the low-processivity mutants, N666A, L681A, G682A, I686A, 790-VVIE-
793-4A, L980A and hTR-A55G, that can extend longer primers normally, had little to no 
activity when using the short tel8 primer (Fig. 2.5a, lanes 13, 17, 21, 29, 33, 37 and 41). 
This suggests these mutations compromised the ability of TERT in promoting RNA/DNA 
duplex formation or positioning the duplex into the active site for the first repeat 
synthesis. As would be expected, the hyper-processive mutants V658A and D684A 
utilized the short tel8 and the longer primers with equal efficiency (Fig. 2.5a, lanes 9 and 
25). The TEN domain N95A mutant, while having a low processivity, can however 
extend the short tel8 primers efficiently (Fig. 2.5a, lanes 1 and 5). The TEN domain thus 
does not appear to play a role in facilitating primer/template realignment, rather 
preventing product release during template translocation through DNA binding. When 
using tel10 and tel12 primers, all enzymes gave rise to stronger first bands (10+2 and 
12+2) than the subsequent bands, indicating a lower efficiency for the first translocation 
event (Fig. 2.5a).  This phenomenon is also consistent with the notion that TEN domain 
binding to the longer DNA primer facilitates template translocation. 
 To quantitatively determine the ability of these processivity mutants to utilize 
short primers as substrate, we measured the Km of the wild-type and mutant enzymes to 
the tel8 DNA primer. All mutants that failed to extend the tel8 primer had higher Km 
values ranging from 2.76 to 5.31 µM, 5-10 fold higher than the 0.56 µM of the wild-type 
enzyme (Fig. 2.5c). In contrast, mutants that retained the ability to extend the tel8 primer 
had Km values similar to or lower than the wild-type enzyme. For example, the most 
42 
processive mutant D684A has a Km of 0.33 µM, significantly lower than that of the wild-
type (Fig. 2.5c). Compared to tel8, primers tel10 and tel12 can still be used efficiently by 
the wild-type and mutant enzymes, with Km ranging from 80 to 680 nM (Fig. 2.5a). 
When the longer tel18 primer (18 nt) was used, the wild-type enzyme and all mutants, 
with the exception of the TEN N95A mutant, had similar Km values around 100 nM (Fig 
2.5c).  
 The hTR-A55G template mutation resulted in a mismatch between the RNA 
template and the DNA substrate (Fig. 2.5b), leading to a high Km for the tel8 primer (Fig. 
2.5c) and a lower processivity (Fig. 2.5a, lanes 41-44). The IFD motif, found first in 
yeast, also contributes to the repeat addition processivity (20). Based on the sequence 
alignment, we divided the IFD into three regions, termed IFD-a, -b and -c (see Figs. 
S2.1b and S2.4). Our human IFD-b mutant (790-VVIE-793-4A) causes a phenotype 
similar to motif 3, CTE and the hTR template mutants, confirming that IFD-b is indeed 
required for processivity (Fig. 2.5a, lanes 33-36). 
 The TEN N95A mutant had a higher Km value of 0.16 µM to the 18 nt tel18 
primer, presumably due to a reduced binding affinity to the 5’-end single-strand region of 
the longer DNA primer (Fig. 2.5c). This supports that the TEN domain is a major 
contributor for the overall substrate affinity as proposed previously. The strong 
correlation between the processivity and the Km to the tel8 primer of the motif 3, IFD and 
CTE mutants ascertain that these elements contribute to the formation or positioning of 
an extendable RNA/DNA duplex substrate in the active site. 
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b. The four different primers are aligned with hTR template sequence. 
 
Fig. 2.5. Activity assay of telomerase mutants using primers with various lengths.
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c. The Kmapp values for telomere primers of various lengths. 
Fig.2.5. continued. Activity assay of telomerase mutants using primers with various 
lengths. (a) Telomerases with specific mutations in TERT or TR indicated were assayed 
for activity using telomere primers, tel8, tel10, tel12 or tel18, with length ranging from 8 
to 18 nt. Due to the difference in overall activity between mutants, the gel image of each 
mutant was adjusted to have similar intensity for better comparison of the products of 
different primers. The numbers (8+2, 10+2, 12+2 etc.) labeled on the right of the gel 
indicate the length of the primer plus the number of nucleotides added. The black triangle 
on the left of the gel indicates the first repeat product extended from the tel8 primer. (b) 
The four different primers are aligned with hTR template sequence. The alignment (nt 
52-56) and template (nt 46-51) regions are shaded in grey and black, respectively. (c) The 
Kmapp values for telomere primers of various lengths. The apparent Km values are 
determined from experiments using tel8, tel10, tel12 or tel18 primers at various 
concentrations and by fitting the data to the Michaelis-Menten equation (see Materials 
and Methods). Standard deviations (n=3-4) are given in parentheses. n/d: not determined. 
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2.4.7 Hyperactive telomerase mutants have higher enzyme turnover rates 
 Since template translocation is the rate-limiting step in a processive telomerase 
reaction, the increased repeat addition rate observed with the hyperactive mutants should 
result from a greater translocation rate. Strand-separation between the telomeric DNA 
and the template RNA is a crucial step of template translocation. Taking advantage of the 
short primer assay, we asked if the hyperactive mutants have a faster dissociation rate for 
extended telomere product from the template, which resembles the strand-separation step 
of template translocation. Since the tel8 primer still gave rise to multiple repeats 
products, indicating successful translocation events, we thus used an even shorter tel7 
DNA primer, 5’-AGGGTTA-3’ (7-nt) and only dGTP in the reaction to prevent any 
possible realignment of the telomeric DNA product with the RNA template after one 
round of repeat synthesis. Without the interference from TEN domain or other DNA 
binding sites, this time-course assay focused primarily on the rate of product dissociation 
from the active site.  
 Our results from this time-course analysis indicated that all hyperactive mutants 
d643-649, V658A, K659A and R669A have higher enzyme turnover rates than the wild-
type enzyme (Fig. 2.6). The higher turnover rates of these mutants were not due to higher 
substrate binding affinity, as these hyperactive mutants had a Km higher or similar to that 
of the wild-type enzyme (Fig. 2.6b) and the reactions were performed at a saturated 
substrate concentration of 10 µM (see Materials and Methods). The high Km values of 
the hyperactive mutants K659A and R669A were consistent with their low processivity 
as shown above (Fig. 2.4 and 2.6b). Conversely, the hypoactive mutants E668A, D684A 
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and V697A that showed lower repeat addition and template translocation rates (Fig 2.4) 
had lower enzyme turnover rates (Fig. 2.6b). Together, these results suggest that the 
increased template translocation rates of the hyperactive motif 3 mutants are likely due to 
the higher dissociation rates of products from the active site after each round of repeat 
synthesis.  
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a. Telomerase activity time course analysis of the hyperactive (d643-649, V658A, 
K659A and R669A) and hypoactive (E668A, D684A and V697A) mutant telomerases. 
 
Fig. 2.6. Enzyme turnover rates of the hyperactive and hypoactive motif 3 mutants. (a) 
Telomerase activity time course analysis of the hyperactive (d643-649, V658A, K659A 
and R669A) and hypoactive (E668A, D684A and V697A) mutant telomerases. The 
reactions were performed using a 7 nt telomere primer 5’-AGGGTTA-3’ and incubated 
for various amounts of time (0, 2, 5 and 10 min) as indicated. The reactions were carried 
out in the presence of only 32P-dGTP nucleotide to prevent processive reactions. A 32P 
end-labeled 15 nt DNA oligonucleotide is used as the loading control (l.c.). The in vitro 
synthesized TERT proteins (wild-type, d643-649, V658A, K659A, R669A, D684A, 
E668A and V697A) were labeled with [35S]-methionine and quantitated after SDS-
PAGE.
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b. Quantitation of enzyme turnover rates of the hyperactive and hypoactive 
telomerase mutants. 
 
Fig. 2.6. continued. Enzyme turnover rates of the hyperactive and hypoactive motif 3 
mutants. (b) Quantitation of enzyme turnover rates of the hyperactive and hypoactive 
telomerase mutants. For each telomerase enzyme, the intensity of products was adjusted 
with protein amount and normalized by the intensity of loading control. For each set of 
reactions, the product intensities are further normalized to that of the wild-type reaction at 
the 10 min time point. The relative product intensities were then plotted against the 
amount of time. Wild-type (filled circle); d643-649 mutant (square); V658A (triangle); 
K659A (reverse triangle); R669A (diamond); D684A (cross); E668A (dotted diamond); 
V697A (plus).  The relative enzyme turnover rates were determined from slopes of the 
linear trend lines in relation to that of the wild-type enzyme. The apparent Km values of 
different telomerase mutants toward the tel7 primer were determined by fitting the data to 
Michaelis-Menten equation. The standard deviation was derived from 3 independent 
experiments. 
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2.4.8 Mutations in motif 3b do not affect the affinity of the RT domain to ssDNA, ssRNA 
or RNA/DNA duplex 
To determine if the higher Km values of motif 3 mutants are due to a lower DNA-
binding affinity, we carried out in vitro direct binding assay in which biotin-labeled 
telomeric DNA oligonucleotides and streptavidin beads were used to pull down the in 
vitro synthesized TERT protein fragment. In addition to ssDNA, we also tested ssRNA 
and RNA/DNA duplex for their affinity to the TERT protein fragment (Fig. S2.7a). The 
TERT fragment (a.a. 601-939) tested here includes the whole RT domain and exhibits 
weak affinity to DNA as shown previously. Our results did not reveal any significant 
differences in binding affinity to either the ssDNA, ssRNA or RNA/DNA duplex 
between the motif 3 mutant and wildtype protein fragments (Fig. S2.7b). We thus 
conclude that in vitro direct binding assay is not sensitive enough to detect the affinity 
difference between wild-type and processivity mutant telomerase toward RNA/DNA 
duplexes.
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2.5 Discussion 
 The repeat addition processivity of telomerase relies on a unique template 
translocation mechanism that presumably requires novel structural elements within the 
TERT protein. The telomerase-specific motif 3 we characterized in this study has been 
overlooked in the past, in part due to the low degree of sequence conservation among 
eukaryotic lineages, the presence of variable linkers and the inefficiency of alignment 
algorithms (Fig. 2.1 and S2.2). In this study, through a comprehensive mutagenesis 
analysis within motif 3 (Fig. 2.2), we identified mutations that unusually increased the 
rate or altered the processivity of telomere repeat addition (Fig. 2.3 and 2.4). By using a 
novel short-primer assay to determine the binding affinity of the mutants to short DNA 
primers (Fig. 2.5) and the time-course analysis to measure enzyme turnover rates (Fig. 
2.6), we showed that motif 3 mutations affect repeat addition rate and processivity, 
suggesting a crucial role for motif 3 in strand-separation and realignment during template 
translocation. 
 Our sequence alignment analysis and secondary structure prediction on motif 3 
provide useful insights into the function and evolution of this motif. The secondary 
structures of motif 3 predicted from different TERT homologs are surprisingly conserved 
(Fig. S2.1A) and consistent with the crystal structure of Tribolium castaneum TERT (34). 
The secondary structure prediction of TERT sequences from all available species 
suggests that the motif 3 region consists of two α-helices separated by a conserved linker 
(Fig. S2.1A), consistent with the Tribolium crystal structure. To display the physical 
location of motif 3 in relation to other TERT domains and the RNA/DNA duplex, we 
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mapped the sequence of the two putative α-helices of human motif 3 onto the crystal 
structure Tribolium TERT based on the structural and sequence homology. To 
specifically denote the different structural features, we divided motif 3 into three sub-
motifs, 3a, 3b and 3c, where 3a and 3c designate the two separate α-helices and 3b 
designates the spanning linker (Fig. 2.7A). While the sequences of helices 3a and 3c are 
well conserved in most organisms, the sequence of linker 3b is conserved most 
specifically within vertebrates, non-yeast fungi, plants and ciliates (Fig. 2.1B and 2.7A). 
This group-specific sequence conservation of linker 3b suggests a role important for 
telomerase function in most species, yet dispensable and lost in species including 
nematodes, insects and yeasts (Fig. S2.2). 
 Our comprehensive mutagenesis surveyed the functional effects of alanine-
substitution at individual residues of motif 3. Although alanine-substitution at most of the 
highly conserved residues resulted in significant changes in telomerase activity or 
processivity, mutations at the residues V664A, L676A and S679A showed no dramatic 
changes (Fig. 2.2B). It was however expected that alanine substitutions do not always 
give the same degree of effects for all conserved residues, due to unique structural and 
chemical properties within various amino acids. Substitutions to amino acids other than 
alanine will presumably produce different phenotypes. 
 The mutations (L681A, G682A and I686A) that severely impair processivity are 
located in linker 3b (Fig. 2.2B and 2.7B, right), suggesting a primary role for this linker 
in regulating the template translocation efficiency and repeat addition processivity. In 
comparison, mutations (d643-649, V658A, K659A and R669A) that significantly 
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increase telomerase activity are located in the helix 3a and its N-terminal linker (Fig. 
2.7B, left), suggesting that helix 3a is more important in regulating the rate of template 
translocation and repeat addition. However, helix 3a might play an additional role in 
telomerase processivity as several mutations (V658A, L661A, N666A, E668A and 
R669A) in motif 3a also substantially altered processivity. 
 
 
a. Sequence alignment and predicted secondary structures of human and Tribolium 
motif 3. 
 
Fig. 2.7. Homologous locations of human TERT mutations on the Tribolium TERT 
structure. (a) Residues critical for repeat addition rate are shaded in green, while critical 
residues for processivity are shaded in blue; asterisk (*) indicates both. The residues that 
abolish activity when mutated are colored red. The secondary structure (α-helix shown as 
a cylinder) based on the crystal structure of Tribolium TERT is shown below the 
predicted secondary structures. The predicted secondary structures (α-helix shown in blue 
and β-sheet shown in red) based on three algorithms, YASPIN, PSI, and JPred (see 
Supplementary Fig. S1A). Black/grey boxes located between human and Tribolium 
sequences indicate identity/similarity.  The alignment is based on optimal positioning 
within the predicted helix sequence.
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b. Mutations in human TERT that affect repeat addition rate and processivity are 
mapped onto the crystal structure of Tribolium TERT. 
 
Fig. 2.7. continued (b) Mutations in human TERT that affect repeat addition rate and 
processivity are mapped onto the crystal structure of Tribolium TERT.  (Left panel) 
Mutations that increase repeat addition rate are located in helix 3a and its N-terminal 
linker that connects motif 2 to helix 3a. (Right panel) Mutations that affect processivity 
and RNA/DNA duplex formation are dispersed in the IFD, motif 3 and the CTE. The 
blue arrowheads indicate putative locations for the human TERT sequences (IFD-b and 
motif 3b) absent from the Tribolium TERT. The (+) and (-) following the mutations 
denote an increase or decrease in processivity. Superimposed hetero-duplex of RNA 
strand (green) and DNA strand (purple). 
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2.5.1 The role of motif 3 on repeat addition rate  
 The three mutations in motif 3a, V658A, K659A and R669A, and the deletion 
d643-649 in N-terminal linker of motif 3a remarkably increased the repeat addition rate 
(Fig. 2.4), presumably due to an increase in template translocation rate. This increase in 
repeat addition rate is independent of the processivity, as some hyperactive mutants have 
decreased processivity (Fig. 2.4). The combination of a high addition-rate mutation with 
a low-processivity mutation did not reduce the repeat addition rate of the enzyme (Fig. 
S2.5, compare lane 5-8 and 9-12), supporting that the rate and processivity of telomerase 
are regulated separately, as previously proposed (27). Likewise, low repeat addition rate 
mutant combining with high processivity mutation did not increase enzyme extension 
rate (Fig. S2.5, compare lane 25-28 and 29-32).  
 The higher enzyme turnover rates measured in the short primer assay suggest 
faster product dissociation (or strand-separation) rates for the motif 3 hyperactive mutants 
(Fig. 2.6), assuming the product dissociation is the rate-limiting step in the assay. This is 
consistent with the faster template translocation rates of the hyperactive mutants observed 
in the processive pulse-chase time-course analysis, in where nucleotide polymerization is 
not rate limiting (Fig. 2.4). We propose that the putative helix 3a and its N-terminal linker 
regulate the strand-separation step of template translocation and thus modulate the rate of 
repeat addition. It remains unclear if the strand-separation of the RNA/DNA hybrid 
involves a conformational change to helix 3a or its N-terminal linker. We hypothesize 
that the long N-terminal linker could function in allowing helix 3a to swing away from 
the active site, permitting the RNA/DNA duplex to dissociate from the active site and the 
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two strands to separate from each other (Fig. 2.7B). A source of energy for such a 
conformational change could originate from the movement and distortion of DNA/RNA 
duplex during repeat synthesis as previously proposed (42). 
2.5.2 The role of motif 3 on repeat addition processivity  
 Mutations at conserved residues within motif 3, the CTE and the IFD of TERT as 
well as the template region of TR affected telomerase processivity and the ability to use 
short telomere primers (Fig. 2.5 and 2.6). The retained ability of the wild-type enzyme to 
extend the short tel7 and tel8 primers indicates that the catalytic core of TERT protein 
alone is capable of promoting the formation of, or recognizing, the RNA/DNA duplex 
substrate inside the active site independent of the TEN domain. The ability of telomerase 
to use the short primer correlates to the processivity of repeat addition as it resembles the 
second step of the translocation event, where the RNA and DNA realign to form the 
hetero-duplex inside the active site for the next round of repeat synthesis. The fact that 
the TEN N95A mutant can efficiently elongate the tel8 primer is consistent with the 
notion that this TEN mutation impairs the binding to the upstream single-stranded region 
of telomeric DNA primer, representing a different mechanism to affect telomerase 
processivity. 
 It was however unexpected that the wild-type enzyme would be capable of adding 
more than one telomere repeats to the 8 nt DNA primer in the absence of upstream 
single-stranded sequence for TEN binding (Fig. 2.5A, lane 1). The synthesis of multiple 
repeats indicates the occurrence of template translocation after the synthesis of the first 
repeat. Although the tel8 primer does not initially leave a single-stranded overhang when 
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base-paired with the RNA template, it would potentially have the 5’-end unpaired from 
the template during cycles of nucleotide addition, while maintaining a constant number of 
base-pairings between the telomeric DNA and the template RNA, as previously proposed 
(43). Since the TEN domain requires a longer single-stranded DNA overhang for binding, 
a more adjacent DNA binding site (the template-proximal anchor site) in the RT domain 
would thus seem responsible for binding the partially unpaired 5’-end of the short tel8 
DNA primer (41,44). 
 Our results suggest that motif 3, CTE and IFD contribute to the realignment of 
telomeric DNA and the RNA template, i.e. the reformation of RNA/DNA duplex. 
Interestingly, based on the crystal structure of Tribolium TERT, these three motifs are 
located adjacent to the RNA/DNA duplex, forming a horseshoe shaped structure 
encircling the duplex (Fig. 2.7B). The majority of the motif 3 mutations that severely 
impaired the enzyme’s processivity and short primer usage are located in linker 3b (Fig. 
2.7). We envision the conserved motif 3b would act as a molecular hinge, positioning 
helix 3a and the CTE to facilitate the RNA/DNA duplex formation or positioning the 
duplex within the active site (Fig. 2.7B). Since motif 3b is not conserved in insects, a 
crystal structure of a vertebrate or ciliate TERT would be necessary to elucidate the 
structural and functional purpose of motif 3b in template translocation. 
 Our phylogenetic and biochemical studies of motif 3 shed light upon the molecular 
mechanism of the translocation process for the processive telomerase reaction. The 
implication of our data provides testable hypotheses and elicits critical questions for 
future studies of telomerase action. Moreover, our hyperactive and hyper-processive 
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motif 3 mutants demonstrate the feasibility of enhancing telomerase enzymatic activity 
through motif 3 targeting. Altering telomerase function can possibly affect the 
proliferative capacity of adult stem cells. Drugs that augment enzymatic activity and 
processivity of telomerase, similar to our mutants, might provide treatments for patients 
suffering from telomerase-insufficiency diseases. Additionally, the abated telomerase 
motif 3 mutants provide potential drug target locals for anti-cancer therapies. 
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CHAPTER 3 
TEMPLATE FREE TELOMERASE UTILIZES RNA/DNA DUPLEX LIKE 
CONVENTIONAL RTS 
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3.1 Abstract 
Telomerase is a specialized reverse transcriptase (RT) that recognizes single 
stranded DNA substrates and synthesizes telomere repeats onto the chromosome termini 
using an intrinsic RNA template. Here, we showed that the template free human 
telomerase reconstituted in either TNT lysate or 293FT cells is capable of extending 
RNA/DNA heteroduplex like other conventional RTs. The template free telomerase, 
which is composed of human telomerase reverse transcriptase (hTERT) and essential 
human telomerase RNA (TR) fragments lacking the template, can reverse transcribe up to 
8 nucleotides along the RNA template with the RNA/DNA duplex ranging from 5 to 16 
base pairs long. Supplying 5’ DNA overhang to the duplex greatly enhanced the 
substrate’s affinity to the enzyme. A comprehensive study on various RNA and DNA 
hybrid substrates suggested RNA/DNA duplex is the preferred substrate of telomerase. 
Ribonucleotide residues can prime the telomerase catalyzed DNA polymerization on the 
RNA/DNA duplex. No telomerase specific RNA polymerase activity was detected using 
this system. 
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3.2 Introduction 
 Telomerase is a unique reverse transcriptase (RT) that synthesizes telomeric DNA 
onto the linear chromosome termini according to the template sequence within its 
intrinsic RNA component. Telomerase activity is important for cell mortality as the germ 
line cells and 90% of the tumor cells require telomerase to maintain telomere length (1). 
Meanwhile, somatic cells undergo telomere shortening and only allow for limited cell 
proliferation capacity due to the lack of telomerase activity (2). As a ribonucleoprotein 
complex, telomerase holoenzyme contains two core components: a telomerase RNA (TR) 
carrying the template sequence and the telomerase reverse transcriptase (TERT).  
 The TR component not only contains the RNA template sequence, but also has 
conserved secondary structure among different groups of species. To date, the secondary 
structure is only determined for TRs from ciliates, vertebrates and yeast (3). The 
pseudoknot structure located to the 3’ of the template appears to be a universal element 
essential for telomerase activity (3,4). In vertebrates, a CR4-CR5 domain interacts with 
TERT protein independent from the pseudoknot domain and is also important for 
telomerase enzymatic activity. The scaRNA domain, located in the 3’ half of the 
vertebrate TRs, is critical for RNA biogenesis (5). Human telomerase activity can be 
rconstituted from only the pseudoknot and CR4-CR5 domains (6). The solution structure 
of hTR pseudoknot triple helix and a critical stem loop within CR4-CR5 domain are 
available (7, 8). However, the detailed mechanism of how TR domains contribute to 
telomerase function is still unclear. It has also been shown that telomerase can be over-
expressed in 293 FT cells, and the resulting “super telomerase” cell extract allows for 
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direct analysis of telomerase activity (9).  
 The TERT protein is composed of an N terminal extension (NTE), a central RT 
domain and a C terminal extension (CTE) (10). The NTE and CTE are specific for 
telomerase RT. The NTE contains the Telomerase essential N terminus (TEN) domain 
for single stranded DNA binding and a TR binding domain (TRBD) (11, 12, 13). The 
CTE is not well conserved among different species and possibly contributes to both 
nucleotide and repeat addition processivity (14, 15). The central RT domain, which 
possesses seven signature reverse transcriptase motifs, is responsible for telomerase 
catalytic reaction (16). The Tribolium TERT structure demonstrated that the domain 
organization of TERT RT domain resembles the HIV RT domain (17). Although lacking 
the TEN domain, the Tribolium TERT has the RNA binding domain making extensive 
contacts with the CTE to form a ring-shape structure. The catalytic site falls in the center 
of the ring structure and can potentially fit 7 base pairs of RNA template/DNA duplex 
(17). Interestingly, the estimation of duplex length within S. cerevisiea active site also 
reveals a constant 7 base pairs between template and telomeric DNA (18). 
 The telomerase rection differs from the reactions catalyzed by conventional RTs in 
several aspects. Telomerase is the only RT specialized to recognize single stranded DNA. 
ssDNA specific binding motifs, especially the TEN domain, have evolved within the 
TERT protein from different species (11, 19). The RNA template helps position the 3’ 
end of telomeric DNA into the catalytic site using a complementary sequence. The one 
and a half repeat of RNA template sequence enables telomerase to evolve a template 
translocation event in order to synthesize a long stretch of telomeric repeats (20). On the 
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other hand, conventional RTs recognize the RNA/DNA duplex as substrate to initiate 
reverse transcription. The conventional RTs also synthesize an extensive strand of DNA 
along very long RNA templates with limited dissociation occasions during this process 
(21). For example, the HIV RT has to complete the replication of 9 kb viral RNA into 
DNA sequence. The retroviral RTs not only conducts reverse transcription but also 
exhibits DNA dependent DNA polymerase activity. Moreover, during the initiation of 
DNA synthesis, the retroviral RTs use an RNA/RNA duplex formed by the viral RNA 
and host tRNA (22). Telomerase RT and the conventional RTs presumably are 
homologous and sharing the common ancestor during evolution. Therefore, telomerase 
might also have the ability to utilize diverse substrates to carry out various 
polymerization reactions. It has been recently reported that telomerase has limited ability 
to function as RNA dependent RNA Polymerase (RdRP) and DNA dependent DNA 
polymerase (23, 24). It has also been suggested that telomerase RT can synthesize the full 
length anti sense RNase MRP RNA in specific conditions (25). This RdRP reaction is 
presumably initiated by a self loop back hairpin at the 3’ end of the RMRP RNA.  
To investigate whether the ssDNA specific telomerase still retains the ability of 
uitilizing RNA/DNA duplex substrate and how well telomerase recognizes other hybrids, 
such as RNA/RNA duplex, we designed a template-free human telomerase missing the 
intrinsic RNA template sequence. A smililar “template-free” system has been previously 
tested using Tetrahymena telomerase but without the supply of duplex substrates (26). 
Here, we show that our template free telomerase can use pre-annealed RNA/DNA as 
substrate and such activity depends on both TERT and TR elements. Various RNA/DNA 
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duplexes were tested. Duplex length didn’t affect telomerase activity while 5’ DNA 
overhang greatly enhance the activity and nucleotide addition processivity. Unlike 
conventional RTs, telomerase can only synthesize a short strand of DNA with limited 
nucleotide addition processivity. Using this template free telomerase, we also directly 
show that telomerase preferred its native RNA/DNA duplex over all other hybrids. This 
study is the first to reveal telomerase’s ability of using RNA/DNA duplex without single 
stranded DNA as the substrate. It also provides a comprehensive understanding of how 
telomerase utilizes different duplex substrates. 
3.3 Materials and Methods 
3.3.1 Oligos and duplex substrates 
 Oligos are purchased from Integrated DNA technology Inc (IDT). Various oligos 
used to assemble duplex substrates in particular experiments are shown in the figures. To 
assemble the duplex, RNA template and DNA oligos are mixed to a final concentration 
of 100 µM in 100 mM Tris-HCl (pH7.5), 500 mM NaCl, 50 mM EDTA (1X annealing 
buffer). The mixture was heated at 80°C for 3 min and slowly cool down to room 
temperature. For fair comparison, single stranded RNA or DNA oligo substrates used in 
reactions were prepared in the same way. In Fig. 3.3b, all reactions were conducted in 
annealing buffer with 100 µM extra KCl, and duplex substrate was added to 100 µM to 
assure 5 bp duplex formation.  
3.3.2 Tm measurement of the duplexes 
 To measure the melting of each duplex, both oligos for the duplex were mixed at 
equal molar in a 150µL volume at 10 µM final concentration in telomerase reaction 
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buffer (1X PE buffer, described below). The OD-260 of the sample was measured along a 
temperature range from 10 to 60°C at 0.5°C intervals in a Cary 300 thermal control 
Spectrophotometer (Varian tech.). The data was collected using the Cary 300 UV-vis 
spectrophotometer and calculated for annealing temperature value, Tm. Alternatively, 
data points were fit into sigmoid curve (variable slope) and calculate for Tm using Prism 
5 (Graphpad). 
3.3.3 In vitro reconstitution of human telomerase 
 Human telomerase was reconstituted in Rabbit Reticulocyte Lysate (Promega) as 
previously described (Chapter 2). Briefly, hTERT was first synthesized in RRL according 
to the manufacturer’s instruction. In vitro transcribed and PAGE-purified hTR fragments 
(hTR nt 32-195/ hTR nt 44-184/ hTR nt 64-184 and hTR nt 239-328) were added to the 
final concentration of 1µM to assemble the telomerase enzyme. For the turnover rate 
assay, hTERTs were synthesized in the presence of 35S Met (>1000 Ci/mmol, 10.2 
mCi/mL, PerkinElmer) and analyzed by SDS-PAGE. The same amount of protein were 
added for different mutants to carry out the reaction. 
3.3.4 Telomerase activity assays 
3.3.4.1 Conventional and template free telomerase activity assay  
 Activity assay was carried out as previously described (Chapter 2). Basically, 3 
µL of in vitro reconstituted telomerase was assayed in a 10 µL reaction with 50 mM Tris-
HCl pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, 1 mM Spermidine, 1 mM dTTP, 1 
mM dATP, 2 µM dGTP, 0.165 µM α32P-dGTP (3000 Ci/mmole, 10 mCi/mL, 
PerkinElmer), and 1 µM (TTAGGG)3 telomeric primer or 10 µM duplex substrate. The 
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reaction was carried out for 60 min at 30°C or room temperature and terminated by 
phenol/chloroform extraction, followed by ethanol precipitation. The product was 
analyzed on 10% or 18% polyacrylamide gel, and the gel was analyzed by a Phosphor 
Imager. To measure the Km of different duplexes to the template free telomerase, 
reactions were carried out with different concentrations of duplex substrate from 0 to 125 
µM as indicated in the figure. In the temperature gradient assay, reaction mixing were 
carried out and held on ice before proceeding to various temperatures to avoid 
background activity from room temperature condition. In the reactions that contain 5 bp 
duplex substrate, temperature was kept at 4°C for 2 hours. 
3.3.4.2 Turnover rate assay 
 Telomerase reconstituted in Rabbit Reticulocyte Lysate (RRL) was incubated 
with 200 µM duplex substrate (indicated in the figure) in 1X telomerase reaction buffer 
(50 mM Tris-HCl pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, 1 mM spermidine) in 
a 5 µL volume at 30°C for 10 min. 5 µL solution including 3.3 µM α-32P-dGTP (3000 
Ci/mmole, 10 mCi/mL, PerkinElmer) in 1X reaction buffer was added to the mixture to 
initiate the reaction. The reaction was carried out at 30°C and terminated at different time 
points by phenol/chloroform extraction. The product was analyzed as stated in 
conventional telomerase activity assay. 
3.3.4.3 Exonuclease I digestion 
 Template free telomerase was reacted with 40 µM of a 7 bp duplex with 9 nt 
overhang (detailed in the figure) in a 20 µL reaction following the condition described in 
conventional activity assay for 1 hour at 30°C. The DNA oligo of the duplex was added 
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to a 10 µM excess in the reaction to prevent any re-annealing of the released single 
stranded DNA to the RNA template. After telomerase reaction, the solution was split 
equally and incubated with or without 20U Exonuclease I (20U/µL, New England 
Biolabs), 2.5 µM 12 bp duplex, 17 nt overhang, 20 nM 24 nt overhang DNA oligo for 30 
min at 30°C. Reactions were terminated by phenol/chloroform extraction, followed by 
ethanol precipitation and the products were analyzed as described above. 
3.4 Result 
3.4.1 Template free telomerase reacts on the RNA/DNA duplex 
 To reconstitute a human template-free telomerase, we assembled hTERT with 
essential hTR fragments omitting the template sequence, hTR pseudoknot nt 64-184 (Fig. 
3.1a) and CR4-CR5 239-328, in Rabbit Reticulocyte Lysate (RRL). As expected, the 
template free telomerase failed to utilize single stranded telomeric DNA primer, while the 
telomerase with template show characteristic 6 nucleotides ladder pattern (Fig. S3.1). We 
then tried to test the ability of telomerase with or without intrinsic template sequence to 
use RNA/DNA duplex substrates (Fig. 3.1a. compare hTR 32-195, 44-184 and 64-184). 
In order to prevent potential base pairing between the intrinsic template and the DNA 
oligo in the duplex, we designed a non-native DNA sequence that would not be 
recognized by wild-type telomerase (Fig. 3.1b). The duplex was set to be 7 base pairs 
long according to the estimation from recently published structural and biochemical data 
that telomerase catalytic core can accommodate 7 base pairs between the RNA template 
and the DNA primer (17,18). When supplied with RNA template pre-annealed to the 
DNA primer, template free telomerase extended the primer by incorporating three dG 
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residues (Fig. 3.1b, lane 5). The observed activity is telomerase dependent, since neither 
hTR nor hTERT alone within RRL reacts on the RNA/DNA duplex (Fig. 3.1b, lane 1 and 
2). Both essential hTR fragments are required for this activity. Assembling either 
pseudoknot or CR4-CR5 fragment with hTERT could not yield comparable level of 
activity as the template free telomerase (Fig 3.1b, lane 3 and 4). Compared to template 
free telomerase, the telomerase with template tethered by both flanking linkers (hTR 32-
195, Fig. 3.1a) yielded 50% activity (Fig. 3.1b, lane 6). It is possible that the wild-type 
template held in place by the linkers reduced the accessibility of the activity site to the 
RNA/DNA duplex. In support with this notion, when the 5’ linker was removed (hTR 44-
195, Fig. 3.1a), the telomerase could utilize the duplex as efficiently as template-free 
telomerase (Fig. 3.1b, lane 7).  
a. Schematic of hTR pseudoknot fragments 
Fig 3.1 Template free human telomerase reacts on RNA/DNA duplex. a, Secondary 
structure of hTR pseudoknot fragments, hTR nt 32-195, 44-184 and 64-184, are 
presented. The RNA template sequences are highlighted with black background. 
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b. Template free human telomerase reaction 
 
Fig 3.1 The template free human telomerase reacts on RNA/DNA duplex. b, Three 
different hTR pseudoknot fragments shown in Fig 3.1a are assembled with the CR4-CR5 
fragment (hTR 239-328) and assayed for activity with pre-annealed RNA/DNA duplex 
substrate. The substrate (7 bp duplex) sequence is shown in the lower panel. The number 
of dG residues added is labeled on the right of the gel. 
 
It has been shown that telomerase possesses a terminal transferase activity under 
specific conditions (27). We asked if the observed activity from template free telomerase 
is a terminal transferase activity. RNA/DNA duplex substrates with various template 
sequences and lengths attached to the same duplex stem were tested with template free 
telomerase. The α 32P is incorporated at a much lower efficiency when the template is rG, 
rA or rU (Fig. 3.1c, compare lane 1 to lane 2, 3, 4). There is no nontemplated 
incorporation detected when RNA template protruding is not available on the duplex 
(Fig. 3.1c, compare lane 5 and 6). Furthermore, the extension of DNA oligo strictly 
followed the sequence presented in the RNA template. For example, the templates range 
72 
from one rC to three rCs directed the synthesis of one dG to three dGs. (Fig. 3.1c, lane 6 
to 8) The rG, rA and rU templates lead to the incorporation of dC, dT and dA 
respectively (Fig. 3.1c, lane 9 to 11). The oligo products with same length did not show 
the same mobilities in the high percentage PAGE gel due to different molecular weight 
and electric properties of the residues added (compare lane 7, 9, 10 and 11). Collectively, 
these data suggested that template free telomerase conducts reverse transcription upon the 
RNA/DNA template rather than terminal transferring 32P dGMPs. 
c. Template free telomerase reaction according to various template sequences. 
 
Fig. 3.1 The template free human telomerase reacts on RNA/DNA duplex. c, Template 
free telomerase was assayed with duplexes having the same stem but different template 
sequences, ranging from 0 to 3 residues. The template residues are shown on the top of 
the gel. Different nucleotide substrate combinations were used as indicated. The 32P 
dGTP is the only radioactive substrate. l.c.: 32P end labeled 15nt DNA 
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3.4.2 Template free telomerase recognizes duplex substrate and releases duplex product 
 Even though the supplied substrates are presumably pre-annealed RNA/DNA 
duplex under our reaction condition, we tested whether the template free telomerase 
recognizes traces of single stranded RNA and DNA respectively and generate RNA/DNA 
duplex substrate within its active site. The following experiments were carried out to 
address this possibility. First of all, all three telomerase used showed activity only when 
supplied with both RNA and DNA oligos, but not with either one of the oligos (Fig. 3.2a, 
compare lane 1, 4 and 7 to lane 2, 3, 5, 6, 8 and 9).  
a. Template free telomerase requires both RNA and DNA strands that can form the 
duplex 
 
Fig. 3.2 Template free telomerase utilizes duplex substrates and releases duplex product. 
a, Three pseudoknot constructs, hTR 64-184, 32-195 and 44-184, as shown in Fig. 3. are 
assembled with TERT and hTR CR4-CR5 domain (hTR 239-328). The reaction substrate 
was either 7bp duplex or the single stranded RNA or DNA, as indicated on the top of the 
gel. l.c., 32P end labeled 15 nt DNA.  
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To insure the RNA and DNA oligos pre-annealed as a heteroduplex before 
telomerase reaction, we tested the UV melting curve of the duplex under the telomerase 
reaction condition (Fig. 3.2b). With the Tm around 40°C, most oligos should be annealed 
as heteroduplex under our reaction temperature at 25°C. Lastly, we carried out a series of 
template-free telomerase reactions under temperatures ranging from 25 to 50°C (Fig. 
3.2c). At the higher temperatures (40-50°C), where RNA and DNA oligos are single 
stranded, the telomerase activity significantly decreased. The wild-type telomerase 
however is active at the temperatures up to 55°C (Fig. 3.2d), indicating the failure of 
reaction is due to the concentration of substrates in the duplex form, instead of the 
inactivity of the enzyme at high temperature. These data indicate that the RNA/DNA 
duplex, rather than single stranded oligos, are the substrate for template free telomerase. 
Fig.3.2 b, The OD260 of 7 bp duplex substrate from 5 to 65°C. Data points are connected 
with sigmoid dose response trend line. c, Template free telomerase using duplex 7bp was 
reacted under temperatures ranging from 25 to 50°C. Specific temperature, such as 30, 44 
and 50°C, are labeled for comparison purpose.
 
 
b. UV melting curve of RNA/DNA 
duplex 7 base pairs 
 
 
 
 
c. Temperature gradient reactions of 
template free telomerase reaction 
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d. Temperature gradient reactions of wild-type telomerase reaction 
 
Fig. 3.2 d, wild-type telomerase was assayed with single stranded telomeric primer 
(TTAGGG)3 under different temperatures as indicated at the top of the gel. Major repeats 
of telomeric DNA extension product are labeled on the left of the gel, showing numbers 
of nucleotides added in each repeat. l.c.: loading control of end labeled 15 nt DNA oligo. 
 
 To confirm our findings using telomerase reconstituted in cells, we overexpressed 
hTR and hTERT to assemble “super-telomerase” as described in Cristofari et. al. (9). 
Instead of using full length hTR, we designed three mutated hTR genes corresponding to 
the three constructs used in the in vitro reconstituted telomerase (Fig. 3.1a). Northern 
blotting analysis indicated correct processing and equal levels of different hTR constructs 
(Fig. S3.2). We reasoned that the super-telomerase cell extract might contain other 
polymerases to react on RNA/DNA duplex, or single stranded oligos. An anti-FLAG 
immuno-precipitation was performed prior to telomerase reaction, since our hTERT 
construct contained a 3X FLAG tag at the N terminus. When supplied with 7 bp 
RNA/DNA substrate, cell reconstituted telomerase yielded similar results as in vitro 
76 
reconstituted telomerase. Template free telomerase (hTR 62-451) is more active than the 
telomerases with hTR tethered in the active site (hTR 1-451) (Fig. S3.2, compare lane 8 
to lane 11). Addition of dCTP in the reaction result in one more nucleotide incorporation 
compared to 32P dGTP only reaction (Fig. S3.2, compare lane 7 and 8). This result 
indicates template free telomerase reconstituted in vivo also reverse transcribed upon 
RNA/DNA duplex.  
We next set out to investigate whether template free telomerase releases the 
product in a duplex form or as single stranded RNA and DNA oligos. It is tempting to 
think that telomerase would unwind the duplex within the active site after repeat 
synthesis because wild-type telomerase has to undergo a template translocation event to 
permit a processive reaction (28). We first conducted a time course reaction to confirm 
that template-free telomerase has enzyme turnover (Fig. 3.2e). The E. coli Exonuclease I 
(Exo I), which specifically cleaves single stranded DNA from 3’ to 5’ end, was mixed 
with the telomerase reaction. If telomerase releases its products as single stranded oligos, 
Exo I would digest the departed product DNA oligo. Our result showed that telomerase 
products as well as a DNA control pre-annealed with RNA oligo remain intact, while a 
single stranded DNA control was significantly digested after incubation (Fig. 3.2f). This 
data suggests that template-free telomerase can recognize substrates and release products 
in the duplex form.
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Fig. 3.2 e, (left panel) Template free telomerase reaction was carried out from 5 to 30 
mins. Reaction products of 3 g extension are labeled on the right of the gel. (right panel) 
The relative intensity of the reaction product was plotted against time. f, template free 
telomerase reaction was carried out with or without Exonuclease I. RNA/DNA* duplex 
indicates the DNA was end labeled and serve as a control in double stranded form. RNA 
oligo: 5’-GCCCGACCCUAACUGA-3’ DNA 5’-32P-
TTAGGGTTAGGGTTAGGTCAGTTAGGGTC-3’ ssDNA*: an end labeled single 
stranded DNA control: 5’-32P-TTAGGGTTAGGGTTAGGATCGGTC-3’.  Template 
free telomerase substrate, RNA oligo: 5’-GCCCGACCGAU-3’; DNA oligo: 5’-
AGGGTTAGGATCGGTC-3’. 
 
 
e. The template free telomerase reaction has turnover 
 
 
f. Exonuclease I digestion of 
template free telomerase 
reaction products 
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3.4.3 Primer extension activity of template free telomerase using various duplex 
substrates 
3.4.3.1 Duplex with 5’ DNA overhang 
Telomerase contains a TEN domain which binds to the 5’ end of the single 
stranded telomeric DNA (11). We extended the 5’ end of the DNA oligo by 3 to 17 nts of 
telomeric sequence overhanging the 7 bp duplex to test how this TEN-DNA interaction 
affects the template-free telomerase reaction. The 5’ overhang greatly enhanced the 
overall activity even when it is only 3 nucleotides long (Fig. 3.3a, compare lane 1 to 6 
with lane 7). The nucleotide addition processivity has also increased, as the ratio between 
+3g/+1g band gradually increased along with the increase of overhang length. This is 
probably due to the existence of the proposed proximal and distal DNA binding sites, 
including TEN domain, in the TERT protein (10,19). To test if the overhang increased 
the affinity between the enzyme and the substrate, we measured the apparent Km of 7 bp 
duplex with or without a 12 nt overhang. The overhang significantly decrease the Km by 
30 fold compared to the duplex without the overhang, which has an apparent Km about 
100 µM (Fig. S3.3). This phenomenon is consistent with the fact that telomerase has 
evolved specific motifs to recognize the single stranded DNA substrate, while the 
recognition of duplex substrate at the catalytic core has a much lower affinity to allow the 
processive telomerase reaction. 
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a. Template free telomerase reaction with various duplexes with different stem lengths 
and 5’ DNA overhang lengths 
 
Fig. 3.3 Template free telomerase reaction on different duplex substrates. a, (left panel) 
the activity assay of template free telomerase on substrates with different stem length and 
5’ DNA overhang length. (right panel) schematic of all the duplexes used in this study. 
The RNA sequences are highlighted with black backround while the DNA sequences are 
highlighted with grey background.
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3.4.3.2 Various duplex lengths 
 
When the wild-type human telomerase is performing reverse transcription, the 
potential base pairs between the RNA template and the DNA primer can be from 5 to 11. 
Therefore, we designed a set of duplexes to test if template free telomerase has length 
requirement for the duplex substrates. We first used the 7 to 12 base pairs non-native 
duplexes, which all have the same duplex sequence in the 3’ DNA and 5’ RNA portion. 
These duplexes all have higher Tm compared to duplex 7, most of which form duplex 
under our reaction condition. In this case, any reaction defect would represent inability of 
the telomerase to use available duplexes. Interestingly, all duplexes yield similar levels of 
activity (Fig 3.3a, lane 7 to 12). Template-free telomerase also show comparable level of 
activity with a 16 bp duplex, suggesting the active site of telomerase doesn’t discriminate 
long duplexes. We then test if telomerase can use shorter duplexes with native sequence 
that are only 5 to 9 base pairs long. Due to the low Tm of these duplexes under standard 
conditions, we conducted the reaction at 4°C with higher concentration of K+ and oligos 
to significantly increase the Tm (see Materials and Methods). Using these extreme 
conditions, we clearly show that template free human telomerase efficiently use native 
sequence duplex ranging from 5 to 9 base pairs (Fig. 3.3b).  
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b. Template free telomerase reaction with telomeric duplexes ranging from 5 to 9 
base pairs 
Fig 3.3 b, (left panel) template free telomerase was assayed with 5 different telomeric 
duplexes from 5 to 9 base pairs. The reaction was carried out under a condition that has 
high salt and high duplex substrate concentration to assure short duplex formation (see 
Materials and Methods). (right panel) schematic of the duplex substrates used in this 
study. 
 
3.4.3.3 Different RNA template lengths 
 Upon binding to the RNA/DNA duplex, conventional RTs can reverse transcribe a 
long strand of DNA along the RNA template. It is interesting to see how long telomerase 
can extend when a long RNA template is available. Template-free telomerase was able to 
reach the end of the template when it is 4 or 7 nt long (Fig. 3.3c, lane 1 and 2). However, 
the extension only goes up to 8 nt when the template is 11 nt long (Fig. 3.3c. lane 3). We 
also tested a different sequence and longer template and still observed an 8 nt extension 
(Fig. S3.4). All four nucleotides were included in our test, addition of dA seems to be less 
processive than the others, indicated by stronger stops in Fig. 3C lane 3. Nonetheless, the 
nucleotide addition processivity of all residues is low despite the template sequence. 
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Pausing/dissociation occurred at each position when a nucleotide was added. This 
processivity is rather low compared to retroviral RTs, such as HIV RT, which can 
synthesis 300 nucleotides along rA template without dissociation (29). Therefore, 
telomerase might have evolved with a special mechanism to use the short template in 
processive reaction cycles to add a large number of DNA repeats.  
c. Template free telomerase reaction with substrates that have long RNA templates 
Fig. 3.3 c, (left panel) Template free telomerase extends duplex with long RNA templates 
(L1: 5 nt, L2:8 nt, L3:11 nt). The nucleotides added to the DNA are indicated on the sides 
of the gel. (right panel) Schematic of the substrates used in this reaction. Three dNTP 
substrates were used, with only 32P dGTP as radioactive.
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3.4.4 Comparison of different hybrids as substrates for template free telomerase 
 
 Telomerase has exhibited limited activity to act as an RNA-dependent RNA 
polymerase (RdRP) and a DNA-dependent DNA polymerase (23, 24). Conventional RTs 
also have both robust RNA-dependent and DNA dependent DNA polymerase activity. 
The RT domain of telomerase is highly conserved compared to other RTs, suggesting that 
the above mentioned polymerization activities could be performed by telomerase RT. 
Testing this idea was previously hampered by the nature of telomerase in that it carries an 
intrinsic RNA template. Taking advantage of the template free telomerase system, we 
directly compared the ability of telomerase to use RNA/DNA, RNA/RNA, DNA/DNA 
and DNA/RNA hybrids. All the hybrids were designed with the same sequences of ribo- 
or deoxyribo- nucleotides (Fig. 3.4a, RD1, RR1, DD1 and DR1). Template free 
telomerase was reconstituted in vitro followed by an anti-FLAG IP, in order to prevent 
background RNA or DNA polymerase activity from the TNT lysate (Promega 
manufacturer handbook). Surprisingly, only RNA/DNA duplex gave rise to telomerase 
specific reaction products (Fig 3.4a, lane 3).  
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a. Template free telomerase reaction with homo- or hetero- RNA/DNA duplexes and 
chimeric duplexes 
 
 
 
b. Template free telomerase reaction with duplexes priming with chimeric oligos 
 
Fig. 3.4 Template free telomerase reaction on different combinations of hybrid duplexes. 
The substrate duplexes are represented as two letter symbols plus one number. For 
example: RD1=RNA/DNA hybrid no.1, DR2=DNA/RNA hybrid no.2. The exact 
sequences are shown on the top of the gel. As previously stated, black background 
represents ribonucleotides, while the grey background represents deoxyribonucleotides. 
The oligo with both grey and black backgrounds stands for a chimeric oligo. The 
substrates were assayed with either template free telomerase RNA (hTR*), hTERT or the 
template free RNP complex. The telomerase specific addition of nucleotides is labeled as 
“+1, +2, +3” and so on. 
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      We then swapped the template overhang in different hybrids, e.g., putting DNA 
template to RNA/DNA duplex stem and RNA template to DNA/DNA duplex stem (Fig. 
3.4a, RD2, RR2, DD2 and DR2). In the third set of duplex hybrids, the chimerical 
sequence of templates was extended into the duplex stem. For example, the RD3 
substrate will have a DNA-DNA base pair at the 3’ end of the DNA, and the template 
overhang is all deoxyribonucleotides (Fig. 3.4a). Again, only RD2 and RD3 can be used 
by telomerase (Fig. 3.4a, lane 15 and 27). These data suggested that the duplex stem is 
the essential factor for telomerase recognition, only the RNA/DNA hybrid can be used. 
The nature of the template and the last base pair of the duplex stem are not important. 
Comparing the reaction pattern of three different RNA/DNA hybrids, the conclusion that 
DNA/DNA stem is not preferred by telomerase active site can be further supported. The 
RD1 produces three dG along three rC templates (Fig. 3.4a, lane 3). The RD2 only 
allowed two dG incorporated along two dC templates (Fig. 3.4a, lane 15), potentially 
because the telomerase active site does not allow more than two DNA/DNA base pairs in 
the hybrid. This is further supported in the RD3 substrate, where the duplex already 
contains a dG/dC base pair in the duplex stem. Addition of only one dG, making two 
DNA-DNA basepairs in the stem, strongly seized the extension (Fig. 3.4a, lane 27). 
 Both RNA and DNA can prime the RNA dependent DNA polymerase reaction for 
retroviral RTs (30). We thus try chimeric primer oligos in our duplexes to see if different 
residues prime the reaction differently. These chimeric oligos were base-paired with 
those chimeric template oligos used in the first set, forming 12 new chimeric hybrid 
duplex substrates (Fig. 3.4b). As expected, with the preferred RNA/DNA duplex 
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substrates, ribonucleotide residue primes the extension as efficiently as 
dexoyribonucleotide residues (compare lane 3, 15 and 27 from Fig. 3.4a and 3.4b). 
Surprisingly, two RNA/RNA hybrids become more favorable substrates when the last 
nucleotide in the primer oligo was changed from ribo- to deoxyribo- nucleotide (compare 
lane 6 and 30 from Fig. 3.4a and 3.4b). This suggests that although both nucleotides can 
prime DNA elongation, deoxyribonucleotides are still more favorable. This also indicates 
that RNA/RNA duplex is the second most favorable duplex substrate after RNA/DNA 
duplex.  
 Lastly, we tried NTPs and α 32P GTP as building blocks with the duplexes we used 
in Fig. 3.4a. However, none of the duplexes show telomerase specific activity (Fig. S3.5), 
indicating the RNA polymerase activity of telomerase is much weaker than DNA 
polymerase activity.  
3.5 Discussion 
 Telomerase is believed to be a single strand specific reverse transcriptase carrying 
an intrinsic template within its RNA moiety. Both the protein and the RNA components 
of the telomerase enzyme have been specifically evolved for utilizing single stranded 
telomeric DNA. TERT protein has evolved single stranded DNA binding motifs to 
interact with telomeric DNA (19). The telomerase RNA template is usually 
complementary to the telomeric DNA and is usually longer than one repeat (20). This 
helps with recognizing the telomeric ends by RNA/DNA base pairing. The other RTs do 
not have an intrinsic RNA template and they have to use duplex substrates. It is believed 
that telomerase is evolutionarily related to other reverse transcriptases, because it 
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contains the seven signature protein motifs in the TERT responsible for RT reactions. 
Due to the existence of the intrinsic RNA template in the TERT active site, the possible 
ability of the telomerase enzyme to react on duplex substrates has therefore been 
overlooked in the past. 
 In this study, we have specifically designed a template free telomerase to assay 
the enzyme’s ability of using duplex substrates. Our biochemical analysis of template 
free telomerase has proven that the catalytic core of the telomerase enzyme retains the 
ability to use RNA/DNA duplex as other RTs (Fig. 3.1). The existence of the intrinsic 
RNA template does reduce the accessibility of the catalytic core to the duplex substrates. 
Both ends of the RNA template are tethered by linkers between template to P1 stem 
(5’end) and to P2a stem (3’end) (Fig 3.1b). When the RNA template is not tethered, the 
template free telomerase reaction on duplex substrate has an increased level of activity. 
The weak signal detected with hTERT assembled with hTR CR4-CR5 only indicates 
these two components are the minimal requirements for an active telomerase (Fig.3.1c). 
In the wild-type telomerase, the function of the pseudoknot fragment might be providing 
the template sequence and enhancing the enzyme activity, rather than supplying the 
catalytic property (4). 
 We have also provided evidence indicating that the telomerase catalytic core 
releases the product as a RNA/DNA duplex (Fig. 3.2e. 2f.) Although template free 
telomerase is a heavily modified artificial system, we believe that the duplex binding and 
releasing shed a light on understanding the natural telomerase reaction cycle. During a 
translocation event of a telomerase reaction, the RNA template and DNA product need to 
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dissociate and re-anneal for the next round of repeat synthesis. This duplex dissociation 
could happen within the catalytic core or elsewhere after being released from the catalytic 
core. Our data suggested that the strand separation between RNA template/DNA product 
hybrid happens outside of the catalytic core. However, we could not rule out the 
possibility that, in a real telomerase reaction cycle, long overhang of DNA primer and the 
tethering of the RNA template provide an anchor site for the interaction between duplex 
and the TERT protein. When a conformational change occurs during translocation, the 
RNA/DNA hybrid got pulled apart due to their interaction to protein respectively. 
The ability of template free telomerase to extend different duplexes with various 
lengths can be explained by the recently solved Tribolium TERT crystal structure (Fig. 
3.3a) (17). The beetle TERT resembles a ring structure with the catalytic site sitting in the 
center of the ring. The RNA/DNA duplex is possibly positioned in the center of the ring 
for catalytic reaction. Although human TERT contains an extra TEN domain compared to 
beetle TERT, it is highly possible that the ring structure also exists in human TERT. 
Thus, as long as the 3’ of the DNA in the RNA/DNA duplex can be positioned in the 
active site, the length of the duplex substrate can be variable. 
 Our test of using GTP as substrates for template free telomerase is somewhat 
contradictary to the recent finding about RdRP activity from hTERT (25). The different 
reaction conditions and substrate nature, such as salt concentration, duplex substrate 
versus potential hairpin substrate and TNT reconstituted hTERT versus E. coli expressed 
hTERT, might explain the different results obtained. Nonetheless, it is reasonable that 
telomerase cannot use NTPs as efficiently as dNTPs, thus insuring the sequence integrity 
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of chromosome ends. 
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CHAPTER 4 
RNA/DNA DUPLEX BINDING IS AN ESSENTIAL STEP 
DURING TEMPLATE TRANSLOCATION  
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4.1 Abstract 
 Telomerase reverse transcriptase (RT) is unique in that it recognizes single 
stranded DNA substrates and synthesizes telomere repeats onto the chromosome termini 
using its intrinsic RNA template. RNA/DNA duplex binding has been implicated in 
template translocation efficiency thus contributing to telomerase processivity (Chapter 3). 
Here, we use the template free telomerase developed previously to react with telomeric 
RNA/DNA duplex substrates. Mutations within telomerase reverse transcriptase (TERT) 
that affect repeat addition processivity correlate with the enzyme’s affinity toward duplex 
substrate, with the exception that N-terminal TERT mutant reduced processivity by 
hampering single stranded DNA binding. Telomerase catalytic core favors 5 and 6 base 
pairs duplex substrates. In consistency, a 5 bp duplex but not 7 bp duplex inhibits 
telomerase processivity in a wild-type telomerase reaction. Moreover, circular 
permutation of 7 base pair duplex indicates that telomerase active site has sequence 
preferences towards duplex substrates. Detailed nucleotide substitution revealed that two 
rA-dT basepairs within the telomeric duplex are responsible for the sequence specificity. 
Our data have not only demonstrated the catalytic core of telomerase specifically evolved 
for the recognition of RNA/DNA duplex with a certain length, but also indicated that 
duplex binding is an essential step during template translocation, which determines 
telomere repeat addition processivity.
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4.2 Introduction 
 Human telomerase is capable of adding multiple telomere repeats upon one 
primer binding event. This repeat addition processivity relies on a template translocation 
mechanism whereby the RNA template dissociates and realigns relatively to the DNA 
substrate. After translocation, a 5 base-pair RNA/DNA duplex would form in the 
catalytic site of telomerase, with the 6 nt RNA template available for the next repeat 
synthesis. Theoretically, the RNA/DNA duplex inside the catalytic core can be extended 
up to 11 base pairs. The processive addition of telomeric DNA can be attributed to the 
intrinsic property of the telomerase core components. The realignment region and 
template boundary element in hTR facilitate template translocation by supplying a 
relocation site for the 3’ end of the DNA and avoiding incorporation of non-telomeric 
sequence (1, 2). In the hTERT protein, mutations in Telomerase esstinal N-terminus 
(TEN), motif 3, Insertion in Finger Domain (IFD) and C-terminus extension (CTE) all 
affect telomerase processivity. While the TEN domain functions as an anchor site for 
upstream telomere substrate binding, motif 3-IFD-CTE might form a molecular clamp to 
facilitate duplex formation or binding during translocation (3). 
 To investigate if duplex binding is a key step during template translocation, we 
used template-free human telomerase designed in chapter 3. When supplied with pre-
annealed telomeric RNA/DNA duplex as substrate, this system allows for direct 
investigation of telomerase’s ability to bind the duplex. Here, we show that our template 
free telomerase reverse transcribed upon telomeric RNA/DNA substrate. More 
importantly, proposed molecular clamp mutations that decrease telomerase processivity 
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had lower affinity to duplex substrate compared to wild-type enzyme, while a mutant 
with augmented processivity shows higher affinity. Including a duplex substrate in 
wildtype telomerase reaction reduces its processivity severely, while single stranded 
RNA or DNA did not have the same effect. The TEN mutation decreased processivity 
through defective upstream binding, therefore leaving the duplex binding ability intact. 
Using this template free telomerase and circular permuted 7 base pair telomeric duplexes, 
we directly showed that telomerase preferred some of its native RNA/DNA duplex over 
other native sequences. These data support that duplex binding is a critical step during 
template translocation, thus contributing to telomerase repeat addition processivity. 
4.3 Materials and Methods 
4.3.1 Oligos and duplex substrate preparation 
 Deoxyribo- or Ribo- nucleotide oligos are ordered from Integrated DNA 
technology Inc. Detail sequence of each oligo can be found in figures. To assemble 
RNA/DNA substrates, the complementary oligos are mixed in indicated concentrations in 
1X annealing buffer (100 mM Tris-HCl (pH7.5), 500 mM NaCl, 50 mM EDTA). The 
mixture was heated at 70°C for 3 min and gradually cool down in room temperature. 
4.3.2 Tm measurement 
 Duplex substrates were supplied in a 250 µL volume at 20 µM final concentration 
in 1X telomerase reaction buffer (50 mM Tris-HCl pH 8.3, 50 mM KCl, 2 mM DTT, 3 
mM MgCl2, 1 mM Spermidine) and 1X annealing buffer. The OD-260 of the solution 
was measured along the temperature change from 70 to -1°C at 1°C intervals using Cary 
300 UV-vis spectrophotometer (Varian tech.) with multicell holder thermal controllable 
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accessory. Data points were fitted to sigmoidal curve (variable slope) to calculate the 
annealing temperature value, Tm (Prism, Graphpad Software Inc.). 
4.3.3  In vitro and in vivo reconstitution of template free telomerase 
 See section 2.3.3 
4.3.4 Template free telomerase activity assay 
 Activity assay was modified from previously described protocol (Chapter 3). 
Basically, 1.5 µL of in vitro reconstituted telomerase was assayed in a 10 µL reaction 
with 50 mM Tris-HCl pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, 1 mM 
Spermidine, 0.165 µM α32P-dGTP (3000 Ci/mmole, 10 mCi/mL, PerkinElmer), and 20 
µM duplex substrate. The reaction was carried on for 60 min at 4°C or 25°C and 
terminated by phenol/chloroform extraction, then ethanol precipitated. The product was 
applied to 18% polyacrylamide gel, and analyzed by Phosphor Imager. For the duplex 
competition of telomerase processivity assay, wildtype telomerase was reacted in 10 µL 
volumne with 50 mM Tris-HCl pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, 1 mM 
Spermidine, 1 mM dTTP, 1 mM dATP, 2 µM dGTP, 0.165 µM α32P-dGTP (3000 
Ci/mmole, 10 mCi/mL, PerkinElmer), and 1.5 µL 1µM (GGTTAG)3 telomeric primer. 
Competition duplexes or oligos were added to 200 µM as final concentration. The 
reaction condition and duplex concentration used in Km measurement and turnover 
measurement assays were specified in the figure legends. For processivity competition 
assay, the telomerase activity assay was altered to include 200 µM of processivity 
inhibitory duplexes. The reaction was carried out under 4°C for 2 hours. Termination of 
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the reaction and data analysis is the same as conventional telomerase activity assay 
described above. 
4.3.5 Immuno-precipitation (IP) of N-FLAG tagged telomerase 
 For each 50µL 293 FT cell extract, 20µL of anti-FLAG M2 affinity agarose beads 
(Invitrogen) was centrifuged 5000 xg for 30 sec. The beads were washed twice with 500 
µL TBS buffer (50 mM Tris HCl, 150 mM NaCl, pH 7.4). 50 µL 293 FT cell extract was 
added to the washed beads allow for binding at 4°C with gentle agitation. After 2 hours 
of IP, the beads were washed 3 times with 500 µL TBS and 1 time with 1X PE buffer 
(telomerase reaction buffer).  
4.3.6 Western blotting  
 Immuno-precipitated telomerase holoenzyme with NFLAG-tagged hTERT from 
50µL 293 FT cell lysate was heated at 95°C for 5 min in 1X Laemmli buffer (0.125M 
Tris-HCl, pH6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol and 0.0025% 
bromophenol blue), fractionated on a 6% or 8% SDS-PAGE gel, and electro-transferred 
onto the PVDF membrane. Blocking (overnight at 4ºC) and incubation with antibodies (1 
hour at room temperature) were carried out in 5% nonfat milk/1X TTBS (20 mM Tris-
HCl, pH 7.5, 150 mM NaCl and 0.05% Tween 20). Anti-hTERT goat polyclonal 
antibody L-20 (Santa Cruz Biotechnology) was used as the primary antibodies. After 
incubation with the HRP-conjugated secondary antibody (Santa Cruz Biotechnology), the 
blots were developed using the Immobilon Western Chemiluminescent HRP substrate 
(Millipore), and the blot images were acquired and analyzed using a Gel Logic440 
system (Kodak).  
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4.3.7 Northern blotting  
 Immuno-precipitated telomerase holoenzyme from 50µL post-transfection 293 FT 
cells was phenol/chloroform extracted and ethanol precipitated. The RNA was resolved 
on a 4% polyacrylamide/8M urea denaturing gel and electro-transferred to the Hybond-
XL membrane (GE Healthcare). Preparation of the riboprobes and hybridization of the 
blot were carried out as described in chapter 5. 
4.3.8 Terminal deoxynucleotidyl transferase (TdT) reaction 
 100 nM of DNA oligo is mixed in 25 µL reaction with 25 mM NaCacodylate 
(pH7.2), 1 mM CoCl2, 0.1 mM DTT and 10 U of TdT (USB scientific) and incubated at 
37°C for 1 min. Reaction was terminated by phenol/chloroform extraction and ethanol 
precipitated.  
4.4 Results 
4.4.1 Template free telomerase extends telomeric duplex better than non-telomeric 
duplex substrate 
 Although telomerase is a single strand specific reverse transcriptase, the catalytic 
site of this enzyme still retains the ability to utilize duplex substrates similar to other RTs 
(Chapter 3). Our previous study focused on a non-telomeric duplex sequences. Due to the 
relative conserved GT rich telomere sequence in all the species identified to date and the 
absolute conserved 5’-GGTTAG-3’ telomeric repeat in vertebrates, we reasoned that 
telomerase active site might have evolved to suit specific telomeric sequence. Therefore, 
we carried out template free telomerase reaction with both non-telomeric and telomeric 
duplex substrates side by side. As illustrated in chapter 3, the template free telomerase is 
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reconstituted in vivo as “super telomerase” using 293 FT cell transfection system (4). 
Instead of using the full length hTR gene, we introduced a hTR lacking the first 63 
nucleotides including the template sequence. Important domains for catalytic activity, the 
triple helix/pseudoknot domain and three way junction/CR4-CR5 (5, 6), remain in the 
construct. The Sno/ScaRNA domain, that is responsible for hTR in vivo biogenesis is 
also present in the template free telomerase hTR (Fig.4.1). 
 
Fig.4.1 Secondary structure of human telomerase RNA and template free hTR construct. 
Full length hTR nt 1-451 (left) and template free hTR nt 64-451 (right) sequences are 
represented as secondary structures. The nucleotides highlighted in red stands for 100% 
conservation in all the vertebrate telomerase RNAs. The basepairs highlighted in green 
represent base pairing supported by phylogenetic comparative analysis. Three major 
domain structures are indicated in dash-line boxes in wildtype hTR structure. The starting 
and ending residues of the two hTR structures are labeled. For the in vivo reconstituted 
telomerase from 293FT cells, hTR 64-451 was introduced. For the in vitro reconstituted 
telomerase, template free pseudoknot domain together with CR4-CR5 domain were 
assembled with hTERT in Rabbit Reticulocyte Lysate to obtain active enzyme (see 
Materials and Methods). 
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 The template free telomerase was extracted from 293 FT cells and immuno-
precipitated with anti-FLAG agarose beads and then assayed for activity with both non-
telomeric and telomeric sequence duplexes (see Materials and Methods). In consistence 
with the data presented in chapter 3, the activity observed is telomerase specific (Fig.4.2, 
lane 3, 4, 14 and 15). Firstly, 293 FT cell without over expression of neither hTERT nor 
hTR gene has no duplex extending activity (Fig. 4.2, lane 1 and 12). Secondly, 
transfection with only the hTERT gene didn’t yield observable activity (Fig. 4.2, lane 2 
and 13). Moreover, we have included a catalytic inactive hTERT D868N construct as a 
negative control. Over expression of hTERT D868N alone produced similar activity as 
hTERT only, indicating hTERT itself does not react on the duplex substrates (Fig. 4.2, 
compare lane 2 with 7 and 13 with 18). Thirdly, only when RNA and DNA oligos were 
presented together, namely, when duplex substrates are available, can telomerase extend 
the DNA oligo, thus excluding the possibility of terminal transferase activity (Fig. 4.2, 
lane 6, 7, 16 and 17). Lastly, the protruding RNA template sequence was designed to be 
3‘-CA-5’, directing the consecutive synthesis of dG and dT residues. When dGTP and 
dTTP substrates are both included in the reaction, telomerase extend one more residue 
than dGTP only reaction (Fig. 4.2, compare lane 3 with lane 4 and lane 14 with lane 15). 
This result again indicated template free telomerase synthesized DNA product along the 
RNA template. The catalytic inactive construct did not show any comparable activity as 
the wild-type telomerase construct (Fig. 4.2, lane 8, 9, 19 and 20). Moreover, to assure 
the correct residues were incorporated into the DNA sequence, we included a terminal 
transferase reaction product on the same DNA oligos as control (lane 10 and 11). The 
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terminal deoxynucleotidyl transferase (TdT) incorporates dG residues onto the oligo, 
presumably having the first residue at the same position as the telomerase reaction 
product. Indeed, the two activities showed the same mobility in the polyacrylamide gel. 
As the second residue incorporated by TdT is still a dG, higher molecular weight than dT, 
we observed a lower mobility of product of TdT reaction compared to second band of the 
telomerase product. These data indicate that the correct residues were added into the 
DNA as predicted by RNA template. 
 To compare activity levels of non-telomeric and telomeric duplex sequences, the 
substrate used in chapter 3 and a newly design telomeric duplex with 5’-GGTTAGG-3’ 
DNA sequence were compared. These two duplexes showed similar melting curves under 
UV melting Tm analysis. Thus, under our reaction condition in room temperature, the 
available amount of duplex substrates is equal. The telomeric duplex activity is 2 fold 
higher than the non-telomeric duplex. 
 To confirm the presence of both hTERT and hTR components in the complex that 
we pulled down with anti-FLAG agarose beads, western blotting and northern blotting 
analysis were performed (see Materials and Methods). The hTERT and hTR were present 
as expected (Fig.4.2, lower panel): when hTERT gene was transfected, protein was 
enriched in the IP’ed beads, and hTR ∆1-63 migrates faster than the full length construct 
(1-451). These data further confirmed that the template free telomerase reacts as a true 
RNP complex with the existence of both hTERT and hTR components. 
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Fig. 4.2 Template free telomerase reaction with both non-telomeric and telomeric 
RNA/DNA duplexes. (Upper panel) Template free telomerase was reconstituted in 293 
FT cells with over expression of hTERT and hTR ∆1-63 and assayed with non-telomeric 
and telomeric RNA/DNA duplexes (see materials and methods). Transfection with either 
the hTERT gene, hTR ∆1-63 gene or hTERT D868 catalytic inactive variant are 
indicated. Sequence of the duplex is indicated on the top of the gel. Characters with black 
background indicate RNA sequence, and characters with grey background denotes DNA 
sequence. Combinations of RNA oligo alone, DNA oligo alone or both, and presences of 
dTTP residue in the reaction are labeled on the top of the gel. M1: terminal transferase 
extension of DNA oligo: 5’ ATCGGTC 3’ as size marker. M2: terminal transferase 
extension of DNA oligo: 5’ GGTTAGG 3’. (Middle panel) Western blot analysis of 
template free telomerase. Template free telomerase was immuno-precipitated by anti-
FLAG agarose beads and immuno blotted with hTERT antibody (see Materials and 
Methods). l.c. A 32P end labeled 15 nt DNA oligo as loading control. (Lower Panel) 
Northern blot analysis of IPed template free telomerase. Template free telomerase was 
immuno-precipitated by anti-FLAG agarose beads and hybridized with anti-hTR 
riboprobe (see Materials and Methods). M3, 1 ng in vitro transcribed full length hTR as 
size marker. M4, 1 ng in vitro transcribed hTR ∆1-63 as size marker. 
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4.4.2 Processivity defect mutants affected duplex binding 
 The RNA/DNA duplex binding was implicated in template translocation during 
wild-type telomerase reaction (Chapter 3). The mutations in motif 3, motif IFD and CTE 
domain of hTERT presumably decreased the enzyme’s ability to bind RNA/DNA duplex, 
thus reducing telomerase processivity (3). To further address the connection between 
duplex binding and telomerase processivity, we chose 7 telomerase processivity mutants 
and assayed their duplex binding ability (Fig. 4.3). Mutant N95A (TEN) resides in the 
TEN domain, which is responsible for the upstream DNA binding away from the 
telomerase active site. Other mutants, N666A, R669A, L681A, D684A (motif 3), 790-
794 VVIE-4A (IFD) and L980A (CTE) sit in the hypothetical molecular clamp 
surrounding the RNA/DNA duplex around the telomerase catalytic site (3). Among all 
the mutants, only D684A augmented telomerase processivity, thus serving as a positive 
control in this study. N95A mutant decreased processivity through a distinctive manner 
compared to molecular clamp mutants, i.e. defective upstream DNA binding versus 
duplex binding (molecular clamp mutants).
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Fig. 4.3 Processivity defect mutants in motif 3, IFD and CTE domain. (Upper panel), 
schematic of mutation distribution in hTERT. Four major structural domains are 
depicted: Telomerase essential N-terminas domain (TEN), Telomerase RNA binding 
domain (TRBD), Reverse transcriptase domain (RT) and C-terminal extension domain 
(CTE).  The signature motifs in each domain are also labeled. (lower panel) Wild-type 
and processivity mutant hTERTs were assembled with hTR nt 32-195 and nt 239-328 in 
RRL to reconstitute active telomerase. Telomerase activity was assayed using 
(TTAGGG)3 primer (see Materials and Methods). l.c.: a 32P end labeled 15 nt DNA oligo 
used as loading control. Expression level of hTERT was monitored using SDS PAGE 
analysis of 35S Met incorporation into the protein. 
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 We subsequently assembled template free telomerase using the processivity 
mutant hTERT proteins and performed activity assay with telomeric duplex substrates. 
Intriguingly, most low processive telomerase failed to extend duplexes, except for the 
N95A and R669A mutants (Fig. 4.4, lane 4-11 and lane 14-17). In contrast, hyper-
processive mutant D684A is as active as wild-type enzyme in this assay. We reasoned 
that duplex affinity to the catalytic site might be responsible for these different levels of 
activity (Fig. S4.1). Hyper-processive D684A has only a 30 µM apparent Km, lower than 
the 58 µM of wild-type enzyme. The N95A TEN mutation reduced the DNA-protein 
interaction between the telomeric primer and hTERT. The higher probability of primer 
releasing contributes to the low processivity for this mutant (3). Therefore, the duplex 
binding ability remains intact. Indeed, the Km value for N95A is comparable to that of 
the wild-type. For the R669A mutant, higher Km (141 µM compared to 58µM of the 
wild-type) was observed, indicating lower affinity to the duplex substrates. Other lower 
processivity mutants did not have high enough activity to allow for Km determination, 
but they possibly have very low affinity to the duplex substrates. It is unexpected for the 
R669A to have a high activity level since the Km to duplex was very high for this mutant. 
We previously showed that it had almost two fold increase in turnover rate when using a 
short primer for activity assay (3). The faster turnover might be the reason behind the 
high activity observed here. When using a duplex substrate, R669A exhibited a 1.5 fold 
increase in enzyme turnover rate compared to wild-type (Fig. S4.2). Our assay using the 
template free telomerase and telomeric duplex thus provides the evidence for a direct 
correlation between processivity and the duplex binding event. This indicates that duplex 
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binding might be one essential step during template translocation, the key event 
determining telomerase processivity.  
 
Fig. 4.4 Template free telomerase reaction with telomeric duplex. Wild-type and mutant 
template free telomerase was assembled in Rabbit Reticulocyte lysate and reacted with 
telomeric duplex with a 5’-GGTTAGG-3’ DNA sequence. Processivity mutants are 
described in Fig. 4.3. Inclusion of dTTP substrate is indicated on the top of the gel. The 
relative amount of hTERT, with incorporation of 35S methionine, of each mutant is 
indicated with SDS-PAGE analysis. The apparent Km of wild-type, N95A, R669A and 
D684A are shown on the bottom of the gel, together with the enzyme turnover rate of 
wildtype and R669A enzyme. The sample gel could be found in Fig. S4.1 and S4.2. n/d: 
not determined. n.a.: not applicable. M2: TdT reaction on primer GGTTAGG as marker. 
 
4.4.3 Telomerase active site favors duplex ranging from 5 to 7 base pairs. 
During the processive addition of telomeric DNA repeats in the wild-type 
telomerase reaction, the duplex length in the telomerase active site could range from 5 to 
11 base pairs (Fig. 1.1). The duplex length could increase from 5 to 11 as the enzyme 
extends the telomeric DNA. However, it is also possible that telomerase is maintaining 
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constant base pairing in the catalytic site, i.e. unwinding upstream base pairs while 
extending downstream DNA. It was shown that a RNA/DNA duplex that is 
approximately 5 to 7 base pairs long was maintained in the yeast telomerase active site 
(7). The recently reported Tribolium TERT structure also suggested that the telomerase 
catalytic core could hold a 7 base pair duplex (8). To gain more detailed information 
regarding the human telomerase active site, we designed 6 duplexes with various length 
ranging from 5 to 10 basepairs and tested which length is the most suitable (Fig.4.5). 
 
 
Fig. 4.5 Telomerase catalytic core favors duplex length from 5 to 7 base pairs. Template 
free telomerase was assembled in RRL and assayed for activity using telomeric duplexes 
ranging from 5 to 7 base pairs (sequences shown in the right panel, duplex lengths are 
indicated). RNA sequences are highlighted in black background, DNA sequences are 
highlighted in light grey background. TdT control: GTTAGGG oligo were extended 
using dGTP substrates by terminal transferase (see Materials and Methods), used as a size 
marker. l.c. loading control: a 32P end labeled 15 nt DNA oligo nucleotides. 
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The duplex sequences were specifically designed to have three consecutive Gs at 
the 3’ end of the DNA, so that even the shortest 5 bp duplex would have a Tm around 
17°C under our reaction condition (Fig. S4.3). We then carried out the template free 
telomerase reaction using duplex 5-10 bp substrates at 4°C, where most of the substrate 
form duplex, thus allowed for fair comparison of all the substrates. To our surprise, the 
shortest 5 bp duplex produced the highest signal and the activity decreased gradually as 
the duplex length increased (Fig 4.5). While the duplex 5 and 6 generated higher activity, 
long duplex 9 and 10 gave significantly lower leveles of activity, indicating the catalytic 
core of human telomerase favors duplex ranging from 5 to 7 base pairs. However, our Km 
measurement suggested 5 bp duplex did not have higher affinity towards the template 
free telomerase than the 7 bp or 9 bp duplexes (Fig. S4.4). The high activity of template 
free telomerase reaction using 5 bp substrate could be attributed to the high enzyme 
turnover rate (Fig. S4.5). It is unlikely for telomerase to have distinct nucleotide addition 
rate upon different duplex substrate ending with the same residues. Thus, we speculate 
that higher turnover rate of the shorter duplex resulted from faster off-rate of their 
products releasing from telomerase active site. Faster off-rate of a short duplex is 
consistent with the idea that the duplex within telomerase active site is maintained in 5 to 
7 base pairs, which allows easier duplex releasing when a complete repeat synthesis is 
finished.  
Another interesting phenomenon is that only the shortest 5 bp duplex did not 
extend one more dT residue when dTTP was present in the reaction. The fact that 
telomerase extends 6 bp duplex and longer ones with higher nucleotide addition 
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processivity indicates that longer 5’ DNA and/or 3’ RNA protrudings in the duplex 
maybe responsible. We therefore created two more 5 bp duplexes with either a 2 nt DNA 
or RNA overhang. Apparently, the DNA overhang in the 5 bp duplex promotes 
nucleotide addition processivity, while the 2 nt RNA overhang does not (Fig. 4.6, 
compare lane 4 to 6). Similarly, a 1 nt DNA overhang also promotes nucleotide addition 
processivity (Fig. 4.6, lane 12). The data again suggested a 5 bp duplex is a better 
substrate than 7 bp, as neither the 2 nt DNA nor RNA overhang affected the activity of 
the 5 bp duplex (Fig. 4.6, compare lane 1-6 with lane 7-8).  
 
 
 
Fig. 4.6 DNA overhang promotes nucleotide addition processivity for duplex substrate. In 
vitro reconstituted template free telomerase was assayed with seven duplex substrates 
with or without overhangs. Including of dTTP and 32P dGTP in the reactions is indicated 
on the top of the gel. Addition of dG and dT residues is labeled in the gel. l.c.: loading 
control, a 32P end labeled 15 nt DNA oligonucleotides.   
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The correlation between low processivity and defective duplex binding indicates 
duplex binding is involved in the template translocation event of wild-type telomerase 
reaction. We designed a duplex competition experiment to explore this possibility. If 
duplex binding is indeed a step during translocation, an excess amount of duplex within 
the telomerase reaction would compete for the catalytic site and affect template 
translocation. In turn, the interference of template translocation will result in lower 
processivity. Intriguingly, a 5 base pair duplex severely decreased processivity, but the 7 
base pair duplex did not (Fig. 4.7). This phenomenon is consistent with the fact that a 5 
bp duplex fits the catalytic site better than the longer 7 bp duplex (Fig. 4.6). The lower 
processivity is indeed a result of duplex competition because high concentration of single 
stranded DNA or RNA did not reduce the processivity (Fig. 4.7, lane 5, 6 and 7). In the 5 
base pair competition, the activity from single stranded duplex DNA could also be 
detected in the reaction as a distinctive banding pattern that is 3 nt different from the 
products of long telomeric substrate (Fig. 4.7, lane 5 and 7).  
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Fig. 4.7 Processivity competition by 5 and 7 base pair duplexes. Wild-type telomerase 
was reconstituted in RRL and assayed for processivity using 100nM 5’-(GGTTAG)3-3’ 
telomeric primer. 200µM of duplex 5bp or 7bp competitor was added when telomerase 
reaction was initiated (see Materials and Methods). Single stranded RNA or DNA oligos 
used to assemble duplexes were added as control competitors in other separated reactions 
as indicated on the top of the gel. Different banding pattern of 5’-TAGGG-3’ and 5’-
(GGTTAG)3-3’ substrates are labeled on the right. l.c.: 32P end labeled 18 nucleotides 
DNA oligo. 
4.4.5 Telomerase catalytic core exhibits sequence specificity towards telomeric duplexes. 
 Other than the length of the duplexes, the sequence of duplex would also vary in 
the active site during wild-type telomerase reaction as the enzyme is incorporating 
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different nucleotides into the duplex. To test whether duplex with different sequences 
would yield different results in the template free reaction, we designed six circular per-
mutated telomeric duplex substrates of the 5’-TTAGGG-3’ sequence. The RNA template 
overhang is 5’-UUC-3’. The first rC directs incorporation of a dG radioactive signal in 
the DNA strand. Consecutive rU templates allows monitoring nucleotide addition 
processivity of different duplexes. The template free telomerase reaction on six different 
duplexes yielded very distinctive reaction patterns. CP1 and CP2 are the best substrate for 
the telomerase active site as they showed the strongest signal and had lower Km values 
compared to others (Fig. 4.8 and Fig S4.6). On the other hand, nucleotide addition 
processivity also varied significantly among 6 different substrates. CP5 duplex, with 
native telomeric repeat ending, has no nucleotide added at all. The CP4 product provided 
a hint on the failure of extending CP5 duplex already, as the CP4 product ends at a native 
telomeric repeat position with the sequence 5’-GGTTAG-3’, which is the exact sequence 
of CP5 duplex. 
Although it allows direct test of the interaction between duplex substrate and 
telomerase active site, template free telomerase is indeed a heavily mutated system. The 
sequence specificity observed in the template free telomerase reaction might play a very 
trivial role in wildtype telomerase, where the RNA template is tethered on both ends and 
the DNA oligo has a long 5’ overhang. Therefore, we assembled telomerase with 6 
circular permutated template sequences within the full length hTR. Surprisingly, the 
duplex sequence is still a major determinant for complete telomeric repeat synthesis. In 
spite of the different template sequences, all 6 circular permutated telomerases have the 
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banding pattern stopped after adding 5’-GGTTAG-3’ (Fig. 4.9). We then used 6 circular 
permutated telomeric primers to react with the circular permutated template mutants. The 
same primer has the same banding pattern when using different template mutants, 
suggesting sequence determinant of repeat synthesis has stronger effect than the P1 stem 
defined template boundary (Fig. S4.7).  
Fig. 4.8 Telomerase active site shows sequence specificity. Template free telomerase was 
reconstituted in RRL and assayed for activity using six circular permutated telomeric 
sequence duplexes. Substrate sequences (CP1-6) are depicted on the top of the gel. Black 
background highlights RNA sequences, while grey background highlights DNA 
sequences. The apparent Km value of each substrate is indicated at the bottom of the gel. 
Original gel image could be found in Fig. S4.6. Addition of dATP and 32P dGTP in the 
reaction is indicated as “+”. Incorporation of dG or dT residues are labeled as “g” and “a” 
on the right of the signal in the gel. l.c. 15 nt DNA oligo with 32P end labeling as loading 
control. 
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Fig. 4.9 Circular permutated template sequences in telomerase RNA. Six circular 
permutated hTR pseudoknot fragments (nt 26-195) were assembled with hTERT and 
CR4-CR5 domain (nt 239-328) and assayed for activity with their corresponding 
telomeric primers. (left panel) Annealing of either 7nt or 18nt primer to template results 
in 4 nucleotides of space for primer extension. (right panel) activity assay of template 
circular permutated telomerase. l.c. 15 nt 32P end labeled DNA oligo nucleotides. 
 
The distinctive duplex sequences result in different nucleotide addition 
processivity for CP1 (3 nt) and CP4 (1nt). To determine which base pair(s) in CP4 duplex 
is responsible for the low nucleotide addition processivity, we swapped three base 
pairings between CP4 and CP1 duplexes. The result clearly indicates that the middle 3 
base pairs encode a signal for the stop after a 5’-GGTTAG-3’ repeat (Fig. 4.10, duplex 
CP 4.a). We then mutated the 3 base pairings one by one to further explore the exact stop 
signal within this region. Interestingly, mutating the first rA-dT base pair of the two 
consecutive A-T base pairs in CP4 duplex resulted in one more dA extension when dATP 
114 
is included in the reaction (Fig. 4.10, CP4.d). The fact that CP4.d could not be extended 
by two dA residues might be because the remaining rA-dT now functions as the stop 
signal. Therefore, telomerase active site can accommodate 4 base pairs after encountering 
the first rA-dT base pair in the RNA/DNA duplex. 
 
 
Fig. 4.10 Sequence determinant of nucleotide addition processivity in the duplex 
substrate. Duplex substrates are depicted on top of the gel. Black background represents 
RNA sequences and grey background represents DNA sequences. The red font highlights 
the mutated sequence within CP4 duplex substrate. Addition of dATP and 32P dGTP 
nucleotides in the reaction is indicated. The incorporated nucleotides (a or g) are labeled 
alongside the gel. 
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4.5 Discussion 
 Template free telomerase provided a unique system to specifically look at the 
template translocation step of processive addition of telomere repeats by the telomerase 
enzyme. The telomerase specific activity on duplex substrate indicates the catalytic core 
of the enzyme obtained the ability to utilize duplex other than single stranded DNA. 
Furthermore, the catalytic core does favor telomeric duplex over non-telomeric duplex 
(Fig. 4.2). The mutations in molecular clamp surrounding RNA/DNA duplex that reduced 
telomerase processivity have lower affinity to the duplex substrates, while the hyper-
processive molecular clamp mutant increases the affinity between template free 
telomerase and the duplex (Fig. 4.3 and 4.4). On the other hand, the hypo-processivity 
mutant in TEN domain did not decrease processivity through low duplex binding affinity 
but through upstream DNA-protein interaction outside the active site. Also, short 
duplexes ranging from 5 to 7 bp are better substrates for telomerase than 8 to 10 bp 
duplexes (Fig. 4.5). Single stranded DNA overhang facilitates duplex movement in 
catalytic site, thus promoting nucleotide addition processivity (Fig. 4.6). Using a 5 bp 
duplex to compete with the telomerase processive reaction severely reduced the 
processivity while the 7 bp duplex competitor did not (Fig. 4.7). This suggests that a 
constant base pairing is maintained in the active site of human telomerase, similar to the 
number estimated in yeast telomerase and tribolium telomerase (7, 8). The data also 
suggested duplex binding and releasing is indeed happening during template 
translocation, thus allowing duplex competitor to reduce the processivity. 
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 The sequence specificity of telomerase active site is very unexpected. However, 
the stopping pattern of nucleotide addition of six circular per-mutated duplexes strongly 
implies a signal is encoded in the 5’-GGTTAG-3’ complete telomeric sequence to finish 
a single repeat synthesis (Fig. 4.8, 4.10). This data is somewhat contradictory to the 
template definition element study reported previously (2). Detailed Km studies shed a 
light on the reason behind telomerase active site sequence specificity. The affinity 
between duplex and active site decreases gradually towards the complete telomeric repeat 
5’-GGTTAG-3’. The CP5 duplex affinity was not tested due to extremely low activity. 
But we speculate this substrate has the lowest affinity as indicated by the trend. Fitting 
this phenomenon into wildtype telomerase reaction makes more sense. When a repeat 
synthesis is initiated (sequence with CP6:GTTAGG, CP1:TTAGGG), the duplex needs to 
sit stably in the active site and allows for following nucleotide addition. When the repeat 
synthesis is finished (CP5:GGTTAG), loosen duplex easily falls off the telomerase active 
site and initiate duplex separation for next round of repeat synthesis.  
 The DNA overhang increaseing nucleotide addition processivity is also not 
completely unexpected. A 5bp duplex with 1 or 2nt DNA overhang mimics the substrate 
formed within the active site in a wild-type telomerase reaction. Without DNA overhang, 
the duplex might get stuck in the active site and result in an unprocessive or inactive 
enzyme. 
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CHAPTER 5 
STRUCTURE AND FUNCTION OF THE SMALLEST VERTEBRATE 
TELOMERASE RNA FROM TELEOST FISH 
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5.1 Abstract  
 Telomerase extends chromosome ends by copying a short template sequence 
within its intrinsic RNA component. Telomerase RNA (TR) from different groups of 
species varies dramatically in sequence and size. We report here the bioinformatic 
identification, secondary structure comparison, and functional analysis of the smallest 
known vertebrate TRs from five teleost fishes. The teleost TRs (312–348 nucleotides) are 
significantly smaller than the cartilaginous fish TRs (478–559 nucleotides) and tetrapod 
TRs. This remarkable length reduction of teleost fish TRs correlates positively with the 
genome size, reflecting an unusual structural plasticity of TR during evolution. The 
teleost TR consists of a compact three-domain structure, lacking most of the sequences in 
regions that are variable in other vertebrate TR structures. The medaka and fugu TRs, 
when assembled with their telomerase reverse transcriptase (TERT) protein counterparts, 
reconstituted active and processive telomerase enzymes. Titration analysis of individual 
RNA domains suggests that the efficient assembly of the telomerase complex is 
influenced more by the telomerase reverse transcriptase (TERT) binding of the CR4–CR5 
domain than the pseudoknot domain of TR. The remarkably small teleost fish TR further 
expands our understanding about the evolutionary divergence of vertebrate TR. 
5.2 Introduction 
 Telomeres are specialized DNA-protein complexes that cap chromosome ends 
and are important for genome stability and cellular proliferation (1). Telomeres consist of 
repetitive DNA sequences and a variety of telomere-associated proteins. The length of 
telomeric DNA in most eukaryotes is maintained by telomerase, a specialized reverse 
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transcriptase that synthesizes telomeric DNA repeats at chromosome ends to 
counterbalance the natural shortening that occurs during DNA replication. Telomerase, a 
ribonucleoprotein (RNP) enzyme, consists of at least two essential corecomponents, the 
catalytic protein component telomerase reverse transcriptase (TERT), and the 
telomeraseRNA (TR) that provides a template for telomeric DNA synthesis. TR is 
remarkably variable in size, sequence, and even secondary structure between different 
groups of eukaryotes. To date, TR sequences have been identified in 28 ciliates, 14 
yeasts, and 38 vertebrates. Due to the lack of sequence similarity between groups of 
species, the TR secondary structures were determined independently for each of these 
three groups (2). The vertebrate TR secondary structure is composed of three highly 
conserved structural domains: the pseudoknot/template domain, the CR4–CR5 domain, 
and the scaRNA domain (3–5). The pseudoknot/template domain contains a template 
region for telomeric DNA synthesis, and a conserved pseudoknot structure essential for 
telomerase activity. The CR4–CR5 domain together with the pseudoknot/template 
domain are both required for reconstituting active telomerase in vitro (6). However, their 
mechanistic roles are unclear. The scaRNA domain is crucial for the 3-end processing of 
TR and telomerase RNP biogenesis in vivo (3, 7). Whereas TRs from 34 tetrapods and 4 
cartilaginous fishes share this three-domain structure (4), they have not yet been 
identified from teleost fish that comprises near half of the extant vertebrate species. 
Teleost fish is the most diverse group among vertebrates (8), and is distinct from the 
cartilaginous fish. The teleost and tetrapods (including amphibian, reptile, birds, and 
mammals)diverged from each other around 450 million years ago. Since then, teleost fish 
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have undergone genome duplication and rediploidization, resulting in an amazing level of 
genomic diversity. The relatively faster evolution rate and the consequent diversity in 
teleost fish offer an attractive model for evolutionary studies. Identification of TR from 
teleost fish using degenerate PCR or BLAST search has, however, not been successful 
due to a high degree of sequence variation in TR. Here we report the identification of 
TRs from five teleost fish, Danio rerio, Oryzias latipes, Gasterosteus aculeatus, Takifugu 
rubripes and Tetraodon nigroviridis, using a novel bioinformatics method. To 
structurally and functionally characterize the teleost TR, we have cloned TR as well as 
TERT protein genes from medaka, fugufish, and zebrafish, and reconstituted telomerase 
activity for medaka and fugufish. The structural and functional analyses of the teleost fish 
telomerase enzyme provide important new insights into the evolution of the vertebrate 
telomerase RNP. 
5.3. Materials and Methods  
5.3.1 Bioinformatics Search of Teleost Fish TR Sequences 
 A sequence search was performed using fragrep2. The input pattern, shown in 
supplemental Fig. S1, consists of eight positionspecific weight matrices (PWMs). The 
quality of match between aPWMand a DNA sequence is measured as a fraction of 
similarity above an unavoidable background (9). The computational approach and 
implementation details of fragrep2 are described in detail in Mosig et al. (10). Our search 
pattern was generated by annotating the eight conserved regions in the TR alignment 
published in Chen et al. (4), and converted to a fragrep2 search pattern using the 
aln2pattern tool and both fragrep2 and aln2pattern (available www.bioinf.uni-leipzig.de/ 
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Software). The initial search pattern (Fig. S1) resulted in a single plausible hit in the 
medaka genome (assembly MEDAKA1). A BLAST search using medaka sequence as 
query against other teleost fish genomes revealed homologs in the stickleback (assembly 
BROAD S1), fugu (assembly FUGU 4.0), and tetraodon (assembly TETRAODON 7). 
Based on the four teleost TR sequences, a modified and less stringent search pattern was 
generated, with which we found 79 candidate sequences in the zebrafish genome 
(assembly Zv6). These were screened using INFERNAL (11) and the secondary structure 
annotated TR alignment from the Rfam data base (12), resulting in a single sequence that 
fit well with other teleost candidates and the previously known vertebrate TR sequences. 
The alignment of all 43 known vertebrate TR sequences can be obtained from the 
Telomerase Data base (telomerase.asu.edu).  
5.3.2 Genomic DNA and Total RNA Isolation  
 For isolation of genomic DNA and total RNA, medaka fish (O. latipes) were 
purchased from Aquatic Eco-Systems (Apopka, FL), and Zebrafish (D. rerio) were 
obtained from Dr. Yung Chang (Arizona State University, AZ) or purchased from 
Aquatical Tropicals, Inc. (Plant City, FL). Green spotted pufferfish (T. nigroviridis) were 
purchased from AquariumFish.net. Liver tissue of fugu (T. rubripes) fish was obtained 
from Dr. Shugo Watabe (University of Tokyo, Japan). Genomic DNA was isolated from 
50 to 100 mg of fish tissue using the DNAzol reagent (Invitrogen) following the 
manufacturer’s instruction. Stickleback (G. aculeatus) genomic DNA was a generous gift 
from Dr. David Kingsley (Stanford University). Total RNA was isolated from 100 to 200 
mg of gill or liver tissues using 1 ml of TRIzol reagent (Invitrogen) following the 
123 
manufacturer’s instructions. Concentrations of DNA and RNA samples were determined 
by A260 measurement using the Nanodrop ND-1000 spectrophotometer (Nano-Drop 
Technologies). 
5.3.3 Sequencing and Cloning of TR Genes  
 To verify the sequences, teleost fish TR genes were PCR amplified from genomic 
DNA and the PCR products were sequenced directly. The verified sequences of five 
teleost fish TR genes were deposited into GenBankTM with the following accession 
numbers: EF569636 (D. rerio), EF569637 (O. latipes), EF569638 (T.rubripes), 
EF680233 (T. nigroviridis), and EF680234 (G. aculeatus).  
  For medaka, zebrafish, and fugu, the PCR products of TRgenes were cloned into the 
EcoRV site of the pZero vector(Invitrogen) to generate pMedaka-TR, pZebrafish-TR, and 
pFugu-TR. Plasmids were sequenced to confirm sequence accuracy of the cloned TR 
genes. 
5.3.4 Identification and Cloning of Teleost Fish TERT Genes 
 To reconstitute telomerase activity, we cloned TERT genes from medaka, 
zebrafish, and fugu. The fugu TERT (AY861384) and medaka TERT (DQ248968) gene 
sequences have been previously identified and were available from GenBank (13). The 
zebrafish TERT gene was identified in this study via a BLAST search of the zebrafish 
genome data base using the fugu TERT protein sequence as query. The exact 5’- and 3’-
ends of the full-length zebrafish TERT cDNA sequence were determined by the 5’- and 
3’-rapid amplification of cDNA ends (RACE) using a SMART-RACE cDNA 
Amplification Kit (Clontech). The cDNA sequence was determined by direct sequencing 
124 
of the reverse transcriptase-PCR products. The sequence of zebrafish TERT gene has 
been deposited into GenBank with accession number EF202140. 
 To clone the TERT genes, the coding sequences of medaka and zebrafish TERT 
genes were PCR amplified from the cDNA samples prepared from total RNA samples 
using Thermoscript reverse transcriptase (Invitrogen) and an oligo(dT)18 reverse primer. 
The fugu TERT cDNA was PCR amplified from a cDNA library obtained from Dr. 
Byrappa Venkatesh (Institute of Molecular and Cell Biology, Singapore). 
ThePCRproducts of the medaka, zebrafish, and fugu TERT cDNAs were cloned into the 
pCITE vector for in vitro synthesis of the recombinant TERT proteins. 
5.3.5 In Vitro Transcription of TR 
 RNA was prepared by T7 in vitro transcription using PCR DNA products as 
template as described previously (14, 15). 
5.3.6 Northern Blotting Analysis 
 Twenty micrograms of total RNA was resolved on a 4% polyacrylamide, 8 M 
urea denaturing gel and electrotransferred to Hybond-XL membrane (Amersham 
Biosciences) at 0.5 A for 1 h. The membrane was UV cross-linked and prehybridized at 
65 °C for 30 min in 20 ml of UltraHyb hybridization buffer (Ambion). Riboprobes with 
sequences complementary to the target RNA were generated by in vitro transcription 
from a PCR DNA template that contained the T7 promoter and labeled internally with [α-
32P]UTP using a MaxiScript kit (Ambion). After incubation at 37 °C for 1 h, 1µl of 
RNase-free DNase I (2 units/µl) was added to the reaction, followed by a 20-min 
incubation at 37 °C to remove the DNA template. Riboprobes were then purified using 
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microspin G-25 columns (GE Healthcare). The membrane was hybridized at 65 °C 
overnight in 20 ml of UltraHyb buffer with the riboprobe added to 1x1000,000 cpm/ml. 
The hybridized membrane was washed twice in 20 ml of 1X SSC (3.0 M NaCl and 0.3 M 
sodium citrate, pH 7.0), 0.2% SDS for 10 min at 65 °C, and twice in 20 ml of 0.2 SSC, 
0.1% SDS for 30 min at 65 °C. The blot was analyzed using a phosphorimager, Bio-Rad 
FX Pro. 
5.3.7 In Vitro Reconstitution of Telomerase 
  Human, medaka, fugu, and zebrafish telomerases were reconstituted using the TNT 
(transcription and translation) Quick Coupled rabbit reticulocyte lysate system 
(Promega). Briefly, recombinant TERT protein was synthesized in 10 µl of rabbit 
reticulocyte lysate at 30 °C for 60 min following the manufacturer’s instructions. To 
assemble the telomerase complex, in vitro synthesized TR was added to the TNT reaction 
of TERT synthesis, and incubated at 30 °C for 30 min. For the titration experiments of 
individual RNA domains, the pseudoknot/template or CR4–CR5 RNA fragment was 
added to a saturated 3 µM, whereas the other RNA fragment was added to various 
concentrations as indicated. 
5.3.8 Conventional Telomerase Activity Assay 
    Enzymatic activity of in vitro reconstituted telomerase was analyzed using a direct 
primer extension assay. A 10µl reaction was carried out with 3 µl of in vitro reconstituted 
telomerase sample in the presence of 1PE buffer (50mM Tris-HCl, pH 8.3, 50mM KCl, 
2mM dithiothreitol, 3 mM MgCl2, and 1 mM spermidine), 1 mM dATP, 1 mM dGTP, 1 
mMdTTP, and 2 pmol of 5-32P-end labeled (TTAGGG)3 telomere primer at 30 °C for 2 h. 
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The products were subjected to phenol/chloroform extraction and ethanol precipitation, 
followed by 10% denaturing PAGE. Gels were dried, and products were detected and 
analyzed using a Bio-Rad FX Pro Imager. For each reaction, activity was determined by 
measuring the total intensity of extended telomere substrate, correcting for background, 
and normalizing against unextended primer (loading control). Relative activities were 
obtained by dividing the activity of each reaction by that of the reaction with saturated 
concentration of RNA fragments. For the titration assay, the relative activities were 
plotted against concentrations of RNA fragment and the nonlinear regression curve fitting 
was carried out using the one-site binding (hyperbola) equation, Y = Bmaxx X/(Kd  + X) 
(Prism 5, Graphpad Software, Inc.). 
5.4 Results 
5.4.1 A novel Bioinformatics approach to identify TR sequences 
  Despite significant efforts to clone TRs from a diverse array of vertebrate species, TR 
sequences have not been identified from teleost fish (4). Computational searches for TR 
candidates using the Basic Local Alignment Search Tool (BLAST) of the sequenced 
teleost fish genomes have been unsuccessful. The inability to identify TR sequences in 
teleost fish using either degenerate PCR or BLAST presumably stems from the fact that 
vertebrate TRs are conserved only in eight relatively short regions (called Conserved 
Region 1–8, or CR1– CR8) that are interrupted by highly variable sequences with a large 
number of indels (4).  
  To identify TR sequences, we employed an improved homology search tool, fragrep2, 
to search teleost fish genomes. The original version of the fragrep program implements a 
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specialized algorithm for homology search that considers gap-free sequence patterns 
separated by variable-length regions of nonaligned sequence (16). This approach has 
been demonstrated to work well for genomewide searches of non-coding RNAs (16, 17). 
However, it had not been successful in finding teleost fish TRs. This is because even the 
relatively well conserved blocks, i.e. CR1–CR8, contained too many variations to be well 
represented by a single consensus sequence. To circumvent this, in fragrep2, we have 
replaced consensus sequences by PWMs to search for matched DNA sequences (10). As 
shown in supplemental Fig. S5.1, the initial search pattern contains a collection of 
PWMsas well as minimal and maximal distances between these PWM blocks.  
  Using this new approach, we successfully found a TR candidate in the medaka 
genome. Homologs of this medaka sequence could then be readily found by means of 
BLAST in stickleback, fugu, and Tetraodon genomes. All four sequences are flanked 
upstream by an ADP-ribosylation factor and downstream by homologs of human LASP1 
and/or PLXDC2 (Table S5.1). Based on the alignment of the four teleost fish sequences, 
we modified the search pattern and were able to retrieve a single convincing candidate 
from the zebrafish genome using fragrep2. Surprisingly, the genomic location of the 
zebrafish TR candidate is neither syntenic with that of the other teleost sequences nor 
with the human locus (Table S5.1). All five teleost TR genes were PCR amplified from 
genomic DNA samples and the PCR DNA products were sequenced directly to verify the 
sequences identified from the genome databases (see “Materials and Methods”).
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5.4.2 Unique transcription elements of Fish TR Genes 
  Analysis of genomic sequences upstream of the fish TR-coding sequences revealed 
transcriptional elements typical of an RNA polymerase II promoter: a conserved TATA 
box-like and a CCAAT box element (Fig. S5.2). This suggests that, like other vertebrate 
TRs, teleost TRs are products of RNA polymerase II. Interestingly, a putative CRE-
BP1/c-Jun binding element, located between the TATA and CCAAT boxes, is conserved 
in both teleost and cartilaginous fishes, and some amphibians (bullfrog and horned frog) 
(Fig. S5.2). This data suggest an evolutionary change in transcriptional regulation of the 
TR gene along the tetrapod lineage. 
5.4.3 The compact size of teleost fish TR  
  To confirm the presence of the identified teleost TR transcripts in cells, we performed 
Northern blotting analysis to detect the endogenous TRs. The medaka and zebrafish TRs 
were each detected as a single band on the Northern blot (Fig. 5.1a, lane 1). Based on the 
Northern result, the size of the endogenous medaka and zebrafish TRs are estimated to be 
slightly smaller than the in vitro transcribed RNA markers that are 317 and 322 nt, 
respectively (Fig. 5.1a, compare lanes 1 and 2). 
  To determine the actual size of the endogenous TR, we mapped the 5’-ends of medaka 
and zebrafish TRs by 5’-RACE. The results showed that the 5’-ends of both medaka and 
zebrafish TRs lie 14 nucleotides upstream of the template sequence. Assuming that the 
3’-end of the fish TR is located, like other vertebrate TRs, 3 residues downstream of the 
box ACA motif, the medaka and zebrafish TRs are predicted to be 312 and 317 nt long, 
respectively, consistent with the sizes observed from the Northern analysis. Based on 
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sequence alignment, the other three teleost TR homologs are predicted to be 348 
(stickleback), 325 (fugu), and 328 nt (Tetraodon). This makes teleost TRs the smallest 
among all known vertebrates, as the size of previously known vertebrate TRs ranges from 
382 to 559 nt (4). 
a. Northern blotting analysis of medaka and zebrafish TRs 
Fig. 5.1 a, Twenty micrograms of total RNA (lane 1), and 50 (lane 2) or 500 pg (lane 3) 
of in vitro transcribed medaka or zebrafish TRs were electrophoresed on 4% denaturing 
polyacrylamide gels. Blots were each hybridized with riboprobes specific to each TR. 
Endogenous TR bands are indicated by solid triangles. The in vitro transcribed medaka 
TR (317 nt) and zebrafish TR (322 nt) serve as markers for size estimation and mass 
quantitation. The levels of endogenous TR in liver cells were quantitated to be 508 and 
110 pg per 20 g of total RNA for medaka and zebrafish, respectively.
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b. positive correlation between the TR size and the genome size 
 
Fig.5.1 continued. b, The genome sizes (Mbp) were derived from C-values (pg) obtained 
from The Animal Genome Size Data base (www.genomesize.com). The sizes of TRs are 
based on data from Chen et al. (4) and this study. Five teleost and four cartilaginous 
(sharks and rays) fishes are clustered into two separated groups at the lower-left and 
higher-right ends of the graph, respectively. The 95% confidence band (dashed) of the 
linear regression line (solid) is shown. The p value is <0.0001. 
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Teleost fishes have notably small genomes, whereas the cartilaginous fishes have 
relatively large genomes (18). Intriguingly, teleost fishes with smaller genomes have the 
smallest TRs, whereas cartilaginous fishes with larger genomes have the largest TRs 
(from 478 to 559 nt) among vertebrates. By plotting the TR size over the genome size, we 
found a positive correlation between the size variation of TR and the genome size with an 
R2 value of 0.5007 and a p value <0.0001 (Fig. 5.1B). This strong correlation suggests 
that the size variation of fish TR resulted from evolution of the fish genome. 
5.4.4 Secondary structure of teleost fish 
 To determine whether these small teleost TRs share a similar secondary structure 
with other vertebrate TRs, we constructed secondary structure models for teleost fish TRs 
using phylogenetic comparative analysis. The primary sequences of the five teleost TRs 
identified were aligned manually as described previously (4). The eight conserved 
regions CR1–CR8 found previously in 35 vertebrate TRs are largely conserved in the 
teleost TRs (Fig. 5.2). Because of their small size and the presence of the CR sequences, 
teleost fish TR sequences can be readily aligned without much ambiguity. The aligned 
sequences were analyzed for covariations to derive a conserved secondary structural 
model for the teleost TR (Fig. 5.3a and b). Homologous to the structures of other 
vertebrate TRs, the proposed teleost structure contains 11 helices (P1, P2a, P2b, P3, P4, 
P5, P6, P6.1, P7a, P7b, and P8) grouped into three separate structural domains: the 
pseudoknot/template domain, the CR4–CR5 domain, and the snoRNA domain (Fig. 5.3a 
and b). All helices, except for the P6.1 and P7a, were supported with at least one 
covariation per helix. All five teleost TRs share a similar secondary structure with 
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variation mostly in the hypervariable region between the P4 and P5 helices (Fig. 5.3a. b. 
and supplemental Fig. S5.3). 
 
Fig. 5.2 Sequence alignment of teleost fish TR. The alignment includes TR sequences 
from zebrafish (D. rerio), medaka (O. latipes), stickleback (G. aculeatus), fugu (T. 
rubripes), and tetraodon (T. nigroviridis). Residues that are 100 (red) or 80% (blue) 
conserved in non-teleost vertebrates TRs (Chen et al. (4)) are shown below the alignment. 
The eight conserved regions (CRs) are indicated with red brackets. Black lines above the 
alignment indicate helices (P1–P8) in the secondary structures. Conserved motifs, i.e. the 
template, box H and box ACA, are indicated with red lines above the aligned sequences. 
Residues shaded in blue indicate conserved nucleotides that form Watson-Crick base 
pairings, whereas the ones shaded in green indicate nucleotides that co-vary and maintain 
base pairing. The residues shaded in yellow are located in the single-stranded regions and 
are universally conserved among the five teleost fishes. Dashes (-) denote alignment 
gaps. Every tenth nucleotide of the zebrafish sequence is marked with dots above the 
alignment. The size of each RNA is indicated at the end of the respective sequence. 
Asterisks (*) indicate organisms for which the 5’-end of the RNA was determined by 5’-
RACE.
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a. secondary structures of medaka TR 
Fig.5.3. a, Residues conserved in all five teleost TRs are shown in red. Three structural 
domains (pseudoknot/template, CR4–CR5, and snoRNA) are outlined and labeled. On 
the medaka TR structure, 11 helices (P1, P2a, P2b, P3, P4, P5, P6, P6.1, P7a, P7b, and 
P8) and every tenth nucleotide of the sequence are labeled. The template region, box H, 
and ACA motifs are indicated by black boxes. 
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b. secondary structures of fugu TR 
 
Fig.5.3. continued b, Residues conserved in all five teleost TRs are shown in red. Three 
structural domains (pseudoknot/template, CR4–CR5, and snoRNA) are outlined and 
labeled. The template region, box H, and ACA motifs are indicated by black boxes.
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c. Vertebrate TRs share a conserved secondary structures 
Fig.5.3. continued c, comparison of secondary structures of medaka, human, and shark 
TRs. The pseudoknot and CR4–CR5 domains are shown in green, whereas the scaRNA 
domain (or snoRNA domain in the teleost TR) is shown in cyan. The structural 
determinants (the P1 helix) for template boundary definition are shown in magenta. In the 
human TR structure, the mammal-specific structural elements required for activity are 
shown in brown.  
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 Being the smallest, the teleost TR resembles the essential core of vertebrate TR 
(Fig. 5.3c). It contains shorter linker sequences between the three conserved domains. 
The commonalities and differences of the vertebrate TR structures are discussed in detail 
below. 
5.4.4.1 Pseudoknot/Template Domain 
 Pseudoknot/template domain consists of a highly conserved pseudoknot structure, 
the template sequence, and the P1 helix that defines the boundary of the RNA template. 
The pseudoknot structure consists of the P2a–P2b and P3 helices that are universally 
present in vertebrate TRs (Fig. 5.3c). The mammalian pseudoknot, however, contains an 
additional helix P2a.1 that extends the P2a helix (Fig. 3B, human TR). This mammal-
specific P2a.1 helix is essential for human telomerase activity and is possibly involved in 
binding to the TERT protein (19). In teleost TR, the P2a and P2b helices are separated by 
a conserved asymmetric (0/6) internal loop (Fig. 5.3a and b), whereas, in other groups of 
vertebrates, this internal loop contains a varying number of residues. 
 The P3 helix, in tetrapods, is conserved as a 9-base pair helix with a single 
nucleotide bulge (Fig. 5.4a, tetrapods). The shark and ray P3 helix has the same length 
but with a 2-nucleotide bulge at a different position (Fig. 5.4a, sharks and rays). Medaka 
TR interestingly lacks any bulge in its P3 helix, whereas other teleost TRs have a 1-
nucleotide bulge at the position identical to the sharks. Notably, the lack of a bulge in the 
medaka P3 helix seems to be compensated by extensions of the P3 helix and J2b/3 loop 
(Fig. 5.4a, medaka). The variation of the size and position of the bulge in the P3 helix 
suggests that it might not be a critical element for the function or structure of the 
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pseudoknot structure. Deletion of the bulge in the human P3 helix results in a minor 
reduction of telomerase activity (20, 21). The real role of the P3 bulge has yet to be 
revealed. Based on an NMR solution structure, the pseudoknot of human TR forms a 
triple helix that involves 5 base triples and a base pair at the junction of P2b and P3 
helices (21). The sequences that form the triple helix are absolutely conserved even in 
teleost TR, confirming its critical role in telomerase function (Fig. 5.4a). In contrast, the 
distal portion of the P3 helix and the J2b/3 are less conserved, and are slightly variable in 
length and sequence (Fig. 5.4a, teleost panel). 
 In all vertebrates, except for some rodents, TRs possess a long-range interacting 
P1 helix upstream of the template region (Fig. 5.3). In human TR, the P1 helix consists of 
two individual helices, P1a and P1b, separated by an internal loop. The teleost P1 helix is 
substantially shorter, containing only the P1b equivalent portion while lacking the P1a 
portion. The integrity of P1b helix and its distance from the template defines the 
boundary of the RNA template (22). In human telomerase, disruption of the P1b helix 
alters the template boundary, resulting in template usage outside of the normal template. 
Likewise, disruption of the P1 helix in medaka TR also altered the template boundary and 
result in decreased processivity (Fig.S5.5). This supports the notion that the P1 helix is 
also the element for template boundary definition in teleost telomerase. 
 Comparing pseudoknot fragments from all vertebrate species show that the linker 
J2a/3 between P2a and P3 stem is extremely flexible (4). The correct folding of 
pseudoknot structure is presumably important for telomerase catalysis. The minimal 
length allowed in J2a/3 linker might therefore indicate the distance between P2a stem and 
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P3 stem when pseudoknot domain folds into a three dimensional structure. The data 
suggested that 8 nucleotides between P2a and P3 stem is shorter than the minimal length 
as the activity decreased greatly, while 12, 16 and 20 nucleotides J2a/3 still permit wild-
type level of activity (Fig. S5.11).
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a.  comparison of the triple helix region within the pseudoknot domain 
Fig.5.4 Structural comparison of the pseudoknot and CR4–CR5 domains, and sequence 
alignment of the CR7 domains. a, comparison of the triple helix region within the 
pseudoknot domain. The schematic of the triple helix region from human (tetrapods), 
sharpnose shark (cartilaginous), and five teleost are shown, based on an NMR structure 
reported previously (21). For human, structural elements, etc. P2b, P3, J2a/3, J2b/3, are 
labeled. The triple helix forming sequence (red) conserved in all species, the bulge 
(purple) on the P3 helix, and the conserved G-C base pair (cyan) close to the triple helix 
are highlighted. The green bars indicate the hoogsteen base pair. The size of the bulge, p3 
stem, and J2b/3 loop are indicated to the right of the schematics. The dashed line in J2a/3 
represents omitted sequences. 
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5.4.4.2 CR4-CR5 Domain  
 The CR4–CR5 domain, in addition to the pseudoknot/template domain, is a 
structural element essential for in vitro telomerase activity. The P6 and P6.1 helices in 
this domain are universally present in all known vertebrate TRs (Fig. 5.3b). Remarkably, 
the sequence (5’-AAGAGNUNGNCUCUG-3’) of the P6.1 stem-loop is highly conserved 
even in the teleost fish. It was previously thought that the invariant sequence of the P6.1 
helix loop was due to a biased sequence collection that resulted from the PCR 
amplification strategy used for cloning most of the vertebrate TRs (4). This PCR strategy 
presumably amplified only the TR sequences with conserved sequence in the P6.1 stem-
loop, part of the annealing site of the PCR reverse primers. However, all five teleost fish 
TRs were identified through bioinformatic searches, instead of PCR. The structure, not 
the sequence, of the P6.1 helix is known to be important for telomerase activity in vitro as 
compensatory mutations that maintain the helical structures of P6.1 do not reduce activity 
of reconstituted telomerase (15). Surprisingly, similar compensatory mutations of P6.1 
helix resulted in reduced telomerase activity reconstituted in vivo (23). The absolute 
sequence conservation in the P6.1 helix suggests that, in addition to its based-paired 
structure, the sequence of this helix might be also important for the in vivo function of 
telomerase.  
 The teleost TR, lacking the distal stem-loop P6b, consists of a shorter P6 (i.e. 
homologous to the P6a in human TR), P.6.1, and P5 helices in the CR4–CR5 domain 
(Fig. 5.4b). Whereas the P6b helix is dispensable in teleost fish and some tetrapods such 
as turtle and frog, the proximal part of the P6b stem-loop is required for human 
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telomerase activity (24). The single stranded regions, J5/6 and J6.1/5, at the three-way 
junction between P5, P6, and P6.1 helices are relatively more variable in teleost than in 
other vertebrates. Although its essential role in telomerase function is evident, the 
mechanistic role of the CR4–CR5 domain remains to be uncovered. 
 
b. comparison of medaka and human CR4–CR5 secondary structure. 
Fig.5.4 continued. b, Helixes P5, P6a, P6b, and P6.1 are labeled. Residues in red indicate 
conserved nucleotides in all vertebrates. Nucleotides in green indicate conservation in 5 
teleost. Whereas nucleotides in blue indicate conservation in other vertebrates excluding 
teleost.
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5.4.4.3 SnoRNA/ScaRNA domain  
 The 3’-portion of vertebrate TR contains a unique secondary structure (hairpin-
hinge-hairpin tail) and sequence motifs (box H and ACA) that are critical for TR 
biogenesis and shared by the box H/ACA snoRNAs (7). Most vertebrate TRs contain an 
additional motif called the CAB box that is shared by the small Cajal body RNAs 
(scaRNAs) (3). Whereas the box H and ACA are important for RNA localization to 
nucleoli, the CAB box is important for localization of the RNA to the Cajal body where 
RNP complex assembly is thought to take place (25). Interestingly, teleost TR lacks an 
obvious CAB box (UGAG) in the CR7 region (Fig. 5.4c). The lack of CAB box implies 
that teleost TR might not localize to the Cajal body. Because the Cajal body has been 
suggested to play a role in telomerase regulation and telomere recruitment (26), it would 
be interesting to understand TR localization in teleost and its correlation with the 
regulation of telomerase function.
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c. Teleost TR lacks an obvious CAB box motif (UGAG). 
Fig.5.4 continued. c, The five teleost TR sequences shaded in gray are aligned manually 
with the alignment of 35 non-teleost TR sequences derived from Chen et al. (4). The 
conserved CAB box is indicated with red lines above the aligned sequences. Residues 
identical to human sequence are shaded in blue (helix P8) or yellow (loop L8). Dashes (-) 
denote alignment gaps.
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5.4.5 Medaka and Fugu Telomerases Reconstituted in Vitro Are Active and Processive 
 Telomerase activity reconstituted in vitro requires both the TR component and the 
catalytic TERT protein. To functionally characterize the structural elements of teleost 
TR, we reconstituted telomerase from in vitro synthesized TERT protein and TR (see 
“Experimental Procedures”). Active telomerases were successfully reconstituted for 
medaka and fugu, confirming the authenticity of the teleost telomerase components 
cloned (Fig. 5.5). As predicted from the presence of the 4-nucleotide alignment sequence 
in their RNA templates, the reconstituted medaka telomerases are processive, generating 
a typical 6-nucleotide ladder pattern of the elongated products (Fig. 5.5a).
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a. Reconstitution of medaka telomerase activity 
Fig.5.5 Activity assay of in vitro reconstituted teleost telomerase. a,  reconstitution of 
medaka telomerase activity. Telomerase reconstitution was carried out in 10 l of rabbit 
reticulocyte lysate in the presence of L-[35S]methionine with TR alone (lane 1), TERT 
alone (lane 2), TR TERT (lane 3), or TR TERT treated with RNaseA (lane 4). 
Reconstituted telomerase were then assayed using the conventional direct assay (see 
“Materials and Methods”). The bottom panel shows the SDS-PAGE analysis of 
[35S]methionine-labeled medaka TERT protein from each reaction. 
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 Vertebrate TERT protein possesses two RNA-binding sites that bind 
independently to the CR4–CR5 and pseudoknot domains of the TR. As shown 
previously, human TERT is functionally compatible with the mouse CR4–CR5 domain 
but not the mouse pseudoknot domain (14). In this study, we also showed that the 
medaka and fugu TERT proteins reconstituted telomerase activity with CR4–CR5 RNA 
fragments, but not the pseudoknot domain, from other teleost fish species (Fig. 5.5b, 
lanes 1–6 and 10–15) or even distantly related vertebrates such as human, quoll, chicken, 
turtle, frog, and shark (Fig. S5.6). This difference in cross-species compatibility indicates 
that the CR4–CR5 domain is functionally more conserved across a wide variety of 
species than the pseudoknot domain. Unlike the fugu TERT, the medaka TERT 
assembled with the fugu pseudoknot RNA to reconstitute telomerase activity with a low 
processivity (Fig. 5.5b, lanes 4–6), suggesting a more relaxed RNA binding specificity of 
the medaka TERT protein. However, the pseudoknot fragment of zebrafish TR failed to 
generate telomerase activity when assembled with medaka or fugu TERT proteins (Fig. 
5.5b, lanes 7–9 and 16–18), suggesting a cross-species incompatibility of the zebrafish 
pseudoknot with the TERT protein.
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b. medaka and fugu TERT proteins synthesized in vitro were assembled with in vitro 
transcribed pseudoknot/template and CR4–CR5 RNA fragments of medaka (md), fugu 
(f), or zebrafish (z). 
 
Fig.5.5 continued. b, The RNA fragments, medaka pseudoknot (1–150), medaka CR4–
CR5 (154 –241), fugu pseudoknot (1–139), fugu CR4–CR5 (143–253), zebrafish 
pseudoknot (1–134), and zebrafish CR4–CR5 (137–242) were assembled in different 
combinations with either medaka or fugu recombinant TERT protein as indicated above 
the gel. The assembled telomerases were analyzed for activity using a conventional 
telomerase assay. The numbers on the left (4, 10,16,22,28,34 etc.) indicate the number of 
nucleotides added to the primer for each major band seen. 
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To analyze activity of zebrafish telomerase, we thus identified and cloned 
zebrafish TERT cDNA (see “Materials and Methods”). Unexpectedly, the in vitro 
synthesized zebrafish TERT protein failed to reconstitute a detectable activity when 
assembled with zebrafish, medaka, or fugu TRs (Fig. S5.7). Based on the alignment of 
TERT amino acid sequences, the cloned zebrafish TERT protein was unlikely to be an 
alternative splicing variant, as it contained all essential motifs. The possibility of 
mutations in the cloned zebrafish TERT gene was ruled out as identical sequences were 
found from two individual zebrafish obtained from different sources. Whereas gene 
duplication is relatively common in teleost, more rigorous BLAST searches of the 
zebrafish genome did not reveal any other candidate sequences for the TERT 
gene.Wespeculate that the in vitro synthesized zebrafish TERT protein, unlike the 
medaka and fugu TERT proteins, might not fold correctly as the recombinant zebrafish 
TERT protein migrated faster than expected on SDS-PAGE (Fig. S5.8).
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5.4.6 The CR4–CR5 Domain Is the Main Determinant in TR for Functional Binding to 
Medaka TERT 
 During reconstituting teleost fish telomerase, we observed a significantly lower 
activity of the reconstituted enzyme using two RNA fragments than that of the enzyme 
reconstituted using the full-length RNA (Fig. S5.9). To determine which RNA fragment 
was responsible for the lower reconstituted activity, we carried out the in vitro 
reconstitution with titrations of each of the two RNA fragments as well as the full-length 
RNA. We define the median effective concentration (or EC50) as the RNA concentration 
required to generate 50% of the saturated activity of reconstituted telomerase. It is 
noteworthy that this EC50 value measured in this assay is related only to the functional 
binding (or assembly) of the RNA fragment to the TERT protein, excluding nonspecific 
or non-functional bindings. A lower EC50 value of the RNA indicates that the RNA 
assembles more efficiently with the TERT protein to generate active telomerase. 
Remarkably, the CR4–CR5 fragments and the full-length TR gave rise to comparable 
EC50 values. The medaka CR4–CR5 and fulllength RNAs had similar EC50 values of 87.4 
and 85.9 nM, respectively, whereas the human CR4–CR5 and full-length RNAs had EC50 
values of 203.9 and 241.6 nM, respectively (Fig. 5.6). In comparison, the medaka and 
human pseudoknot RNA fragments had high EC50 values of 506.2 and 523.5 nM, 
respectively (Fig. 5.6). The reduction of reconstituted activity at high concentrations of 
the full-length TR might be due to the multimerization or aggregation of TR as 
previously reported (27). Our result indicates that the CR4–CR5 domain is the main 
determinant for efficient binding and assembly of TR to the TERT protein.
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Fig. 5.6 Effective concentrations of the pseudoknot and CR4–CR5 domains to assemble 
active telomerase in vitro. Titration experiments were performed with pseudoknot and 
CR4–CR5 RNA fragments or fulllength TR alone for reconstituting medaka (upper 
panel) and human (lower panel) telomerase enzymes. Various concentrations of 
pseudoknot or CR4–CR5 RNA fragments were assembled with the other RNA fragment 
at a saturated 3µM and the in vitro synthesized TERT protein, followed by the 
conventional telomerase assay. The pseudoknot (medaka, nt 1–150 and human, nt 32–
195) and CR4–CR5 (medaka, nt 170–220 and human, nt 241–328) RNA fragments were 
titrated as indicated. The relative activity represents the ratio of total activity of each 
reaction over the total activity of the reaction with saturated concentrations of both RNA 
fragments. The median effective concentration (EC50) values of each RNA fragment are 
indicated. 
151 
5.5 Discussion 
 Unlike the TERT, TR is prominently divergent in size, sequence, and even 
structure. In this study, by using a novel bioinformatics approach, we have successfully 
identified TR sequences from five teleost genomes. The structural and functional 
analyses of teleost fish telomerase provide important insights into the structural evolution 
of vertebrate TR as well as the co-evolution of the TR and TERT protein. 
5.5.1 Fast Evolution of TR Structure and Size 
 Because of the various numbers of species-specific structural elements, the size of 
TR is remarkably variable, up to 1 order of magnitude, from 150 nt in ciliates to 1500 nt 
in yeasts. From the evolutionary point of view, the emergence or disappearance of 
structural elements in TR over a short evolutionary time scale is rather intriguing. The 
unusual plasticity of TR structure was likely facilitated by the non-lethal and progressive 
nature of the consequences of TR mutations. In organisms with long telomeres, the 
impact of telomerase mutations is delayed for a number of generations (28). Such delay 
could allow an accumulation of secondary mutations, some of which might compensate 
for the initial deleterious mutation, eventually leading to emergence of novel structural 
elements in TRs.  
 A possible scenario for the emergence of new structural elements is the insertion 
of a transposable element into the TR gene during evolution. For example, the scaRNA or 
snoRNA domains in the vertebrate TR is absent in both the ciliate and yeast TRs, and has 
been acquired during evolution along the vertebrate lineage. As some snoRNA and 
scaRNA contain characteristics of retrotransposons (29), it is possible that a transposition 
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event may have occurred and fused a mobile scaRNA gene with an ancestral TR gene. 
Because most vertebrates, including the early branched cartilaginous fish, contain the 
scaRNA specific motif (CAB box), we propose that it was a scaRNA, rather than a 
snoRNA, that was inserted into the vertebrate TR gene. Teleost fish and some bird TRs 
that lack an obvious CAB box, might have subsequently evolved to function without a 
CAB box motif. Notably, other scaRNAs, e.g. U100, from teleost fish contain a 
conserved CAB box sequence (30). Identification of TRs from early branching chordates 
such as the sea squirt will provide crucial clues about the origin of the vertebrate-specific 
structural domains. Based on the phylogenetic tree derived from the aligned TR 
sequences, tetrapods, teleost fishes, and cartilaginous fishes are grouped into three 
monophyletic clades (Fig. 5.7), representing three separated evolutionary lineages that 
lead to three distinct size groups of TR molecules. Cartilaginous and teleost fish TRs 
evolved in opposite directions toward size expansion and reduction, respectively, 
corresponding to their genome size evolution. The small sizes of teleost genomes are 
mainly due to the low abundance of transposable elements and the significant reduction 
in intron size (31). Our data suggest that genome compression affected not only the 
intergenic or intronic DNA sequences but also the RNA genes. Similarly, teleost RNaseP 
RNA is about 50 nt shorter than the 350-nt long human RNaseP RNA. 
 Interestingly, teleost fish TR appears to be more divergent than cartilaginous fish 
TR from tetrapod TR (Fig. 5.7). This is consistent with a recent comparative genomic 
study that showed a higher degree of sequence conservation between the human and 
elephant shark genomes than that of human and teleost fish genomes (32, 33). It is 
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generally believed that the teleost fish has experienced a genome duplication after 
diverging from tetrapod lineage and before the fish radiation (34). However, no extra TR 
gene or pseudoknot gene was found in the 5 teleost fish species, suggesting either the 
teleost TR gene was not duplicated or the duplicated TR copy has been lost from the 
common ancestor of teleost fish. 
 
 
Fig. 5.7 The neighbor-joining tree inferred from the vertebrate TR sequences. The tree 
was derived using the neighbor-joining method from the aligned TR sequences of 14 
vertebrates including 5 tetrapods (human, mouse, macaw, turtle, and frog), 5 teleost 
fishes (fugu, tetraodon, stickleback, medaka, and zebrafish), and 4 cartilaginous fishes 
(stingray, cownose ray, sharpnose shark, and dogfish shark). The phylogenetic tree was 
constructed using the program MEGA3.1 (37). The number next to each node indicates a 
value as a percentage of 1000 bootstrap replicates. Branch lengths are proportional to the 
number of residue changes. Scale bar indicates an evolutionary distance of 0.05 
nucleotide substitution per position in the sequence. 
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5.5.2 Co-evolution of the TR and TERT Protein 
 During structural diversification, the function of the telomerase RNP has to be 
conserved through co-evolution between the RNA and protein components, which can be 
reflected by the interspecies compatibility of the components. For example, the CR4–
CR5 RNA fragments from distantly related species such as human were able to 
reconstitute telomerase activity with medaka TERT (Fig. 5.5 and Fig. S5.6). In contrast, 
the pseudoknot/template RNA domain appears to be incompatible even between closely 
related species (e.g. between medaka and fugu, or between human and mouse), 
suggesting a faster rate of co-evolution between the pseudoknot RNA domain and the 
TERT protein. 
 The triple helix within the pseudoknot domain contains invariant sequences and is 
one of the most conserved structural elements in vertebrate TRs (Fig. 5.4a). As the triple 
helix seems to be an ancient feature conserved in many species (2, 21, 35), it is, thus, 
unlikely to be responsible for the interspecies incompatibility of the pseudoknot domains. 
The distal helix of P3 stem and J2b/3 loop, on the other hand, demonstrate some extent of 
variation among vertebrate species (Fig. 5.4a). Swapping the whole pseudoknot structure 
(P3, P2b, and J2b/3) between medaka and fugu TRs did not improve their inter-species 
compatibility (Fig. S5.10). 
 The teleost CR4–CR5 domain is considerably smaller than other vertebrates as it 
lacks the distal P6b helix. Nonetheless, the smaller medaka CR4–CR5 RNA fragment (50 
nt) exceeds its human counterpart (89 nt) in effectiveness of reconstituting telomerase 
activity in vitro (Fig. 5.6). The higher assembly efficiency is likely due to a higher 
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binding affinity between the medaka TERT protein and the CR4–CR5 RNA fragment, 
which would require substantial co-evolution between the medaka TERT protein and the 
TR. Because the P6b helix in the CR4–CR5 domain of human TR is essential for binding 
to the human TERT protein (24), the human TERT might have evolved with an 
additional binding pocket for the P6b helix. 
 Whereas we were able to reconstitute activity from medaka and fugu telomerases, 
it is unclear why the zebrafish TERT failed to reconstitute detectable telomerase activity. 
Among the five teleost species studied, zebrafish branches out early and is more 
divergent than the other four teleost fishes (36).  
 In summary, the identification of teleost TR and characterization of its structure 
and function reveal an unusual divergence of vertebrate TR. The novel bioinformatic tool 
fragrep2 is an effective approach to find notoriously divergent TR sequences in 
eukaryotic genomes. The small teleost fish TR and the large cartilaginous fish TR reflect 
the unusual plasticity of TR structure during evolution. Teleost fish telomerase is very 
processive and contains a functional P1 helix that defines the template boundary. The 
conservation of the structure and function of teleost fish telomerase supports the use of 
teleost fish as a model organism for the study of telomerase biology. 
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CHAPTER 6 
CONCLUSION 
 Processive addition of telomeric repeats by the enzyme telomerase is a 
complicated but delicate process that involves a series of well-coordinated movements 
within the telomerase core components. The detailed steps behind telomerase 
processivity remain to be revealed. However, the fact that telomerase can perform 
multiple repeat addition before complete dissociation from the substrate suggests that a 
template translocation event must occur between each repeat addition to provide an 
empty template for the following repeat synthesis. 
 Many conserved motifs in telomerase core components were indicated to involve 
in processivity. Our work based on a comprehensive sequence alignment has identified a 
processive-telomerase specific TERT motif, name motif 3, in the RT domain. This motif 
has been overlooked in the past because of the inefficient alignment algorithm and the 
lack of TERT sequences. We have associated telomerase processivity defect with its 
duplex binding ability as motif 3 low processivity mutants failed to extend short 
telomeric primers. Because the short primer lacks an upstream region to interact with 
other parts of the protein, defect of using short primer thus imply a defect of binding 
RNA template/DNA primer in the telomerase active site. One other intriguing 
phenomenon observed in motif 3 study is that telomerase repeat addition processivity and 
addition rate are functionally independent from each other. Motif 3 also contributes to 
repeat addition rate by regulating the translocation rate. 
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 To take one step further. A novel template free telomerase was designed to 
directly test duplex binding by telomerase active site. Comparison between template free 
telomerase and other RTs using duplex substrate indicates that telomerase catalytic core 
has adapted for short repeat synthesis. More importantly, processivity defect mutants, 
whose translocation efficiency is significantly lower than wild-type, showed lower 
affinity towards telomeric RNA/DNA duplex. Using a 5 bp RNA/DNA duplex in 
wildtype telomerase reaction largely reduced telomerase processivity. This data strongly 
argue for duplex releasing/binding as a critical step during template translocation. We 
thus described the translocation event to a greater detail.  
 Vertebrate telomerase is a great system to study telomerase processivity because 
of its conserved 6 nucleotides repeat sequence and its relatively processive reaction. 
Teleost fish telomerase components were identified to broaden the knowledge of 
vertebrate telomerases. Teleost fish is a fast evolving group since branching from the 
tetrapod lineage. The telomerase RNA represents some unique properties compared to 
other vertebrates. Notebably, fish TR is the smallest vertebrate TR identified to date, yet 
still retained all the essential conserved regions important for function, providing a 
valuable model for structural study of telomerase RNP.  
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APPENDIX A 
 
SUPPLEMENTAL INFORMATION FOR CHAPTER 2 
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a. Secondary structure prediction of TERT motif 1, 2, 3, A and B from representative 
species (Homo sapiens, Oryzias latipes, Arabidopsis thaliana, Aspergilus fumigatus, 
Tetrahymena thermaphila, Euplotes aediculatus, Tribolium castaneum, 
Schizosaccharomyces pombe and Saccharomyces cerevisiae). 
 
Fig S2.1 Secondary structure prediction of TERT motifs 3 and IFD. a, Predicted 
secondary structures (α- helices colored blue, β-sheets colored red, and random coil 
colored grey) and the crystal structure of Tribolium TERT (α-helices denoted by 
cylinders, β-sheets by arrows, and random coil by a black line) are shown below the 
amino acid sequence. The primary sequence of the entire RT domain (motif 1-E) was 
input in three online secondary structure prediction algorithms 
(YASPIN<http://zeus.cs.vu.nl/programs/yaspinwww>, PSI 
<http://bioinf.cs.ucl.ac.uk/psipred/psiform.html> and JPred 
<http://www.compbio.dundee.ac.uk/~www-jpred>), and the output were combined. The 
predicted structures of motif 1-B are shown.
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Fig. S2.2 Multiple sequence alignment from motif 2 to motif A of TERT, other RTs and 
RdRp. The TERT sequences includes additional species along with the representative 
species from Fig. 5.1b. The RT sequences are grouped as two monophyletic clades based 
on their evolutionary distance to TERT. The secondary structures (arrows: β-sheets, 
cylinders: α-helices) shown below the sequences are derived from the respective crystal 
structures of Tribolium castaneum TERT (3DU6), HIV1 RT (1HYS) and FMDV RdRp 
(1WNE). Motif 2 and A have identity/similarity set at 55% conservation, shaded 
black/grey with invariant residues are shaded in dark cyan and dark blue respectively. 
Red/light red shading indicates the motif 3 TERT identity/similarity. An analogous helix-
turn-helix sequence within closely realted RTs has been previously identified as motif 2a. 
The identity/similarity for the residues in motifs 2 and A are derived from all sequences, 
while the linker/motif 3 identity/similarity is derived from each grouping. Consensus 
residues with 55% identity are shown below each group. 
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Fig. S2.3 Additive effects of motif 3 mutations on telomerase activity and processivity. 
Mutant telomerase were reconstituted in RRL and assayed by using the conventional 
telomerase activity assay. The telomerase mutants that contain different combinations of 
the motif 3 mutations (del-643-649, V658A and the double mutation del-643-
649/V658A) or the hTR template mutation (57C) were assayed as indicated. The relative 
activity and processivity of different mutants are shown below the gel. l.c.: loading 
control. The signal of each repeat added was normalized with dGTP incorporated and the 
signal of first repeat. Log10[normalized intensity] was then plotted against repeat number. 
Processivity was derived using equation processivity=- ln2/(2.303k), where k is the slope 
of each line. 
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Fig. S2.4 The effect of motif3 N-terminal linker mutation on telomerase activity. 
Telomerase were assembled and assayed for activity as described in Materials and 
methods. hTERT d643-649: deletion of amino acid 643-649. i644AAA645: insertion of 
three alanines between amino acids 644 and 645. 
178 
 
 
Fig. S2.5 Telomerase processivity and repeat addition rate are functionally separated. 
Four telomerase mutants, d643-649 with high repeat addition rate, R657A with low 
repeat addition rate, Y667A with low processivity and D684A with high processivity 
were combined into double mutation constructs. The single mutation or double mutation 
constructs were incubated with (TTAGGG)3 primer in the pulse reaction for 5 min in 
which the [α-32P]dGTP is incorporated to the newly synthesized telomere repeats. After 5 
min of pulse reaction, non-radioactive dGTP was added to 100 µM to initiate the chase 
reactions and the reactions were terminated at different time points (2-10 min). The 
vertical lines on the gel denote the major bands of telomere products synthesized and 
labeled in the initial 5-min pulse reaction, and extended in the following chase reactions. 
Numbers on the right (+1, +2, +3 etc.) indicate the number of repeats added to the 
telomeric primer. Repeat-extension rate, expressed as repeats per minute, of each enzyme 
were calculated (see Materials and Methods) and indicated below the gel. 
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a. Sequence alignment of motif 3 from human and Tetrahymena TERTs. 
 
b. Activity assay of Tetrahymena TERT motif 3 mutants. Telomerase reconstituted in 
vitro were subjected to activity assay. 
 
Fig. S2.6 Activity assay of in vitro reconstituted Tetrahymena telomerase. a, Homologous 
mutant positions emphasized in black, and indicated by the numbers above and below the 
sequence. N-terminus of motif 3a was not listed in detail. b, Telomerase reconstituted in 
vitro were subjected to activity assay. l.c.: loading control, [32P] labeled 15mer DNA 
oligonucleotide. Below the gel, the [35S] methionine labeled TERTs analyzed by SDS-
PAGE for quantitation are shown. Quantitation of telomerase activity and processivity 
performed relative to wildtype.  A 32P-labeled 15 mer DNA oligonucleotide used as a 
loading control (l.c.). n/d: not determined. 
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a. The RT fragments (601-639) of human TERT protein that contain the motif 3 
mutations were synthesized in vitro and analyzed for binding to various biotin-conjugated 
oligonucleotides. 
 
b. TERT protein binding assay with biotin-labeled oligonucleotides 
Figure S2.7. Interactions between the RT domain of TERT, and ssDNA, ssRNA or 
RNA/DNA duplex. a, The sequences, length and biotin tag of oligonucleotides used in 
the TERT binding assay are listed in the table. The RNA/DNA duplex formed from the 
hybridization of the ssRNA (hTR-template-bio) and the ssDNA (GTTAGG)2 is shown. 
An internal control, human TERT fragment (601-927) fused with a N-terminal MBP tag, 
was used in the binding assay. b, The RT fragments (hTERT-601-939) containing motif 3 
mutants (L681A and G682A), together with the internal control, MBP-hTERT-601-927, 
were pulldown using various biotin-label oligonucleotides, biotin-(TTAGGG)3, biotin-
(AATCCC)3, hTR-temp-bio, RNA/DNA duplex [hTR-temp-bio/(GTTAGG)2] or 
(GTTAGG)2 (a negative control). The input protein mixtures of hTERT 601-939 and 
MBP-hTERT 601-927 used in each reaction were analyzed by SDS-PAGE. The ratios 
between hTERT-601-939 and MBP-hTERT-601-927 bound to each biotin-labeled oligo 
are indicated below the gel.  
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Fig. S3.1 Template free telomerase and wild-type telomerase reaction with single 
stranded telomeric DNA substrate. Three different telomerase RNA pseudoknot 
constructs with (hTR 32-195, hTR 44-184) or without template sequence (hTR 64-184) 
(see Fig. 3.1a for structure and sequence), are reconstituted with hTERT and hTR CR4-
CR5 for active enzymes. These enzymes are the same batch as the ones used in Fig. 3.1 
(TTAGGG)3 primer was used. The major telomerase repeats added are labeled on the 
right, the numbers indicate the number of nucleotides incorporated. l.c.: loading control, a 
32P end labeled 15 nt DNA oligo.
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a. Template free telomerase reconstituted in 293 FT cells react with RNA/DNA duplex 
substrate. 
 
b. Northern blot of telomerase RNA expressed in 293 FT cells 
 
Fig. S3.2 In vivo reconstituted telomerase react on duplex as well. a, Template free hTR 
(64-451) and full length hTR (1-451) are overexpressed in 293 cells with hTERT. The 
reconstituted telomerase was IPed and assayed for activity with duplex (d), RNA oligo 
(R) or DNA oligo (D) respectively. dCTP is included in the substrate in one of the 
reactions as indicated. The dG residues extended by telomerase are labeled as “g”. b, 
Total RNA from 293 FT cells transfected with different RNA constructs were extracted 
and blotted with anti hTR riboprobe. 5s rRNA serves as a loading control.
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a. Km measurement of template free telomerase with RNA/DNA duplex substrate 
without overhang. 
b. Km measurement of template free telomerase with RNA/DNA duplex substrate with 
12nt DNA overhang. 
 
Fig. S3.3 Km measurement of template free telomerase with duplex substrate with or 
without DNA overhang. The template free telomerase was assayed with a series of 
different concentrations of duplex substrates. Addition of 3 G residues by template free 
telomerase is all considered as telomerase activity. The signal for each substrate 
concentration was expressed as relative activity to the highest duplex concentration 
(100%). Relative activity was plotted against primer concentration and fit with the 
Michaelis Menten curve to find the Km values. 
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Fig. S3.4 Template free telomerase extends DNA primer along long RNA template. A 
substrate with 60 nt free RNA template and 12 nt DNA oligo was used. 32P dGTP is 
presented in all the reactions. The addition of dATP, dCTP and dTTP in the reaction is 
indicated on the top of each lane. The predicted sequence added to the DNA primer is 
shown on the right of the gel.
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Fig. S3.5 Template free telomerase react with various duplex substrates and the 32P GTP 
building blocks. The substrate duplexes are represented as two letter symbols plus one 
number. For example: RD1=RNA/DNA hybrid no.1, DR2=DNA/RNA hybrid no.2. The 
exact sequences are shown on the top of the gel. Black background represents 
ribonucleotides, while the grey background represents deoxyribonucleotides. The oligo 
with both grey and black backgrounds stands for a chimeric oligo. The substrates were 
assayed with either template free telomerase RNA (hTR*), hTERT or the template free 
RNP complex. 
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Fig. S4.1 Apparent Km measurement of processivity mutant template free telomerase 
toward CP6 duplex substrate.  Processivity mutants were expressed in RRL and 
assembled with template free hTR pseudoknot fragment (nt 64-184) and CR4-CR5 
fragment (nt 239-328). Sequence of duplex CP6 can be found in Fig. 4.2. Duplex were 
added in gradient concentrations as indicated on the top of the gel. The apparent Km was 
analyzed by fitting relative intensity of each concentration into Michaelis Menten curve. 
The Km value shown was the actual data for this specific run of experiment.
189 
Fig. S4.2 Turnover rate of wildtype and R669A template free telomerase using telomeric 
CP6 duplex substrate. Wild-type and processivity mutant R669A TERT proteins were 
expressed in RRL and assemble with template free hTR pseudoknot fragment (nt 64-184) 
and CR4-CR5 fragment (nt 239-328). Sequence of duplex CP6 can be found in Fig. 4.2. 
Template free telomerase was pre-incubated with 20 µM duplex substrate at room 
temperature for 5 min. 0.165 µM 32P dGTP was added to initiate the reaction. The 
reactions were terminated at various time points as indicated. Reaction signals were 
expressed in relative to the wildtype 20 min reaction (100%). Data points were plotted 
against time and fit with linear curve. The slopes of the lines represent enzyme turnover 
rate.
190 
Fig. S4.3 Tm values of telomeric duplex 5 to 10 base pairs. 20µM of each duplex were 
mixed in telomerase reaction buffer and heated to 75°C for 5 mins. OD260nm were 
collected in 1°C intervals while the temperature gradually decreases to -1°C. OD260 was 
plotted against the temperature and a sigmoid curve was fitted. The procedure was carried 
out in Cary 300 UV-vis spectrophotometer (described in Materials and Methods). 
Sequences of each duplex are depicted on the left. The estimated Tm values were labeled 
on the right of the melting curve graph.  
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Fig. S4.4 Apparent Km measurement of template free telomerase toward telomeric 
duplex substrate ranging from 5 to 9 base pairs. Template free telomerase was expressed 
in RRL and assemble with template free hTR pseudoknot fragment (nt 64-184) and CR4-
CR5 fragment (nt 239-328). Sequence of duplexes 5 to 9 base pairs can be found on top 
of the gel. Reactions were carried out at 4°C. Duplex were added in gradient 
concentrations as indicated. The apparent Km was analyzed by fitting relative intensity of 
each concentration into Michaelis Menten curve.  
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Fig. S4.5 Turnover rate of template free telomerase reacting on duplex substrate ranging 
from 5 to 9 base pairs. Wild-type TERT was expressed in RRL and assemble with 
template free hTR pseudoknot fragment (nt 64-184) and CR4-CR5 fragment (nt 239-
328). Sequence of duplex 5 to 9 bps can be found at the bottom of the gel. Template free 
telomerase was pre-incubated with 20 µM duplex substrate at room temperature for 10 
min and in 4°C for 20 min. At 4°C, 0.165 µM 32P dGTP was added to initiate the 
reaction. The reactions were terminated at various time points as indicated. Reaction 
signals were expressed in relative to the wildtype 30 min reaction (100%). Data points 
were plotted against time and fit with linear curve. The slopes of the lines represent 
enzyme turnover rate.
193 
Fig. S4.6 Apparent Km measurement of template free telomerase toward six 7 base pair 
circular per-mutated telomeric duplex substrate. Template free telomerase was expressed 
in RRL and assemble with template free hTR pseudoknot fragment (nt 64-184) and CR4-
CR5 fragment (nt 239-328). Sequence of six CP duplexes can be found in Fig. 4.8. 
Duplex were added in gradient concentrations as indicated on the top of the gel. The 
apparent Km was analyzed by fitting relative intensity of each concentration into 
Michaelis Menten curve. The Km value shown was the actual data for this set of 
experiment. 
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Fig. S4.7 Circular permutated hTR template mutant telomerase reaction with 7 nt circular 
permutated telomeric primers. Circular permutation of hTR template was generated in 
hTR nt 26-195 with 45g and 57g double mutations to exclude base pairing between 
telomeric sequence and the non-template region of the RNA. hTR nt 26-195 and nt 239-
328 were assembled with hTERT to form active telomerase (Materials and Methods). 
(upper panel) The putative annealing scheme of circular permutated telomeric primer to 
each mutant hTR template was depicted on top of the gel. The corresponding stop 
patterns in the gel are labeled on the schematic as solid triangle (sequence determined 
boundary) and open triangle (structure determined boundary). (lower panel) activity 
assay of mutant telomerases using 6 circular permutated telomeric primers. Primers used 
in each reaction are indicated. Incorporation of nucleotides of the 5’-GGTTAGG-3’ are 
labeled on the right of the gel. Banding patterns determined by duplex sequence (solid 
triangle) and structure (open triangle) are labeled on the side. 
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Fig. S5.3 a, Secondary structure models of zebrafish telomerase RNA. Residues 
conserved in all five teleost TRs are shown in red. Conserved nucleotides in the template 
region, box H and ACA motifs are indicated in black boxes.
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Fig. S5.3 b, Secondary structure models of stickleback telomerase RNA. Residues 
conserved in all fivet eleost TRs are shown in red. Conserved nucleotides in the template 
region, box H and ACA motifs are indicated in black boxes.
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Fig. S5.3 c, Secondary structure models of Tetraodon telomerase RNAs. Residues 
conserved in all five teleost TRs are shown in red. Conserved nucleotides in the template 
region, box H and ACA motifs are indicated in black boxes.
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Fig. S5.4 Reconstitution of medaka and human telomerase activity with titration of full 
length telomerase RNA (TR) or TR fragments. For the titration of each TR fragment, the 
other essential fragement (either the pseudoknot or CR4-CR5 fragments) were added to a 
saturated concentration at 3 µM. Loading controls (l.c.) were shown at the bottom of the 
gel. 
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Fig. S5.5 Medaka TR P1 stem mutation decreased telomerase processivity. (left panel) 
the schematic of Medaka TR P1 stem mutations used in the activity assay. The major 
portion of medaka pseudoknot is represented using dots and cyan background. The P1 
stem is expressed using the actual nucleotide sequence. The wildtype sequence is shown 
in black font. Mutations are shown as red letters. P1 down, the 5’ side of the P1 stem was 
mutated to disrupt the base pairing. P1 up, the 3’ side of the P1 stem was mutated to 
disrupt the base pairing. P1 comp, both 5’ and 3’ sides of the P1 stem were mutated and 
the base pairings are restored. (right panel) medaka TR pseudoknots were assembled with 
mdTERT and CR4-CR5 domain to reconstitute activity. Various mdTR pseudoknots used 
are indicated on the top of the gel. 
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Fig. S5.6 Cross species compatibility of vertebrate CR4-CR5 fragments. Telomerase 
were assembled with mdTERT and mdTR pseudoknot domain with CR4-CR5 domains 
(the three way junction structure starting from P5 stem) from various species. 
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Fig. S5.7 Undetectable zebrafish telomerase activity. TERT from medaka (md) fish and 
zebrafish (z) were assembled with medaka TR (mdTR) and zebrafish TR (zTR) with 
different combinations and assayed for activity as indicated on top of the gel.  
 
 
 
 
 
 
Fig. S5.8 SDS-PAGE analysis of 35S Methionine labeled fish TERTs. Zebrafish TERT 
(1098 a.a.) migrates faster than medaka TERT (1091 a.a.) and Fugu TERT (1075 a.a.). 
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Fig. S5.9 Fish telomerase assembled using full length TR is more active than telomerase 
assembled with pseudoknot and CR4-CR5 domains separated. The TR concentration 
used to assemble fish telomerase was 200 nM. The combinations of TR fragments are 
labeled as the following. FL: full length. mo+45: two TR pieces with pseudoknot domain 
and CR4-CR5 domain separated. mo-45: one TR piece from pseudoknot to CR4-CR5 
domain. 45-sca: one TR piece including CR4-CR5 domain and scaRNA domain. mo+ 
45-sca: two TR pieces with one pseudoknot domain and one including CR4-CR5 and 
scaRNA domain. 
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a. P3 and J2b/3 swapping between medaka TR and fugu TR pseudoknot domains. 
 
 
 
Fig. S5.10 b. Activity assay of fish telomerase with pseudoknots containing P3 and J2b/3 
swapped between medaka TR (purple) and fugu (green). Pseudoknot fragments used (md, 
fugu-md, fugu, md-fugu1 and md-fugu2) are depicted on the upper panel. 
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Fig. S5.11 Effective J2a/3 linker length on medaka TR pseudoknot domain. Medaka TR 
pseudoknot domain J2a/3 linker is shorten to various lengths as indicated on the left 
panel. J2a/3 mutant pseudoknots are assembled with mdTERT and CR4-CR5 domain to 
reconstitute telomerase and assayed for activity (right panel). 
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